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Name: Sarah Hannah Ellwood 
Title: Testing the gliocentric hypothesis of brain pathology. 
Ischaemic stroke is a leading cause of death and disability worldwide, causing 
cell death and tissue damage. All cell types are affected by ischaemia, however 
until recently, the impact of acute ischaemia has been studied from a neuronal 
point of view. Currently, there is a greater interest in glial cells such as 
astrocytes and oligodendrocytes as they are essential for the correct working of 
the central nervous system (CNS). This thesis aimed to investigate the regional 
sensitivity of the glial cells and the mechanisms behind any regional differences. 
Three mechanistic areas were chosen to be examined; the role of glycogen 
stores, cytotoxic ion influx through glutamate receptors and the involvement of 
sodium and cell swelling. 
Investigation into glial sensitivity was carried out via live imaging of brain slice 
and optic nerve preparations from transgenic mice which specifically expressed 
GFP in either astrocytes or oligodendrocytes. Ischaemia was modelled using 
oxygen glucose deprivation (OGD). It was determined that astrocytes display 
regional differences in sensitivity to ischaemic insult. The most sensitive region 
was the dentate gyrus (DG), and corpus callosum (CC) was the least sensitive. 
Mature oligodendrocyte somas were found to be tolerant to acute ischaemia.  
Mechanistic investigation revealed that the presence and access to glycogen 
prevented and attenuated OGD induced cell death in CC. It was found that 
astrocyte injury may be mediated by AMPA receptors. OGD induced astrocyte 
cell death was found to be sodium dependent in DG but not in CC. The findings 
strongly indicate that astrocyte regional sensitivity to ischaemia exists and that 
there are different OGD induced cell death mechanisms depending upon the 
physical location of the astrocyte population. This provides further information 
about the effect of ischaemia on glial cells and provides targets to be further 
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Historically, brain anatomy and neurological disease have been studied 
from the neuronal point of view. Neurons have had more appeal since they are 
the active output cell of the central nervous system (CNS). However, over the 
last 25 years the important role of glial cells has been recognised and research 
into this area has increased. The CNS contains different glial cell types which 
can be broadly divided into macroglia and microglia. Of the macroglial cells, the 
following work is concerned with astrocytes and oligodendrocytes. When first 
described, these cells were thought to exist only to give shape to the CNS and 
structural support to neuronal cells. This myth has since been dispelled and we 
now know that these cells are essential partners for neurons and are intimately 
involved in all the cellular functions of the CNS. 
1.1.1 Astrocytes overview 
Discovered in 1858 by Rudolf Virchow, astrocytes are known to be the 
most abundant cell type in the CNS. It was not until the 20th century that these 
glial cells became of greater interest and became a more prominent focus of 
research. Astrocytes are a heterogeneous cell population which are classically 
divided into two groups; fibrous and protoplasmic (figure 2.1). Fibrous 
astrocytes are found in white matter (WM), they have a smaller soma and have 
long, branched processes. Protoplasmic astrocytes reside in the grey matter 
(GM) and have shorter processes which are arranged around a larger cell body. 
The protoplasmic astrocyte processes are highly branched with ramified 
morphology. These cells occupy their own non-overlapping micro-domains 
which they monitor and modulate (Halassa et al., 2007; Ogata & Kosaka, 2002). 
4 
 
Protoplasmic astrocytes have the capability of partially wrapping synapses with 
their processes, giving rise to the tripartite synapse (Araque et al., 1999). This 
allows protoplasmic astrocytes to interact and respond to synapses. Fibrous 
astrocytes directly contact and interact with neurons at axonal nodes of Ranvier 
(Butt, Duncan & Berry, 1994; Serwanski, Jukkola & Nishiyama, 2017). It has 
been suggested that this may allow astrocytes to monitor axonal function (Butt 
et al., 1999). Nodes of Ranvier and perinodal processes contain a high 
concentration of sodium channels (Butt, Duncan & Berry, 1994), the clustering 
of which are thought to be encouraged by astrocytes (Black et al., 1989). 
1.1.2 Astrocyte development 
The exact process of astrogenesis and development is unclear, although 
it has been suggested that in rodents astrocytes arise from neural stem cells 
(NSC) in the subventricular zone (SVZ) (Levison & Goldman, 1993). First these 
cells undergo asymmetric division to increase the pool of NSCs within the 
ventricular zone (VZ) (Molofsky & Deneen, 2015). These stem cells gain the 
ability to generate into glial cell precursors during the late gestation and 
perinatal period. At this time there is a molecular switch which causes the NSCs 
to become astrogenic, this occurs around embryonic day 16-18 in the cortex 
(Ge et al., 2012; Hirabayashi & Gotoh, 2005). The regulation and stimulation of 
astrogenesis has been found to involve Sox9. Sox9 can modulate Nuclear 
Factor I-A, which has also been found to be involved in astrogenesis (Deneen et 
al., 2006; Kang et al., 2012). 
The astrogenic NSCs leave the SVZ and migrate throughout the 
developing brain. The migration of astrocytes from their origin can occur along 
the processes of specialized radial glia, which act as a physical guide 
(Jacobsen & Miller, 2003; Zerlin, Levison & Goldman, 1995). Radial glia retain 
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the potential to differentiate into astrocytes, once neurogenesis is complete 
(Levison, de Vellis & Goldman, 2005). Astrocyte precursors can be identified 
through their expression of GLAST (glutamate aspartate transporter) (Shibata et 
al., 1997). It has been shown that astrocytes display subtype patterning and are 
spatially connected to their origin (Tsai et al., 2012). When situated in their final 
position, astrocyte proliferation occurs to populate CNS regions. The majority of 
the increase in cells occurs in the second and third postnatal weeks (Bandeira, 
Lent & Herculano-Houzel, 2009). A proportion of the astrocyte population is due 
to migratory cells, however the majority of cells are generated locally (Ge et al., 
2012). Intermediate astrocytes can then develop into mature fibrous and 
protoplasmic astrocytes dependent upon their final location. In mice structures 
such as the cortex, are only fully developed at the third or fourth week after birth 
(Rusnakova et al., 2013). 
1.1.3 Role of astrocytes in the CNS 
Astrocytes occupy a complex niche within the brain, they are essential for 
the correct working of the CNS and are involved in almost every functional 
aspect of the CNS. They have structural, homeostatic, biochemical, signalling, 
maintenance and protective roles and are involved in CNS development. These 
multiple responsibilities illustrate the importance of astrocytes, how they support 
neurons and how they maintain the cellular environment. The various roles of 
astrocytes are discussed below. 
1.1.3.1 Structural role of astrocytes 
The compact ramified morphology of protoplasmic astrocytes and the 
non-overlapping nature of these cells (Bushong et al., 2002; Ogata & Kosaka, 
2002) creates micro-domains which are controlled by the individual astrocytes. 
This produces the effect of tiling the GM, which gives structure and organisation 
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to the brain (Halassa et al., 2007). Perivascular astrocytes are a population of 
astrocytes which have close associations with blood vessels. These cells are 
involved in forming the structure of the blood brain barrier (BBB). The process 
endfeet contact and wrap around the blood vessels, covering their surface 
(Kacem et al., 1998; Simard et al., 2003). Tight junctions between perivascular 
astrocytes and endothelial cells (Janzer & Raff, 1987), as well as astrocyte 
interactions with pericytes help to form this physical barrier. The presence of 
astrocytes at the BBB and around blood vessels allows them to modulate blood 
flow and the permeability of the BBB through the secretion of vasodilators 
(Gordon, Mulligan & MacVicar, 2007). 
1.1.3.2 Astrocyte control of homoeostasis 
One of the major and perhaps most important functions of astrocytes is 
their role as homeostatic regulators of the extracellular space (ECS). The 
extracellular homeostasis of water, neurotransmitters, ion concentrations (figure 
1.1) and pH is the responsibility of astrocytes. The micro-domains created by 
the arrangement of protoplasmic astrocytes allow the environment surrounding 
an astrocyte to be tightly controlled and monitored (Bushong et al., 2002). 
Astrocytes express aquaporin channels through which the homeostasis 
of water is achieved. Aquaporin 4 is highly expressed on the astrocyte endfeet 
that contact blood vessels (Engelhardt, Patkar & Ogunshola, 2014; Nielsen et 
al., 1997). Through the regulation of water entry and exit from the blood flow, 
astrocytes maintain the volume of the ECS (Yao et al., 2008) and are able to 
regulate synaptic interstitial fluid (Iliff et al., 2012).  
Neurotransmitter homeostasis, clearance and recycling is largely carried 
out by astrocytes, for example glutamate. This occurs via the uptake of 
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neurotransmitter from synapses by high affinity sodium dependent transporters 
and glutamate transporters such as EAAT1 and EAAT2 (Rothstein et al., 1996). 
Glutamate is taken into astrocytes where it is converted into glutamine 
(glutamate precursor) (Deitmer, Bröer & Bröer, 2003), which is released for 
uptake by neurons where it is transformed into active neurotransmitter. 
Astrocytes also have the ability to synthesize glutamine, de novo, which 
neurons are unable to do (Schousboe et al., 2014), thereby supplying neurons 
with neurotransmitter precursor when required. Astrocytes also express 
glutamate receptors, such as NMDA and AMPA glutamate receptors (Bowman 
& Kimelberg, 1984; Burnashev et al., 1992; Seifert & Steinhauser, 2001). The 
binding of glutamate to the receptor causes the receptor pore to open and allow 
ion influx to occur (Clark & Barbour, 1997; Matsui, Jahr & Rubio, 2005). 
However, it is well known that in the case of NMDA receptors the receptor pore 
contains a magnesium ion block which prevents the opening of the pore. The 
magnesium block is voltage sensitive and so is removed when the cell 
depolarizes (Papadia & Hardingham, 2007; Schipke et al., 2001). Neurons 
depolarize more frequently than astrocytes and so it may be that a different 
subunit arrangement is present in astrocyte expressed NMDA receptors 
(Burnashev, 1996; Seifert et al., 1997) which makes the magnesium block more 
easily removed. There is evidence that astrocyte expressed NMDA receptors 
may be magnesium insensitive and lack a magnesium block (Lalo et al., 2006).  
The regulation of extracellular pH and maintenance of ion concentrations 
largely falls to astrocytes (Deitmer & Rose, 1996). This is achieved through a 
variety of exchangers and transporters (figure 1.1), some are active (Deitmer & 
Rose, 1996) whilst others are driven by ionic gradients, such as sodium as there 
is a maintained sodium gradient entering astrocytes. The main transporters 
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involved in this process include; the sodium-hydrogen exchanger (NHE) which 
allows the entry of sodium in exchange for hydrogen (Deitmer & Rose, 1996; 
Kintner et al., 2004). The sodium/calcium exchanger (NCX) can move sodium 
out and calcium into the cell (Kirischuk, Kettenmann & Verkhratsky, 1997; 
Minelli et al., 2007). This is a reversible transporter which will change direction 
depending on ion concentration and membrane potential. The voltage-
insensitive sodium channels (NX) (Rose & Verkhratsky, 2016) allow for sodium 
entry into astrocytes. The sodium-bicarbonate co-transporter (NBC) facilitates 
the entry of sodium and bicarbonate into the cell (Soleimani & Burnham, 2001). 
The sodium-potassium-chloride co-transporter (NKCC1) simultaneously 
transports a sodium ion, a potassium ion and two chloride ions into cells (Plotkin 
et al., 1997). Sodium independent and sodium dependent bicarbonate/chloride 
exchanger (BCX) (Mellergard, Ouyang & Siesjo, 1994), which allow chloride 
entry and bicarbonate efflux. The sodium/potassium ATPase (NKA) is 
predominantly responsible for sodium extrusion (Rose & Verkhratsky, 2016; 
Watts et al., 1991). Ion concentrations are also maintained through the action of 
cation chloride co-transporters such as NKCC1 and the potassium-chloride co-
transporter. The pH is also maintained through proton buffering and 
sequestration (Deitmer & Rose, 1996). 
Astrocytes are important for ECS potassium clearance (Djukic et al., 
2007), via a process known as spatial buffering (Orkand, Nicholls & Kuffler, 
1966). It was determined in salamander retinal Müller cells that extracellular 
potassium increases cause potassium to enter Müller cells (Newman, Frambach 
& Odette, 1984). Newman et al. (1984) discovered the excess potassium almost 
immediately leaves cells via endfoot processes, creating a syphoning effect. 
They suggested that this may be carried out by astrocytes due to the interaction 
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of their process endfeet with blood vessels, thereby syphoning excess 
potassium into cerebrospinal fluid and the blood stream. 
Figure 1.1: Key routes of astrocyte ion movement. Summary of key astrocyte 
ion transporters and channels, the ions transported and direction of transport. 
NCX – Sodium/Calcium exchanger, KCC – Potassium-chloride co-transporter, Nx 
– sodium channel, GluR – glutamate receptor, NBC – sodium/bicarbonate co-
transporter, Na/K ATPase – sodium/potassium ATPase, NHE- sodium/proton 
exchanger, BCX – bicarbonate/chloride co-transporter, NKCC1 – sodium-
potassium-chloride co-transporter. 
1.1.3.3 Astrocyte involvement in axon growth and synaptogenesis 
Astrocytes, their precursors and radial glia are involved in the stimulation 
and direction of neurite outgrowth (Liesi & Silver, 1988; Rakic, 1971). This 
guidance of growing axons occurs through the secretion of factors which either 
promote or inhibit neurite extension (Powell & Geller, 1999) or via cell-cell 
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interactions. Axonal growth can also be directed and inhibited through the 
formation of boundaries by immature astrocytes and radial glia (Laywell & 
Steindler, 1991).  
The major role of astrocytes in synaptogenesis was illustrated by Pfrieger 
et al. (1997), who found that when cultured, neurons had sevenfold fewer 
synapses when grown in the absence of glia (Pfrieger & Barres, 1997). Synapse 
formation occurs through the involvement of astrocytes and the secretion of 
thrombospondins (Christopherson et al., 2005). These were discovered in the 
media of cultured astrocytes and are known to have a role in cell adhesion. 
Hevin, an extracellular matrix protein, is another astrocyte derived factor which 
encourages the formation of excitatory synapses (Kucukdereli et al., 2011). Both 
of these factors promote the structural formation of the synapse. Synapses only 
become mature and active with the release of glypicans from astrocytes (Allen 
et al., 2012). The formation of synapses can also be activated by physical 
contact between astrocytes and neurons and is directed through integrin 
receptors (Hama et al., 2004), which leads to synapse maturation. 
Synaptic morphology is not static and is constantly changing depending 
on need and use. Synapses can be created, altered and eliminated via the 
actions of astrocytes (Slezak, Pfrieger & Soltys, 2006). The plasticity of 
synapses is achieved through the secretion of proteins by astrocytes. For 
example the function of glutamate receptors (GluRs) is affected by SPARC 
(secreted protein acidic and rich in cysteine), which alters the stability of GluRs 
(Jones et al., 2011). 
Synaptic function is also monitored and modulated by astrocytes. Within 
their individual territory it is possible for one astrocyte to contact several 
synapses, in the hippocampus this can be up to 140,000 synapses (Bushong et 
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al., 2002). The interaction of astrocytes with the pre- and post-synaptic terminals 
has been termed the tripartite synapse (Araque et al., 1999). This position 
allows astrocytes to directly respond to synaptic activity and enables the 
clearance of excess neurotransmitter. Synaptic efficacy is modulated by 
astrocytes releasing gliotransmitters, such as ATP (James & Butt, 2002) which 
is secreted via calcium dependent exocytosis (Pangrsic et al., 2007). In the 
adult CNS a proportion of hippocampal astrocytes retain their ability to trigger 
neurogenesis in the developed brain and are responsible for the regulation of 
neurogenesis in the adult CNS (Song, Stevens & Gage, 2002).  
1.1.3.4 Astrocyte involvement in metabolism 
Due to their ensheathment of blood vessels and involvement in the BBB, 
metabolites such as glucose have to pass through astrocytes to get from the 
blood stream to neurons. Glucose can be retained by astrocytes, where it is 
converted into glycogen and can be stored. Astrocytes are known to be the 
major glycogen store in the brain (Wender et al., 2000) and so have an 
important role to play in CNS metabolism. 
It has been proposed that in times of hypoglycaemia or elevated neuronal 
activity these glycogen stores are utilized to preserve the function of neurons 
(Brown, Tekkok & Ransom, 2003). It has been suggested that the metabolites 
produced from glycogenolysis can be transported to neurons via the astrocyte-
neuron lactate shuttle hypothesis (ANLS) (Pellerin et al., 1998). This hypothesis 
suggests the export of lactate from astrocytes followed by its movement into 
axons where it is converted into pyruvate and can enter the Krebs cycle (Brown 
& Ransom, 2007; Pellerin et al., 1998). First astrocytic glycogen is converted to 
lactate and exits the cell via monocarboxylate transporters (MCTs), both MCT1 
and MCT4 are expressed by astrocytes (Bergersen et al., 2001; Pierre et al., 
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2000). The lactate is taken up by neuronal MCT2 (monocarboxylate transporter 
2) into axons where it is converted to pyruvate by lactate dehydrogenase 
(Brown, Tekkok & Ransom, 2003). The existence of a lactate gradient between 
astrocytes and neurons further supports the ANLS hypothesis and suggests an 
important role for lactate in the CNS (Machler et al., 2016). The lactate 
produced by astrocytes is not exclusively used by neurons, it has been 
discovered that lactate can be utilized as a metabolite by cultured 
oligodendrocytes, as well as for lipid synthesis (Sanchez-Abarca, Tabernero & 
Medina, 2001). The astrocytic MCTs may not only play a role in releasing 
lactate for neuronal use, but also to release lactate as a signalling molecule 
(Lauritzen et al., 2014). 
1.1.3.5 Astrocyte signalling 
Astrocyte communication with neurons and other astrocytes occurs 
through the use of molecules such as nucleotides and amino acids, collectively 
termed gliotransmitters (Innocenti, Parpura & Haydon, 2000; Wang, Haydon & 
Yeung, 2000). Adenosine triphosphate (ATP) is a major substrate for glial 
communication (Butt, 2011) and causes increases in intracellular levels of 
calcium. Gliotransmitters are used by astrocytes to communicate with other 
astrocytes and cell types. When a signal is detected, astrocytes are able to tailor 
their response, thereby responding in a non-linear manner to stimuli (Perea, Sur 
& Araque, 2014).  
Throughout the CNS astrocytes are coupled creating networks known as 
syncytia. Astrocytes couple via gap junctions which are formed at contact points 
between the fine processes of neighbouring cells, which express hemi-channels 
(Dermietzel et al., 1991). Gap junctions are formed from connexins which create 
pores in the cell membrane; the predominant connexin expressed by astrocytes 
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is connexin 43 (Dermietzel et al., 1991). The coupling of hemi-channels from 
different cells forms the gap junction, allowing the transport of ions and 
molecules to occur between cells. These pores allow the movement of 
signalling molecules between astrocytes (Ye et al., 2003), allowing astrocyte 
communication across regions of the CNS through interconnected cells.  
Instead of electrical excitability astrocytes are excited by changes in 
intracellular calcium concentration (Charles et al., 1991). Calcium signalling 
occurs via waves (Cornell-Bell et al., 1990; Dani, Chernjavsky & Smith, 1992; 
Innocenti, Parpura & Haydon, 2000) which utilize the astrocyte syncytium for 
transmission to neighbouring cells. Gap junctions are not just formed between 
astrocytes but are also formed between astrocytes and oligodendrocytes (Tress 
et al., 2012). This allows communication to occur for axon maintenance and the 
transfer of metabolites. 
Recently it has been discovered that astrocytes can use lactate as a 
signalling molecule as well as a metabolite. Lactate can be released in 
response to synaptic activity and glucose utilization due to energy consumption 
of the synapse (Pellerin & Magistretti, 1994). It is known that the release of 
lactate can cause cerebral vasodilation, thereby increasing blood flow. 
Excitatory synapses have been found to express the G-protein coupled receptor 
81(GPR81), which binds lactate, suggesting that lactate can also act as an 
intercellular signalling molecule (Lauritzen et al., 2014). The binding of lactate to 
GPR81 has been found to cause a decrease in cyclic adenosine 
monophosphate (cAMP) which reduces glycolysis (Lauritzen et al., 2014). 
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1.1.4 Astrocyte Response to disease 
When the CNS is injured or diseased, astrocytes respond by undergoing 
a process known as reactive gliosis (Sofroniew, 2009). This is a complex 
process which has not been clearly defined. However, four key features of 
reactive astrocytes have been suggested, 1) reactive gliosis is a spectrum of 
functional and expression changes, 2) these changes vary with the amount of 
damage from the insult, 3) any changes that occur relate to context, 4) during 
reactive gliosis astrocytes can undergo gain and loss of function which can be 
beneficial and damaging to the CNS (Sofroniew, 2009).  
During reactive gliosis there is an up-regulation of GFAP expression 
(Eddleston & Mucke, 1993) which accompanies cell body and process 
hypertrophy (Wilhelmsson et al., 2006). Whilst reactive, astrocytes retain their 
homeostatic functions to protect CNS tissue from further damage. They can 
take up any excess a glutamate (Rothstein et al., 1996), thereby reducing 
excitotoxicity. They produce glutathione which prevents oxidative stress that can 
be caused by free radicals, reactive oxygen species (ROS) and nitric oxide 
(Chen et al., 2001; Shih et al., 2003). Astrocytes can protect neurons from 
ammonia induced cell death, which has been demonstrated in a co-culture 
model (Rao et al., 2005). BBB damage can be repaired though the involvement 
of astrocytes as they form part of its structure, ablation of reactive astrocytes in 
this location resulted in failure of BBB repair (Bush et al., 1999). Reactive 
astrocytes can regain ion balance and reduce oedema due to AQP4 expression 
(Manley et al., 2000). Reactive astrocytes also regulate CNS inflammation 




1.1.5 Oligodendrocytes overview 
Oligodendrocytes are another type of macroglia and they are 
predominantly responsible for the myelination of axons in the CNS. These 
specialized cells are also responsible for the maintenance and survival of axons 
(Morrison, Lee & Rothstein, 2013). This role as a support cell is still being 
determined, but investigation has found that oligodendrocytes may have a 
significant part to play in metabolite transport and supply for axons (Saab, 
Tzvetanova & Nave, 2013). If oligodendrocytes are damaged or injured this can 
negatively affect axons and lead to neuronal injury (Morrison, Lee & Rothstein, 
2013). Oligodendrocytes form networks by coupling to other oligodendrocytes 
and can form gap junction connections with astrocytes. This produces a network 
of glial cells in the WM, similar to the astrocyte syncytia found in the GM (see 
above) (Tress et al., 2012). 
1.1.6 Oligodendrocyte development 
After neurogenesis, neural precursor cells are affected by a molecular 
switch which triggers the next phase of development, the gliogenic phase. 
Oligodendrocytes arise from oligodendrocyte precursor cells (OPC), this occurs 
in three waves. In mice, the first wave begins at around embryonic day  12.5 (E 
12.5) and completely populates the cortex by E18 (Kessaris et al., 2006). The 
second wave joins the existing cells, all of these OPCs are of ventral origin. 
After E18 the third wave arises from within the postnatal cortex and there is a 
reduction in the cells of ventral origin (Kessaris et al., 2006). Migration of OPCs 
from their origin to their destined region is directed by growth factors and 
chemokines. When in their final position most OPCs differentiate into 
oligodendrocytes, whilst a subset remain as OPCs (Bradl & Lassmann, 2010). 
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1.1.7 Role of oligodendrocytes 
Initially it was thought that oligodendrocytes were only responsible for the 
myelination of axons. However, it is becoming apparent that these cells play a 
greater role in the CNS by being involved in the maintenance and support of 
axons. 
1.1.7.1 Myelination 
Prior to myelination, oligodendrocytes must be correctly situated as 
mature cells are unable to move once differentiated. Myelination is the process 
of oligodendrocyte processes wrapping and insulating axon fibres. First the 
axon is contacted and the initial ensheathment of the axon occurs. This is 
followed by the wrapping of the axon fibre and the compaction of the membrane 
(Remahl & Hildebrand, 1982). One oligodendrocyte cell will contact and 
myelinate relatively few axons, approximately 20 – 60 (Chong et al., 2012). The 
myelination of axons does not occur by chance and the axons to be myelinated 
are carefully selected by oligodendrocytes. These cells find axons that have a 
diameter greater than 0.2µm (Bradl & Lassmann, 2010), the desired axonal size 
is enough for myelination to begin. Larger diameter axons are myelinated prior 
to smaller diameter axons (Lee et al., 2012a). Once myelination has been 
triggered it takes relatively few hours to produce the compacted myelin sheath 
(Simons & Nave, 2015).  
Myelination can be triggered by the amount of neuronal differentiation 
which has occurred around the oligodendrocyte (Brinkmann et al., 2008). It has 
also been established in a co-culture model that myelination can occur in a 
neuronal activity independent and dependent manner. The type of myelination 
is modulated by neuroregulin which can stimulate myelination through the action 
of NMDA receptors on oligodendrocyte precursors, which triggers the cells to 
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differentiate into myelinating oligodendrocytes (Lundgaard et al., 2013). The 
effect of neuronal activity has been further investigated in brain slices and has 
found that the pattern of activity can elicit different responses from OPCs and 
can effect proliferation and differentiation of these cells (Nagy et al., 2017). 
1.1.7.2 Metabolism 
Recently it has been discovered that oligodendrocytes have a wider role to 
play in the CNS than just the myelination of axons. Evidence has been found 
that suggests they are involved in axonal metabolism. Due to their close position 
with neuronal axons, oligodendrocytes are able to communicate with axons and 
can respond to axonal signals. Axons project far away from their cell body and 
those which are myelinated are insulated from contact with the extracellular 
space by their myelin sheath (Simons & Nave, 2015). Therefore, 
oligodendrocytes are in a more beneficial position to respond to axonal needs 
than the cell body itself and are able to transport metabolites directly to the 
axon. It is possible that oligodendrocytes may provide an extra step in the ANLS 
hypothesis since they express MCT1 which is able to export lactate (Lee et al., 
2012b). It has been suggested that lactate is shuttled from astrocytes to 
oligodendrocytes before it reaches its final destination in neurons, or that lactate 
may be directly transported from oligodendrocytes to neurons, in response to 




1.2 ISCHAEMIC STROKE 
Stroke is the second leading cause of death in the world and causes 6.7 
million deaths per year, accounting for approximately 12% of deaths worldwide 
(WHO, 2014). Strokes are most likely to occur during the perinatal period and in 
the elderly (Fernandez-Lopez et al., 2014). Perinatal stroke has an incidence of 
approximately 1 in 4000 (Lynch & Nelson, 2001). Over the age of 75, one in five 
men and one in six women will have had a stroke, which is responsible for 1 
in14 deaths (Stroke.org.uk, 2016). The main risk factor for ischaemic stroke is 
age and the chance of suffering a stroke doubles every decade after the age of 
55 (Stroke.org.uk, 2016). There are many other well-known contributing factors 
that can increase the risk of stroke such as high blood pressure, diabetes, atrial 
fibrillation, high cholesterol, smoking and excessive alcohol consumption. 
Ischaemic stroke usually occurs in the GM but insults can occur in WM, 
which result in lacunae infarcts (Fern, Matute & Stys, 2014). Infarcts that arise 
from GM insults are not restricted to this region and have the propensity to 
affect WM tracts as well. Therefore it is important to examine how all areas of 
the brain and all cell types are affected by ischaemic stoke. Cerebral ischaemic 
insults can occur in a global or focal manner. Global cerebral ischaemia is 
caused when the whole brain is starved of glucose and oxygen which is usually 
caused by other events such as cardiac arrest. Focal ischaemia occurs when 
cerebral blood supply is locally reduced to tissues and is usually caused by the 
obstruction of blood vessels by a clot or embolism (figure 1.1). Focal insults 
account for the majority of ischaemic stroke, which is approximately 85% of all 
strokes (Parpura et al., 2017). The remaining 15% include haemorrhagic stroke 




Figure 1.2 Schematic illustration of ischaemic infarct. The obstruction of the 
blood vessel prevents adequate blood flow causing the ischaemic lesion, which 
is formed of an ischaemic core where there is no blood flow and the penumbra 
where collateral blood flow may be retained. The glial scar forms around the 
ischaemic core to prevent damage to the penumbra. 
The primary effect of cerebral ischaemic stroke is the withdrawal of the 
blood supply from a region of the brain due to a blood vessel occlusion. This 
deprives the affected area of oxygen and glucose, which are necessary for 
tissue to survive, causing the development of an ischaemic lesion (figure 1.2). 
The absence of the blood supply causes major disruption of homeostatic 
mechanisms, which in turn cause secondary insults such as oedema. Primary 
and secondary insults both contribute to the cell death and necrosis of tissues 
which is responsible for the injury seen in stroke patients. Different regions of 
the brain will be affected depending upon the location of the occluded blood 
vessel.  
Astrocytes in the ischaemic core and a proportion in the penumbra 
succumb to cell death as opposed to reactive gliosis. Prior to soma loss 
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astrocytes undergo clasmatodendrosis, which is the shedding of their processes 
(Hulse et al., 2001; Salter & Fern, 2008) and indicates that astrocytes are 
entering the cell death phase. Astrocyte cell death triggered by ischaemia 
occurs via apoptosis or necrosis, these pathways can occur simultaneously as a 
result of this injury (Cao et al., 2010). Apoptosis occurs at the beginning of the 
insult but it is an energy intensive process and so ceases when the energy 
supply is depleted (Cao et al., 2010). At this point necrosis becomes the 
predominant astrocyte cell death pathway. Necrosis is a spontaneous, un-
programmed event which is ATP independent and thought to be mediated by 
calpains (Liu, Van Vleet & Schnellmann, 2004). Astrocyte cell death also occurs 
through cell swelling, an early response to ischaemic insult which is caused by 
the disruption of ion homeostasis (Gurer et al., 2009). Cells which are severely 
swollen can lose membrane integrity and rupture thus dying due to bursting 
(Gurer et al., 2009). There is evidence to suggest that as a result of ischaemic 
insult astrocyte cell death precedes neuronal death (Liu et al., 1999). If astrocyte 
cell death can be understood and prevented, then neuronal cell death may be 
attenuated. 
A great amount of damage is initially caused by the insult and 
subsequent development of the ischaemic lesion. Further damage is caused by 
reperfusion, when oxygenated blood returns to the area affected by stroke. The 
re-introduction of oxygen causes the production of free radicals and reactive 
oxygen species (ROS) (Lee et al., 2000). These provide mechanisms of 
secondary injury which increase the amount of damage, by expanding the size 
of the initial infarct into previously uninjured tissue (Minnerup et al., 2012). 
Regardless of age, the hallmarks and potential results of ischaemia 
remain the same. There is the formation of an ischaemic lesion, consisting of an 
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ischemic core with a surrounding penumbra (Verkhratsky & Parpura, 2015). In 
the ischaemic core cell death is very high, as there is complete depletion of 
oxygen and glucose here. In the penumbra a proportion of cells are able to 
survive as this area is not completely deprived of blood flow by the insult and 
may be served by collateral vessels. The widespread tissue damage that occurs 
from ischaemic stroke can result in motor and memory deficits in patients and 
may even cause the development of some forms of dementia (Stroke.org.uk, 
2016). Focal cerebral stroke can result in a variety of disabilities, many of which 
will have a major effect on patient life. When a hypoxic-ischaemic event occurs 
at birth, this can result in white matter injury which causes hemiplegic cerebral 
palsy, behavioural changes and many other conditions (Stroke.org.uk, 2016). 
1.2.1 Current treatment strategies for ischaemic stroke 
The available treatments administered for ischaemic stroke are few and 
have changed very little since the discovery of thrombolytic agents. Current 
treatments for stroke are limited, as the cause cannot be readily accessed. 
Preventative or prophylactic treatments would be difficult to administer as it 
cannot be predicted when a stroke will occur. Thrombolysis is the major 
treatment used to break down the clot and is achieved through the 
administration of tissue-plasminogen activator (tPA) (National Institute of 
Neurological & Stroke rt, 1995), the thrombus may also be surgically removed. 
The tPAs are serine proteases that cleave plasminogen to produce its active 
plasmin form, which then break down fibrin (Christophe et al., 2017) thus 
destroying the clot. Thrombolytic treatment, in the form of tPA, can only be 
administered up to 4.5 hours after stroke onset. However, the quicker treatment 
can be received, the faster the blood supply can be re-established which 
provides a better outcome for the patient (Stroke.org.uk, 2016). In some cases 
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thrombolytic agents and surgery can be used in tandem to improve patient 
outcome (Berkhemer et al., 2015). 
After the initial treatment to remove the occlusion patients are then 
administered a variety of drug therapies to combat the resulting symptoms of 
ischaemic insult. For example, reducing pressure caused by oedema resulting 
from ischaemia. In some cases external cerebrospinal fluid (CSF) drainage is 
required to reduce the intracranial pressure (Kahle et al., 2009). In severe 
cases, partial skull removal may be carried out in order to reduce overall 
cerebral pressure. 
Recently, the reduction of cerebral temperature in improving outcome 
after ischaemic injury has been investigated. The use of hypothermia has been 
introduced and has been found to reduce damage from hypoxic brain injury 
caused by cardiac arrest (Hypothermia after Cardiac Arrest Study, 2002; Wu & 
Grotta, 2013). There are different cooling techniques that can be employed such 
as surface cooling or endovascular cooling (Vaity, Al-Subaie & Cecconi, 2015). 
There was a promising study carried out in rats where reducing brain 
temperature to 33°C caused a decrease in glutamate release (Busto et al., 
1989). Excess glutamate release and over-activation of GluRs is an important 
mechanism of neuronal cell death due to ischaemia, via a process termed 
excitotoxicity (Lucas & Newhouse, 1957; Pulsinelli, Sarokin & Buchan, 1993). 
Evidence from a number of studies suggests that endovascular cooling is the 
most effective method of achieving hypothermia and is most successful when 
combined with shivering suppression, shivering is a side effect of the reduced 
body temperature. This treatment has the potential to reduce damage in all cell 
types affected by ischaemia. 
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1.2.2 Future therapeutic strategies 
The current treatments for stroke are few and have their limits in respect 
of the neurological functional outcome and time restrictions on administration. 
Thus, research is being carried out into areas beyond thrombolytic drugs. The 
main interests of current investigation include neuroprotection and reducing the 
size of infarct, in order to rescue more neurons. However, neurons are not the 
only cell type in the brain to be affected by ischaemia. Ischaemic insults affect 
all cell types including glial cells, which have many important roles in the CNS. 
These cells also need to be protected in the event of injury. 
Many neuroprotective agents have provided positive results in a laboratory 
setting, both in cultured cells and in animal models. However, these compounds 
have failed to translate beneficial outcomes when it comes to patients in clinical 
trials (O'Collins et al., 2006), in some cases they were found to be detrimental to 
stroke recovery. Ischaemia triggers a large biochemical cascade, which 
provides many options to potentially target. If these can be targeted as well as 




1.3 ROLE OF GLIA IN ISCHAEMIA 
It was previously mentioned that the majority of work investigating the 
cellular effects of ischaemia has focussed on neuronal response to injury and 
neuronal death. The important roles that glial cells have suggests that damage 
to these supporting cells will have an effect on neuronal response and sensitivity 
to ischaemia. Thereby linking neuronal survival to the surrounding astrocytes 
and oligodendrocytes. 
1.3.1 Astrocyte response to ischaemic insult 
During ischaemic insults one of the main cell types to respond are 
astrocytes, which become reactive and proliferate, a process termed 
astrogliosis. This complex process produces reactive astrocytes which arise 
from the existing population, these form a glial scar around the injury site 
(Faulkner et al., 2004). This is a physical and biochemical barrier that prevents 
the migration of inflammatory and potentially infectious cells and factors from 
the infarct area to healthy tissue (Faulkner et al., 2004; Voskuhl et al., 2009). 
The formation of the scar also restricts the size of the infarct, containing the 
damaged tissue (Barreto et al., 2011; Hayakawa et al., 2010). The astrocytes 
which become reactive are from the surviving penumbral astrocytes, by doing 
so they enable the protection of unaffected tissue and promote tissue 
regeneration after damage (Takano et al., 2009). The hallmarks of glial 
activation are the upregulation of glial fibrillary acidic protein (GFAP), 
hypertrophy of cells and cell proliferation (Wilhelmsson et al., 2006).  
Whilst astrocytes are reactive they release molecules to try to prevent 
damage and repair the CNS, including neuroprotective factors and those which 
control blood flow (Barres, 2008). However, the phenomenon of reactive gliosis 
has the potential to harm the CNS as much as it protects it. A number of the 
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factors released by reactive astrocytes have harmful effects on the CNS, such 
as chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon 
extension and so can prevent axonal growth and regeneration after neuronal 
damage (Liu & Chopp, 2015). The downregulation of glutamate transporters as 
a result of injury contributes to the damage of surviving neurons (Allaman, 
Belanger & Magistretti, 2011). The lack of transporters allows extracellular 
glutamate to accumulate and so excitotoxicity can develop, which causes 
cytotoxic influx of calcium ions into neurons (Pulsinelli, Sarokin & Buchan, 
1993). 
The effects of ischaemic insult can cause irreversible cellular damage 
which leads to cell death (summarised in figure 1.3). Ischaemia induced 
astrocyte cell death occurs firstly via apoptosis which is the process of 
programmed cell death. During ischaemia the mitochondria intracellular calcium 
concentration can increase which causes membrane depolarisation and the 
release of cytochrome C (Sekerdag, Solaroglu & Gursoy-Ozdemir, 2018). This 
release causes the activation of caspases which leads to cell death. ER stress 
or the release of pro-apoptotic protein into the cytosol triggers the caspase 
cascade, which initiates apoptosis (Aoyama et al., 2005). This mechanism of 
cell death also occurs in penumbral astrocytes where collateral blood supply 
remains (Astrup, Siesjö & Symon, 1981). 
The lack of glucose and oxygen delivery to cells causes a switch in cell 
death programme as no energy can be produced to sustain apoptosis. Astrocyte 
cell death then occurs via necrosis (Gurer et al., 2009; Lukaszevicz et al., 2002), 
which accounts for the majority of astrocyte death, especially within the 
ischaemic infarct core. Necrosis can be triggered via many pathways. The 
prominent triggers of necrotic cell death include cell swelling, cytotoxic ion 
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influx, acidosis due to pH change and possibly an inability to utilize glycogen 
stores. 
Necrotic cell death can be characterised by the loss of cell membrane 
integrity, cytoplasm vacuolation, loss of cell contents, and inflammation (Edinger 
& Thompson, 2004). In some cases the involvement of calpains are required for 
necrotic cell death to occur (Liu, Van Vleet & Schnellmann, 2004). Ischaemia 
induced astrocyte death can involve cytotoxic ion influx, leading to cell death. 
Cell swelling causes cell death by increasing osmotic pressure within the cell 
which strains cell membranes, resulting in rupture (Gurer et al., 2009). 
The mechanism of cell death also depends on the location of cells in 
relation to the injury. Those cells within the infarct core undergo necrotic cell 
death due to the drastic reduction in ATP production. However, those in the 
penumbral region still have a moderate energy supply and so apoptosis may be 





Figure 1.3: Astrocyte cell death mechanisms. Withdrawal of blood flow causes 
two cell death pathways to be triggered, either apoptosis or necrosis. Apoptosis 
occurs predominantly due to cellular distress, mitochondrial dysfunction and 
nitric oxide. Necrotic cell death results from the initial insults and subsequent 
effects of ischaemia such as cytotoxic ion influx, acidosis, lack of access to 




1.3.2 Oligodendrocytes and ischaemic insult 
Oligodendrocytes are naturally vulnerable to injury and insult due to the 
amount of membrane that they support and the metabolic demand they are 
under. They are particularly targeted in ischaemic stroke and periventricular 
leukomalacia, as WM can be just as much affected by ischaemia as GM is 
(Dewar, Underhill & Goldberg, 2003). Damage to oligodendrocytes can cause 
demyelination of neurons though loss or injury to myelin, which alters the ability 
of axons to function and may trigger degeneration. In mice without proteolipid 
protein, which is important for myelin formation, it was found that axonal 
swelling and degeneration occurred (Griffiths et al., 1998). This shows that 
disruption to myelin is detrimental to neurons by causing structural changes to 
axons which will affect conduction of action potentials and the survival of 
neurons.  
Oligodendrocytes are accepted as been very vulnerable to ischaemic 
insult. The main mechanism of oligodendrocyte injury and death is excitotoxicity 
(Matute et al., 2002), a susceptibility they share with neurons. Excitotoxicity 
occurs via the over activation of glutamate receptors and the subsequent 
cytotoxic influx of calcium (Matute, Domercq & Sánchez-Gómez, 2006). 
Oligodendrocytes can be severely injured by oxidative stress and mitochondrial 
disruption (Mifsud et al., 2014). These cells are also affected by ATP mediated 
toxicity (Domercq et al., 2010), ischaemia triggers the release of ATP from other 
cells, such as astrocytes, causing the over-activation of purine receptors which 
contributes to cytotoxic calcium influx. Both oligodendrocyte processes and 
somas are vulnerable to ischaemic insult (Salter & Fern, 2005). Damage may 
occur to myelin processes, whilst the cell soma remains intact, however process 
loss usually occurs prior to cell death (McIver et al., 2010), similar to astrocytes. 
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1.4 AIMS AND OBJECTIVES OF THIS THESIS 
The aims and objectives of this body of work are: 1) determine whether 
regional sensitivity to acute ischaemic insult exists in adult astrocytes in situ. 
The hypothesis being that regional differences in ischaemia induced astrocyte 
cell death exist. 2) Investigate the mechanistic reasons behind any observed 
differences in astrocyte sensitivity to ischaemia. The second objective is split 
into three aims guided by previous work and evidence from the literature. These 
are; the role of astrocytic glycogen during ischaemia, the involvement of 
glutamate receptors in cytotoxic ion influx and sodium mediated astrocyte cell 
death via cell swelling (All mechanisms will be discussed further in relevant 
chapters). 
1.4.1 Glycogen in OGD induced glial cell death (chapter 4) 
Glycogen is utilized for many different processes throughout the CNS. 
Astrocytes are the major glycogen store in the brain and as such may be able to 
access this store in times of injury or insult to enable survival. The presence of 
glycogen stores has been determined to confer tolerance of ischaemic insult to 
astrocytes in optic nerve (Fern, 2015). The breakdown of glycogen results in 
lactate which can be exported and used as a metabolite by other cells such as 
neurons (Pellerin et al., 1998). It has been found that lactate is critical for 
neuronal energy and for axonal function (Lee et al., 2012b). We hypothesize 
that the presence of glycogen is required for astrocyte survival during ischaemic 
conditions. 
1.4.2 Glutamate receptors and glial ischaemic injury (chapter 5) 
The over-activation of glutamate receptors resulting in cytotoxic calcium 
influx is caused by ischaemia and is the predominant mechanism of neuronal 
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cell death (Coyle et al., 1981; Lucas & Newhouse, 1957; Pulsinelli, Sarokin & 
Buchan, 1993). It is well known that astrocytes are resistant to excitotoxicity and 
so another mechanism is responsible for astrocyte ischaemic death. Astrocytes 
do express glutamate receptors, which have been found to be permeable to a 
variety of cations including sodium and potassium (Burnashev et al., 1992; 
Matthias et al., 2003). Therefore it is possible that adult astrocyte cell death 
occurs through the cytotoxic influx of a different ion. We hypothesize that 
glutamate receptors are involved in ischaemia induced astrocyte cell death. 
1.4.3 Role of sodium influx on astrocyte swelling and death (chapter 
6) 
Ischaemic insults disrupt the ionic gradients which exist between the 
ECS and astrocytes. This dysregulation can result in ion influx followed by 
water, causing cell swelling. The increase in astrocyte volume strains the cell 
membrane leading to membrane rupture and cell death (Gurer et al., 2009). Cell 
swelling and subsequent bursting is a major mechanism of ischaemic astrocyte 
cell death. It has been suggested that astrocyte cell swelling is mediated by 
sodium influx (Thomas et al., 2004). Many transporters have been implicated in 
this mechanism of cell death, most notably the sodium-potassium-chloride co-
transporter 1 (NKCC1) (Chen & Sun, 2005; Thomas et al., 2004). Here we 
hypothesize that cytotoxic sodium influx plays a significant role in ischaemia 
induced astrocyte cell death. 
Ischaemic injury is a complex event which causes a variety of effects on all 
CNS cell types. The mechanisms responsible astrocyte cell death are not fully 
understood and may depend on the physical location of astrocyte populations. 
Investigation into these mechanisms will provide further information about the 
effects of ischaemia on astrocytes and the sensitivity of astrocytes to insult. The 
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elucidation of these mechanisms may provide a suitable candidate which can 
be used to develop therapies to rescue surviving cells after stroke or even 















2 MATERIALS AND METHODS  
2.1 TRANSGENIC MOUSE MODELS 
Throughout this work two transgenic mouse lines were maintained and 
used for experimentation these were GFAP-GFP mice for the study of 
astrocytes and PLP-GFP which were for the study of oligodendrocytes. Below is 
further information about these mice and how the two colonies were maintained. 
 
2.1.1 GFAP-GFP mice 
All astrocyte work was carried out using FVB/N-Tg(GFAPGFP) 14Mes/J 
transgenic mice. These mice have the hGFP-S65T form of EGFP, the 
expression of which is controlled by the human astrocyte specific, glial fibrillary 
acidic protein (GFAP) promoter (Zhuo et al., 1997). This enables the expression 
of GFP to be achieved in astrocytes to allow easy detection and visualisation of 
this cell type. GFAP is an essential intermediate filament protein found in 
astrocytes, which has an important role in the cytoskeleton and maintaining cell 
structure (Middeldorp & Hol, 2011). The fluorescent cells can be seen when the 
GFP is excited at 470nm, with emission detected at 535nm. 
2.1.2 PLP-GFP mice 
Through the work on astrocytes, it became apparent that glial cells may 
be more affected by ischaemic insult than previously realised. Therefore, the 
sensitivity of oligodendrocytes to ischaemic insult was also investigated. For this 
work a different transgenic mouse line was used; PLP-GFP. In this model EGFP 
is ligated to the myelin proteolipid protein (PLP) promoter regulatory elements 
and the 3’ untranslated region (UTR) of the PLP gene (Mallon et al., 2002). This 
allows for the specific expression of fluorescent protein in oligodendrocytes. 
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PLP is a protein unique to oligodendrocytes and is the most abundant protein 
found in myelin (Mobius et al., 2008). It has been found that PLP promoter 
activity is restricted to mature oligodendrocytes by P28 in the CNS (Michalski et 
al., 2011), during development this promoter is active in many cell types, 
including some which are outside of the oligodendrocyte lineage. The excitation 




2.1.3 PCR Genotyping and agarose gel electrophoresis 
Both mouse lines were maintained as heterozygous for the presence of 
the GFP gene and so for breeding purposes genotyping was required. This was 
achieved via polymerase chain reaction (PCR) in conjunction with agarose gel 
electrophoresis. The DNA to be tested was extracted from ear notch samples 
which were acquired exclusively for the purposes of genotyping.  
PCR is the method of amplifying a region of DNA containing a gene of 
interest to see whether the gene is present within a chosen sample. Through 
cycles of heating and cooling the DNA strands separate allowing access by 
primers, re-annealing can then occur allowing the copying of the target region. 
Many cycles of this results in the target region being amplified which is then 
present in the PCR product. The PCR products are separated out from other 
DNA fragments via size with agarose gel electrophoresis.  
2.1.3.1 Experimental Protocol 
DNA extraction was carried out using the hotSHOT method which is 
outlined below (Truett et al., 2000). This method uses two solutions for the DNA 
extraction which are: an alkaline lysis reagent containing NaOH 25mM, 
disodium EDTA (dissolved in H2O) 0.2mM and a neutralising reagent Tris-HCL 
40mM. 
Single ear notches were placed in 0.5ml eppendorf tubes and 75µl 
alkaline lysis reagent was added. The samples were then heated at 95°C for 1.5 
hours in a thermal cycler (MJ research PTC-100). These were then cooled to 
4°C and 75µl of neutralising reagent was added and gently mixed. 
The PCR master mix was then made for the required number of samples. 
PCR mix for one sample contained: 18.9µl ddH20, 2.5µL Dream Taq buffer 
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(Thermo Scientific), 0.15µl dNTP (Invitrogen), 0.15µl forward primer, 0.15µl 
reverse primer (primer sequence 5’-GCGGATCTTGAAGTTCACCTTGATGCC, 
both primers Sigma Aldrich) and 0.15µl Dream Taq polymerase (Thermo 
Scientific). For each sample 3µl of extracted DNA was added to 22µl of PCR 
mix added to give a total volume of 25µl. The samples were then mixed, 
centrifuged and where placed in the PCR machine and the cycle was started 
(BIORAD IQ PCR machine). 
After completion of the PCR cycles, 4.2µl of 6x loading dye (Thermo 
Scientific) was added to each sample. Next, 12.5µl of the sample was taken to 
run on a 1% agarose gel in 1xTBE buffer (10 x TBE Invitrogen, Tris 1M, Boric 
Acid 0.9M, EDTA 0.01M). The agarose gel contained 2µl of gel red (Biotium) per 
50ml gel, this was used instead of ethidium bromide, so that the DNA bands can 
be visualised. The gel was run for one hour at 130v and then imaged using a UV 
gel imager.   
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2.2 LIVE IMAGING OF OPTIC NERVES AND BRAIN SLICES  
To assess the regional sensitivity to ischaemia, a live imaging technique 
has been developed by the lab. This technique allows acute cell death caused 
by ischaemic conditions to be observed and recorded in real time, in live tissue 
preparations, either brain slices or optic nerve. Throughout this thesis the model 
of ischemia used is oxygen-glucose deprivation (OGD), during which glucose 
containing aCSF and oxygen are switched simultaneously and are replaced by 
sucrose containing aCSF and nitrogen, respectively. 
2.2.1 Artificial cerebrospinal fluids (aCSF) and cutting solution 
Below are all solutions used throughout this work for predominantly the 
live imaging. All chemicals used were obtained from Sigma Aldrich unless 
otherwise stated. 
All aCSFs and cutting solutions were checked to ensure they had an 
osmolarity between 300 and 310 mOsm using a Wescor vapour pressure 
osmometer and were adjusted if required. The control solutions and cutting 
solutions were bubbled with 95% O2/5% CO2 for one hour prior to use and 
continued to be bubbled throughout experiments. The OGD solutions were 
bubbled in the same manner but with 95% N2/5% CO2.  
aCSF and glucose free aCSF (OGD aCSF) 
aCSF was made up to one litre with deionised water and then was split to 
form the normal and OGD solutions. The following was present at these 
concentrations; NaCl 126mM; KCl 4mM; MgSO4 2mM; Ca2+(gluconate) 2mM; 
NaHCO3 25mM; NaH2PO4 2mM; Na+ cyclamate 2mM. At this point solutions 




Zero sodium aCSF  
This aCSF was used as a non-selective method to prevent the function of 
sodium transporters. The following was present at these concentrations; NMDG 
chloride 128mM; KCl 2mM; MgSO4 2mM; Ca2+ (gluconate) 2mM; Choline-HCO3 
25mM; KH2PO4 and either 10 mM glucose or sucrose. 
Zero calcium aCSF 
Zero calcium aCSF was used to assess calcium dependent and 
independent astrocyte cell death. The following was present at these 
concentrations; NaCl 126mM; KCl 4mM; MgSO4 2mM; EGTA 0.05 mM, 
NaHCO3 25mM; NaH2PO4 2mM; Na+ cyclamate 2mM and glucose or sucrose at 
10mM. 
Modified HEPES cutting/holding aCSF 
This cutting solution was used for preparation of brain slices and for 
holding them in a brain slice keeper. For one litre of solution the following was 
present at these concentrations; NaCl 92mM; KCl 2.5mM; NaH2PO4 1.2mM, 
NaHCO3 30mM; HEPES 20mM; Glucose 25mM; sodium ascorbate 5mM, 
thiourea 2mM, sodium pyruvate 3mM, MgSO4.7H2O 2mM and CaCl2.2H2O 2mM 
(Ting et al., 2014). Made up to one litre with deionised water and pH adjusted to 
7.3-7.4.  
2.2.2 Optic nerve and brain slice tissue preparations 
All animal procedures adhered to local ethical guidelines and were in 
accordance with British Home Office regulations, I obtained a HO personal 
licence in order to comply with regulations for the use of transgenic animals. For 
work on adult glial cells, mice of age P30 and over were used. For neonatal 
experiments (P10) mice of age P8-P12 were used. Adult mice were sacrificed 
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by schedule 1 via exposure to a rising concentration of carbon dioxide followed 
by exsanguination. Neonatal mice were sacrificed via cervical dislocation 
followed by decapitation. 
Optic Nerves 
The optic nerves (ON) were isolated from the head by first severing the 
nerve behind the eye ball and then removing the brain from the top of the skull 
with the nerves still attached. Brains were placed into cold oxygenated aCSF on 
ice and the ON were then removed at the optic chiasm and placed in ice cold 
oxygenated aCSF. The nerves were then separated by cutting the optic chiasm 
and were returned to ice cold oxygenated aCSF 
Vibratome sectioning hemi-brains  
For all live brain slices, the mice were sacrificed and the brain was 
dissected out as above and placed into oxygenated ice cold cutting/holding 
solution. After one minute, when cool, the brain was then hemi-sected using a 
scalpel and hemi-brains were placed in a mould and embedded in 0.5% low 
melting point agarose and was left to set on ice. The embedded hemi-brains 
were blocked; then the specimen and a support block (made of 4% agarose) 






Figure 2.1: Schematic showing vibratome cutting chamber.  
 
Coronal slices of hemi-brains were cut using a Leica VT1200 S vibratome 
with ordinary razor blades (Wilkinson Sword), in ice cold oxygenated 
cutting/holding aCSF, the temperature was maintained using ice around the 
cutting chamber. Slices were transferred to petri-dishes containing cold 
cutting/holding aCSF on ice, using a cut-off pipette. The cutting angle of the 
blade was set at 15°, which cut at a speed of 0.2 mm/s and 0.95mm amplitude, 
the slices obtained were between 160µm and 200µm thick. This depended on 
the region, as some regions were more delicate than others and so a thicker 
slice was required to keep the region of interest intact. Slicing was carried out 
for a maximum of 20 minutes to ensure the health of the slices obtained. 
After cutting, slices were transferred to a brain slice keeper (BSK, 
Scientific Systems Design Inc.) containing oxygenated cutting/holding aCSF at 
37°C for 30 minutes, temperature was maintained using a water bath. After this 
30 minute recovery period (Ting et al., 2014) the BSK was left to cool to room 
temperature and slices were constantly oxygenated throughout, which 




2.2.3 Live Imaging 
ON 
For live ON recording the nerve was mounted to the bottom of a plexi-
glass perfusion chamber (Warner instruments), secured at each end with 
cyanoacrylate glue (Loctite) (figure 2.2). The perfusion chamber was sealed to a 
22mm x 40mm glass cover slip with vacuum grease (Dow Corning). 
Brain Slices 
For live brain slices, recording occurred in the same chamber as for ON. 
A single brain slice was transferred from the keeper to the perfusion chamber 
using a cut-off Pasteur pipette and was kept in place using a slice anchor 
(Warner instruments).  
 
Figure 2.2: Schematic illustration of the recording chamber 
 
In the chamber slices or nerves were continually perfused with aCSF 
heated to 37°C and were oxygenated, aCSF was removed via a vacuum line. 
The time-lapse recording of live tissue preparations was carried out as follows: 
recording lasted a total of 100 minutes. 0-10 minutes was the control period, 
with sections constantly perfused with aCSF at 1.5 - 2ml/min at 37°C and 
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95%O2/5%CO2 at approximately 0.1LPM. At 10-70 minutes was the OGD 
period, with glucose free aCSF perfusion and 95%N2/5%CO2. 70-100 minutes 
was the reperfusion period where control conditions were restored. When 
changing conditions, the solution and gas were switched simultaneously. The 
recording chamber temperature was maintained at 37°C through the use of 
objective mounted heater. 
Confocal and wide-field images were obtained using Nikon Eclipse 
TE2000-U inverted microscope with x40 oil immersion objective and spinning 
disc confocal unit (X-LIGHT, Crest Optics). The confocal unit was set to a 70µm 
aperture and the excitation of the GFP was achieved with 470nm LED and 
535nm detection. MetaMorph software (version 7.8.9 Molecular Devices LLC, 
Cairn Research) was used to acquire images and run time-lapse image 
acquisition. Images were obtained every 60 seconds with a 2 second exposure. 
Images of 10 second exposure were also acquired for time 0 and time 100. For 
tissue preparations from PLP-GFP mice, the GFP expressed by the 
oligodendrocytes was much brighter than in astrocytes in GFAP-GFP mice and 
so shorter exposures of 50 milliseconds were used along with a lower intensity 
of light to avoid image saturation.  
Mechanism of sensitivity 
To investigate injury mechanisms during OGD, chemical inhibitors were 
added to the aCSFs during the standard experimental protocol. The possible 
mechanisms investigated in this work were cell death due to due to cytotoxic 
sodium influx, the role of astrocyte glycogen stores and the involvement of 
ionotropic glutamate receptors. The chemical inhibitors used were added to 
target particular aspects of the proposed mechanisms, such as transporters and 
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receptors (see table 1) and were applied either throughout the experiment or 
during OGD only. 
Table 1: Drugs employed during OGD experiments 
2.2.4 Analysis of cell death 
The images and time-lapse recordings were analysed off-line using 
Image J software, where cells and cell death events were counted manually. 
During the experiment the tissue can swell and distort, thereby altering the focal 
plane, only cells that were clearly visible throughout the experiment were 
counted. Astrocyte cell death was determined by the visual loss of fluorescence 
due to cell lysis which arises from membrane rupture and the release of 
fluorescent protein (Gurer et al., 2009; Shannon, Salter & Fern, 2007). This 
same criteria was used to judge cell death of oligodendrocytes. Data from 
manual counts was processed and analysed using GraphPad Prism 6. To 
investigate the rates of cell death throughout this work, the time (t) at which cell 
death was half of the maximum was determined. 
2.2.5 Statistical analysis 
Throughout this work to compare the means of two groups the unpaired 
two-tailed T-test was used. This test is used when the populations follow normal 
distribution and it is assumed that the variance is the same for the two 
populations. If the variances differ then the Welch’s T-test is used which 
Drug Source Target Concentrat ion Solvent Added
Bumetanide Sigma-Aldrich NKCC transporter 50µM Ethanol Throughout
Furosemide Sigma-Aldrich CCC transporters 5mM DMSO Throughout
DIOA Abcam KCC transporter 50µM DMSO Throughout
MK801 Tocris NMDA glutamate receptors 10µM DMSO Throughout
NBQX Tocris non-NMDA, AMPA and 




dehydrogenase 2mM H2O OGD only
2 deoxy-glucose Sigma-Aldrich Block glycogenolysis 10µM H2O OGD only
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accounts for unequal variances and does not assume that the two populations 
have the same standard deviation (Motulsky, 2019).  
For multiple comparisons one way ANOVA was used, which compares 
the means of three or more groups. This statistical test was used in conjunction 
with Tukey’s multiple comparison follow up test, which compares every mean 
with every other mean. This test allows for any unequal sample sizes and 
accounts for the scatter of groups (Motulsky, 2019). In all cases a confidence 
interval of 95% was used and significance was set at p<0.05. All graphs show 




2.3 FIXING AND IMMUNO-STAINING OPTIC NERVE AND BRAIN SECTIONS  
Tissue fixation was carried out using 4% paraformaldehyde (PFA) in 
PBS.10x PBS was made up with deionised water and then diluted for use, one 
litre contained 80g NaCl, 2g KCl, 26.8g Na2HPO4 and 2.4g KH2PO4. The pH 
was checked and adjusted to 7.4. For 4% PFA, 20g PFA was added to 450ml 
PBS and heated to 60°C whilst stirring until dissolved, the volume was then 
corrected to 500ml. When cool, the pH was checked and adjusted to 7.4. The 
PFA was then divided into 50ml and 15ml aliquots and stored at -20°. PFA was 
thoroughly defrosted before use. 
2.3.1 ON Fixation 
ON were dissected out into cold aCSF on ice before being transferred to 
4% PFA in PBS for 30 minutes at room temperature. The fixed nerves were first 
rinsed in PBS before been placed in 30% sucrose PBS, which cryoprotected the 
tissue. This was carried out at room temperature until the nerves sank. The 
nerves were then embedded in OCT embedding medium (Thermo scientific) 
and frozen at -80°C.  
2.3.2 Brain fixation 
Brains were dissected out into cold aCSF on ice, and were then 
hemisected (as previously). The hemi-brains were placed in 4% PFA in PBS 
overnight at 4°C. Brain halves were then rinsed in PBS and cryoprotected in 
30% sucrose PBS at 4°C until sinking. The halves were then dried off and 
embedded in OCT embedding medium (Thermo Scientific) and frozen at -80°C. 
2.3.3 Cryosectioning and staining 
The tissue block to be sectioned was removed from - 80°C and was left 
to warm to -20°C for one hour to allow the specimen to acclimatize to the 
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temperature in the cryostat. Optic nerves and brain halves were cryosectioned 
using a Leica CM1860 UV Cryostat at a temperature of around -22°C. Coronal 
sections of 20µm thickness were obtained and were mounted on Superfrost plus 
slides (Thermo Fisher). The sections were outlined using a hydrophobic pen 
(Sigma Aldrich) and washed in PBS for five minutes. The sections were then 
permeabilised and blocked in PBS containing 10% goat serum and 0.5% Triton-
X-100 (PBGST) for two hours at room temperature. The primary antibody was 
diluted in PBGST and was added to the sections until they were well covered 
and incubated overnight at 4°C. After incubation, sections were washed three 
times with PBGST, each wash was for five minutes. The secondary antibody 
was diluted in PBGST and was applied to the sections as for the primary 
antibody. This incubation was for one hour at room temperature. Sections were 
then washed three times with PBGST for five minutes each time, followed by 
four PBS washes for five minutes each. Coverslips were then mounted using 
Citifluor (glycerol PBS Thermo Scientific) or Fluoromount (aqueous mounting 
medium, Sigma).   
2.3.4 Double staining 
For double staining the same protocol was carried out as for single 
staining until the washes after the first primary antibody. After the three, five 
minute washes the second primary antibody, diluted in PBGST, was applied as 
previously and left to incubate for two hours room temperature. The incubation 
was then followed by six, five minute washes with PBGST. Both secondary 
antibodies were diluted in PBGST and were incubated together with the 
sections for one hour at room temperature. The sections then underwent two, 
five minute washes with PBGST followed by four, five minute washes with PBS. 
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Coverslips were then mounted using Citifluor (glycerol PBS solution Thermo 
scientific) or Fluoromount (aqueous mounting medium, Sigma). 
2.3.5 Antibodies 
Other than for glycogen staining described below, the antibodies and the 
concentrations used were; rabbit anti-GFAP (Abcam) 1:500, Rabbit anti-Aldh1l1 
(Abcam) 1:1000, Mouse anti-GFP (Abcam) 1:500. Secondary antibodies used at 
1:1000: Goat anti-rabbit Alexa Fluor 568 (Life Technologies) and goat anti-
mouse Alexa Fluor 488 (Life Technologies). 
2.3.6 Image acquisition and processing 
All immunofluorescence images were obtained using a Leica DM6000 
inverted laser scanning confocal microscope and Leica LAS X software. Images 




2.4 GLYCOGEN STAINING 
2.4.1 Periodic Acid Schiff stain and protocol 
The periodic acid Schiff (PAS) stain allows for the detection of glycogen 
by creating a pink colouration and involves a three step process. The first step 
oxidises any glycogen in the tissue to form aldehyde groups. The second step 
blocks the aldehyde groups which are not attached to glycogen molecules. 
Finally the third step is the reaction with the Schiff’s reagent that reacts with the 
exposed aldehyde groups creating a pink stain showing the presence of 
glycogen in the tissue.  
Following the absence of the blood supply, brain glycogen is quickly 
depleted and so the usual method of tissue fixation could not be used. Instead 
mice were sacrificed via Schedule 1 cervical dislocation and and then 
decapitated heads were immediately placed in liquid nitrogen. When frozen, the 
heads were removed and quickly embedded in OCT and were frozen again at -
80°C. The embedded heads were placed in a -20°C freezer for one hour prior to 
cryosectioning to allow the heads to acclimatize to the temperature in the 
cryostat. Whole heads were then sectioned and 20µm thick coronal sections 
were obtained. The sections were mounted onto Superfrost plus slides (Thermo 
Fisher) and then were fixed with 4% PFA in PBS, 10mM glucose and 0.5% 
periodic acid for one hour at 4°C. After fixing the sections were rinsed with PBS 
and then were used for PAS stain. Fixing was carried out under these conditions 
to try and prevent any loss of glycogen from the fresh frozen sections prior to 
fixing. 
Sections were incubated in 0.5% periodic acid for 10 minutes at room 
temperature which oxidises the sections (Newman, Korol & Gold, 2011). The 
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sections were rinsed in distilled water before been placed in a saturated solution 
of dimedone in distilled water for 30 minutes at 60°C (Gurer et al., 2009). The 
sections were rinsed in distilled water and then were reacted with Schiff’s 
reagent for 30 minutes at room temperature. The slides were then rinsed 
thoroughly in distilled water and further rinsed in tap water. Coverslips were 
mounted using Fluoromount (aqueous mounting medium, Sigma).  
2.4.2 GFAP PAS co-stain 
For co-staining, sections were fixed as described above for PAS staining 
and rinsed in PBS. Sections were then permeabilised and blocked in PBGST for 
two hours at room temperature. The PBGST was removed and sections were 
incubated with mouse anti-GFAP-CY3 conjugated monoclonal antibody 
(Sigma). The antibody was used at 1:400 dilution in PBGST and was incubated 
with sections overnight at 4°C. Sections were then washed in PBGST three 
times for five minutes and then in PBS three times for five minutes. PAS staining 
then proceeded as above. Sections were coverslipped and imaged the same 
day. 
2.4.3 Imaging  
Images were acquired using Nikon eclipse 80i microscope with colour 
and fluorescence cameras and x20 or x40 air objectives. The Cy3 conjugated 
antibody was excited using a TRITC filter set which provides a wavelength 






2.5 GLYCOGEN IMMUNOFLUORESCENCE  
Due to limitations with the PAS stain an alternative method of visualising 
glycogen stores was pursued. Currently, there are no commercially available 
anti-glycogen antibodies and so we were kindly given an aliquot of an anti-
glycogen IgM antibody, developed by Professor Hitoshi Ashida’s group in 
Japan. The IgM antibody ESG1A9 has a high specificity (Nakamura-Tsuruta et 
al., 2012) and has been shown to preferentially bind to higher molecular weight 
natural granules of glycogen (Oe et al., 2016). The binding nature of this 
antibody means that is a useful tool for the quantification of glycogen stores 
within a region of interest (Nakamura-Tsuruta et al., 2012). This IgM antibody 
was used to stain for glycogen in brain slices that had undergone the live 
imaging protocol in control, OGD and 2DOG (2-deoxy glucose) conditions. 
2.5.1 Experimental Protocol 
The live brain slices used for glycogen immunofluorescence (IF) were 
obtained as previously, however for IF 100µM thick slices were used. After 
cutting the slices underwent the 30 minute recovery step (as previously for live 
imaging slice preparation) and then were mounted in the recording chamber, 
although no images were obtained during the following protocol. The recovery 
step was important to replenish astrocyte glycogen stores that may have been 
depleted during dissection. Control slices were put on the rig for the length of 
the live imaging protocol (100 minutes) and were oxygenated and constantly 
perfused with aCSF. After this time period, slices were removed from the 
recording chamber and immediately placed in ice cold 4% PFA PBS for one 
hour at 4°C. For ischaemic conditions and OGD with 2DOG treatment slices 
underwent the live imaging protocol without the reperfusion period, as this may 
allow any surviving cells to replenish their glycogen stores. After 10 minutes of 
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control conditions and 60 minutes of OGD slices were removed from the 
recording chamber and treated as the control slices.  
Once fixed, the free floating slices were washed thoroughly in PBS and 
then were incubated with the anti-glycogen IgM antibody. The antibody was 
diluted, 1:50, in PBS containing 0.1% Triton X-100 and was incubated with the 
slices for 24 hours at 4°C with gentle shaking (Oe et al., 2016). A long 
incubation period was necessary for this antibody due to its nature as an IgM 
and because of the thickness of the sections. 
The slices were then washed in PBS three times for five minutes and 
incubated with goat anti-mouse IgM Alexa-fluor 568 secondary antibody (Life 
Technologies). This was diluted 1:1000 in Triton PBS and was incubated with 
slices for one hour at room temperature, whilst shaking.  
After the incubation slices were washed thoroughly in PBS, then mounted on 
slides and coverslipped using Permafluor mounting medium (Thermo Scientific). 
2.5.2 Imaging and analysis 
Z stack images of the slices were taken using a Leica DM6000 inverted 
laser scanning confocal microscope and Leica LAS X software using x40 oil 
immersion objective. The Z stacks averaged around 30µm with a step size of 
either 0.5µm or 1µm. 
To quantify the presence and location of glycogen, Z stack images were 
analysed using ImageJ software. Stacks were loaded and the colour channels 
(green – GFP in astrocytes, red – glycogen labelled with Alexa-fluor 568 
secondary) were merged and overlaid. The resulting stacks were put through 
the “RG2B localization plugin” (Christopher Philip Mauer 2004) via ImageJ. This 
software tool detects co-localised red and green pixels and converts them to 
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blue, saving the data in the blue channel and allowing the visualisation and 
quantification of glycogen present in astrocytes. 
By drawing regions of interest around whole cells (soma and processes), 
the average pixel intensity (measured from 0 to 255) of the blue co-localisation 
was obtained. Figure 2.3 illustrates the process from the merged image and the 
conversion of the overlapping pixels to blue. The final panel shows a zoomed in 
image of the square depicted in the previous image and shows how the region 
of interest was drawn. Cells that were present in multiple planes were assessed 
for each plane they were present in. Background levels were obtained by taking 
co-localisation readings from planes beyond the cells. These values were then 
subtracted from those taken for glycogen levels to give a final value of co-





Figure 2.3: Measuring co-localisation. Merge - overlaid image green GFP, red 
glycogen. RGB co-localisation – image treated with ImageJ tool, co-localised 
pixels shown in blue. Blue pixels – image generated by the RG2B co-localisation 
tool showing the co-localised pixels. Outline – yellow line drawn around cell 




2.6 COBALT STAIN 
Ionotropic glutamate receptors (iGluRs) are expressed by many cells in 
the CNS including glia (Seifert & Steinhauser, 2001). They are involved in the 
widely accepted mechanism of excitotoxicity that occurs in response to 
ischaemia, which results in cytotoxic calcium influx into neurons and neuronal 
death (Choi, 1987; Lucas & Newhouse, 1957; Pulsinelli, Sarokin & Buchan, 
1993). 
The cobalt stain allows for the visualisation of cells expressing receptors 
that are permeable to cations, such as calcium and sodium. Inhibition of 
glutamate receptors has been found to increase neuronal survival after OGD 
(Nishizawa, 2001). There is also the possibility that glutamate receptors may 
have a role to play in astrocyte response to ischaemic insult. Thus, it was 
necessary to determine whether they were being expressed by cells in our 
tissue preparations.  
This cobalt stain involves stimulating the receptors of interest with an 
agonist (L-glutamate or kainic acid) in the presence of extracellular cobalt which 
then enters the cells through activated receptor pores. This is achieved by 
placing live tissue slices in a series of oxygenated solutions, after which they are 
fixed and treated to enhance the cobalt precipitate. 
2.6.1 Experimental Protocol  
The main solution used was the assay buffer which contained the 
following at these concentrations; NaCl 57.5mM; KCl 5mM, NaHCO3 20mM, 
glucose 12mM; sucrose 139mM; CaCl2 0.75mM and MgCl2 2mM. The assay 
buffer was adjusted to pH 7.4. This buffer was then used as a base to form the 
following staining solutions; the cobalt solution contained 5mM CoCl2 and 
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agonist (L-glutamate) at 100mM; the ammonium sulphide solution contained 
1.2% (NH4)2S and the EDTA solution contained 2mM EDTA and was adjusted 
to pH 7.4. 
For this procedure I used the protocol devised by Aurousseau et al 
(2012) as a guide. Mice were sacrificed and 250µm thick vibratome slices were 
obtained in ice cold cobalt cutting solution. The cutting solution used for the 
cobalt staining was slightly different to that used for the live imaging slices and 
contained the following at these concentrations; NaCl 125mM; KCl 2.5mM; 
NaH2PO4 1.25mM; NaHCO3 28mM; glucose 7mM, sucrose 223mM; sodium 
ascorbate; 0.88mM; sodium pyruvate 3mM; CaCl2 0.3mM and MgCl2 7mM. The 
slices were then allowed to recover in oxygenated cobalt cutting solution in the 
brain slice keeper for 30 minutes at room temperature. For the staining 
procedure all solutions needed to be freshly made (Albuquerque et al., 2001) 
and constantly bubbled with (95%O2/5%CO2) (Aurousseau, Osswald & Bowie, 
2012).  
First the slices were incubated in assay buffer with cobalt chloride and 
agonist (100mM L-glutamate) for 30 minutes. This activated glutamate 
receptors and allowed cobalt entry into cells. The slices were then incubated 
with EDTA assay buffer for five minutes, this step chelated any remaining cobalt 
that had not entered cells. This was followed by a five minute wash in assay 
buffer only. The slices were then transferred to ammonium sulphide assay 
buffer for 10 minutes. This step precipitates the cobalt that has entered cells. 
The slices were then washed in assay buffer twice, for five minutes each time. 
For staining with the use of glutamate antagonists the tissue specimens 
were incubated in assay buffer containing NBQX (20µM) and MK801 (10µM) for 
30 minutes prior to the staining procedure. When investigating the effect of OGD 
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on cobalt uptake into cells, all solutions had glucose removed and were bubbled 
with nitrogen. Glutamate as an agonist was also excluded as during glucose 
deprivation exogenous glutamate can be used as a metabolite by astrocytes 
(Schousboe et al., 2014). The staining procedure for OGD conditions was 
carried out at 37°C as room temperature is protective and cell death would not 
occur. 
For all conditions the cobalt stained slices were then fixed in 4% PFA 
PBS for three hours at 4°C and cryoprotected in 30% sucrose PBS overnight. 
ON were also stained, these were dissected out as for live imaging and were 
allowed to recover for 30 minutes also. The same staining and fixing procedure 
was followed as for the brain slices. 
2.6.2 Sectioning and silver enhancement 
After cryoprotection the slices or nerves were embedded in OCT and 
frozen at -80°C. The tissue was left to thaw to -20°C and then 20µm thick 
cryosections of the slices and nerves were obtained and left to air dry. Silver 
enhancement of the cobalt precipitate then followed, this step develops the stain 
and fixes it so it can be viewed. A sliver enhancer kit was used (Sigma Aldrich), 
which contained solution A (silver nitrate), solution B (12-wolframosilicic acid) 
and sodium thiosulphate. The following protocol was supplied as a technical 
bulletin with the silver enhancer kit. First, immediately before use solutions A 
and B were mixed 1:1, 20µL of this mixture was then added to each section for 
27 minutes. The slides were washed for five minutes in distilled water and then 
were placed in 2.5% sodium thiosulphate solution (3.9g sodium thiosulphate 
pentahydrate in 100ml distilled water) for three minutes to fix the enhanced 
precipitate. The slides were then thoroughly washed before mounting coverslips 
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using 10% glycerol PBS; coverslips were secured in place with clear nail 
varnish. 
2.6.3 Imaging and analysis 
The stained and enhanced sections were imaged using a Nikon eclipse 
80i microscope. The acquired images were processed using ImageJ, where 
cobalt positive cells were manually counted. A minimum of 10 regions of interest 
were counted per tissue region from three animals for each condition. For 















3 GLIAL SENSITIVITY TO ISCHAEMIA 
3.1 INTRODUCTION 
The recent change in focus of ischaemic research from neurons to glia has 
followed the discovery of the vital role that astrocytes play in the maintenance 
and functioning of the CNS. During times of injury and insult, astrocytes are 
pivotal to rescuing CNS function and for recovery. If astrocytes themselves are 
damaged this will have a detrimental effect on the CNS. The impact of astrocyte 
dysfunction on neurons and on the wider CNS is now beginning to be 
investigated. Studies carried out on ischaemic neurons in vitro have found that 
neuronal sensitivity to OGD is increased in the absence of astrocytes (Tanaka 
et al., 1999), suggesting that astrocytes are vital for neuronal survival. 
Astrocyte-neuron calcium signalling is preserved in the penumbra, despite 
ischaemic insult (Choudhury & Ding, 2015), showing the importance of 
astrocyte interaction with neurons post injury.  
3.1.1 Neuronal regional sensitivity 
For many years it has been known that brain regions have different 
sensitivities to ischaemic insult as well as neuronal populations within regions 
showing varying regional vulnerability to ischaemia (Kirino, 1982). It is widely 
accepted that GM is very sensitive to ischaemia and that WM is more resistant 
(Marcoux et al., 1982; Pantoni, Garcia & Gutierrez, 1996). Pulsinelli et al. (1982) 
found specific brain regions in which neurons were very sensitive to injury. They 
determined that the most sensitive neurons were those in the hippocampus, 
cortical neurons were the next sensitive followed by striatal neurons (Pulsinelli, 
Brierley & Plum, 1982). Orders of sensitivity also exist within these regions and 
differences were found between neurons within different cortical layers and 
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hippocampal regions. The model used by Pulsinelli et al. (1982) was global 
ischaemia, achieved via four vessel occlusion, during which the carotid arteries 
were transiently occluded and vertebral arteries were permanently blocked. It 
was found that only 20 minutes of ischaemia was required to observe neuronal 
damage in all of these regions (Pulsinelli, Brierley & Plum, 1982). This suggests 
that only a relatively short period of ischaemia is necessary to cause irreversible 
damage to neurons.  
3.1.2 Astrocyte heterogeneity 
Since the discovery of astrocytes, it has been accepted that there are two 
general groups: fibrous, which are found in the WM, and protoplasmic found in 
GM. The clear morphological differences seen between these two astrocyte 
populations relate to their specialized functions (figure 2.1 and 2.2). WM fibrous 
astrocytes have a smaller cell body and long reaching branched processes. 
Fibrous astrocytes have been found to have minimal branching, with a 
branching frequency of two to three in ON (Butt et al., 1994), and not all 
processes branch at all. The processes of these astrocytes interact with nodes 
of Ranvier by partially encircling the nodes with other processes (Butt, Duncan 
& Berry, 1994; Serwanski, Jukkola & Nishiyama, 2017). They also contact blood 
vessels and project out to the pia where they terminate in the glial limitans. GM 
protoplasmic astrocytes have a central cell soma from which project highly 
branched and ramified processes. These processes are involved in neuronal 
synapses and enable protoplasmic astrocytes to maintain and modulate the 
area immediately surrounding them (Nedergaard, Ransom & Goldman, 2003), 
thus dividing the GM into individual microdomains. 
However, it is has been found that within these groups there may be 
many different subtypes of astrocyte which vary depending upon their location 
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and individual function. Each region of the brain has its own microenvironment 
and so the cells within these regions are unique to that region and will be 
specialized through protein and receptor expression (Thoren et al., 2005).  
Astrocytes are a very heterogeneous population. This heterogeneity 
exists for different cellular aspects such as in morphology, density, expression 
profiles and strength of gap junction coupling. These are discussed below. 
Investigation into astrocyte morphological heterogeneity found that 
differences existed between regions and these differences appeared to define 
structures of the brain (Emsley & Macklis, 2006). The regions that were defined 
corresponded to those seen when structures are determined by neuronal cell 
type. It has also been found that morphological heterogeneity also exists 
between astrocytes within the same brain region (Zhang & Barres, 2010). 
Astrocytes do not only show regional variation in morphology but also in 
cell number. Differences in cell densities have been observed between many 
brain regions and a cell density map of the adult CNS has been produced by 
Emsley and Macklis (2006). They determined that astrocyte density varies 
across CNS regions and sub-regions. The astrocyte density recorded also 
depended upon the labelling method used either GFAP positive cells, GFP 
expressing cells under GFAP promoter or S100β (astrocyte marker). GFAP and 
S100β are not universal astrocyte markers, they both only detect subsets of the 
larger astrocyte population. In some regions the number of cells was similar 
regardless of the labelling method used such as in the substantia nigra pars 
compacta which contained approximately 80 positive cells mm-2 (Emsley & 
Macklis, 2006). Whereas, in regions such as the preoptic nucleus of the 
hypothalamus the density varied from 3-5 positive cells mm-2 with GFAP 
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labelling and GFP, to 15-20 positive cells mm-2 with S100β labelling (Emsley & 
Macklis, 2006). 
The expression profile of specific astrocyte proteins varies between 
astrocytes across the CNS, which was discovered through the analysis of 
microarray data (Bachoo et al., 2004). The variation in expression levels of 
intracellular proteins, membrane receptors and other factors will results in 
subpopulations of astrocytes having functions specialized to region in which 
they are situated and for their specific role. 
A surprising way that astrocytes show heterogeneity is through the 
strength of gap junction connections. The astrocyte syncytium is a major feature 
of the CNS, but this has been found to show variation between subtypes of 
astrocytes. Lee et al. (1994) measured the strength of gap junction coupling via 
the diffusion of Lucifer yellow dye and found that the strength of coupling 
depended on region. The spinal cord showed weak coupling, whereas regions 
such as optic nerve and hippocampus showed strong gap junction interactions 
(Lee et al., 1994). Variation in the strength of gap junctions may affect the ability 
or speed of astrocyte signalling.  
Due to this diversity, distinct populations may also show different 
tolerances to disease and insults such as ischaemia. It is well known that 
neurons have different sensitivities to ischaemia depending upon the region that 
they occupy (Pulsinelli, Brierley & Plum, 1982) and it would be logical to suggest 
that this is also the case for other CNS cell types. 
3.1.3 Astrocyte sensitivity to ischaemia 
Ischaemic insults affect all CNS cell types including astrocytes and 
astrocyte sensitivity to ischaemia has been debated. Any injury to astrocytes will 
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cause structural and functional deterioration to the affected CNS region. The 
majority of which occurs in the ischaemic core (Lukaszevicz et al., 2002), where 
there is a high amount of necrosis. Ischaemia induced structural changes that 
have been observed include the breakdown of the BBB, widespread astrocyte 
cell death, astrocyte swelling and separation of myelin sheets (Pantoni, Garcia 
& Gutierrez, 1996). Breakdown of the BBB is caused through the death and 
swelling of astrocyte endfeet as well as an increase in permeability (Takata et 
al., 2011). The swelling of endfeet causes changes to the basement membrane 
integrity (Kwon et al., 2009), causing BBB disruption. Fragmented DNA in dead 
or dying glial cells was also identified (Petito et al., 1998), showing the effect of 
ischaemia on glia.  
Much of what is known about astrocyte sensitivity has been discovered 
through the study of astrocytes in culture. Although, it has been realised that in 
vitro astrocytes may behave and respond differently to those in vivo (Shannon, 
Salter & Fern, 2007). The in vitro studies that have been carried out do not 
account for the individual environments that are found in different brain regions. 
The physical position of these cells, the surrounding microenvironment and the 
presence of other cells such as neurons, oligodendrocytes and microglia will 
affect how astrocytes react to insults.  
For some time it was believed that astrocytes were very resistant to 
ischaemia and long periods of OGD were required to cause cell death. 
However, it has subsequently been found that astrocytes and neurons vary little 
in their vulnerability to insult (Shannon, Salter & Fern, 2007). It has been 
discovered that in many cases astrocyte cell death may precede neuronal death 
(Liu et al., 1999) and this glial cell death may also impact neuronal survival. 
Work carried out by Xu et al. (2001) used cells from neonatal animals for 
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primary cultures and allowed the cells to mature. They found that after 4 to 6 
hours of OGD, astrocytes from the striatum were the most sensitive to 
ischaemia followed by hippocampal astrocytes and then cortical astrocytes (Xu, 
Sapolsky & Giffard, 2001). They did not examine WM regions and concentrated 
on astrocytes from GM regions. Another study found that hippocampal 
astrocytes cultured from embryos were very sensitive to OGD (Zhao & Flavin, 
2000). Zhao and Flavin (2000), also suggested that astrocyte sensitivity to 
ischaemia may be coupled to neuronal sensitivity, whereby injury or damage to 
one directly affects the other. 
Middle cerebral artery occlusion (MCAO) is one model, which gives a 
better representation of focal ischaemia and a truer depiction of astrocyte 
sensitivity as the cells are in situ. A limitation of this is that not all astrocytes 
experience the same amount of ischaemia as the technique aims to replicate an 
ischaemic lesion and so not all regions are affected. This model has been used 
to try to determine differences in astrocyte sensitivity to ischaemia. Lukaszevicz 
et al. (2002) used MCAO to investigate astrocyte sensitivity in GM and WM 
regions. In this study it is was found that cortical protoplasmic astrocytes were 
remarkably sensitive to ischaemia, with swelling and detrimental changes to 
cells seen within the first hour of ischaemia (Lukaszevicz et al., 2002). 
An earlier group using MCAO in adult rats found visible astrocyte 
swelling in WM after just 30 minutes of ischaemia (Pantoni, Garcia & Gutierrez, 
1996). Astrocyte damage increased as the period of ischaemia increased, after 
six hours of ischaemic conditions, some astrocyte processes had swollen to 
approximately 10µm diameter. This is a severe effect caused by the extended 
period of ischaemia and shows the kind of injury that can be sustained by 
astrocytes. Swelling will impair astrocyte function and if all cell types swell then 
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this will cause physical changes to the tissue. Pantoni et al (1996) found 
alterations in the oligodendrocyte population and concluded that WM is very 
sensitive to ischaemic insult. Here it was also observed that cells may die prior 
to any observation of physical evidence of damage. Changes were also 
observed in the nerve fibres themselves, which could inhibit the transmission of 
action potentials, thus causing further CNS dysfunction (Pantoni, Garcia & 
Gutierrez, 1996). 
A preliminary study carried out by Shannon et al (2007) investigated 
regional differences in astrocyte sensitivity to OGD. For this work neonatal 
animals (postnatal day (P) 10) were used and the regions examined were optic 
nerve and hippocampal brain slices. At this age, it was found that ON astrocytes 
were more sensitive to OGD than the GM astrocytes. The model of ischaemia 
used here ensured that all regions were exposed to the same levels of OGD. 
This gave a more accurate reading of astrocyte sensitivity to ischaemia. The 
study of astrocytes in situ allows different CNS regions to be compared under 
the same conditions. We hypothesize that regional differences in astrocyte 
sensitivity to acute ischaemia exist. Astrocytes are not the only glial cell type 
that are affected by ischaemic insult. Oligodendrocytes also play an important 
role as the myelinating cell of the CNS.  
3.1.4 Oligodendrocyte sensitivity to ischaemia 
It is widely accepted and documented that oligodendrocytes experience 
high sensitivity to ischaemic insult. The literature shows that most 
oligodendrocyte cell death appears to occur during the reperfusion period, 
within three hours of the initial insult (Pantoni, Garcia & Gutierrez, 1996), with 
changes to oligodendrocytes occurring after just 30 minutes of MCAO. Physical 
damage to oligodendrocytes worsened as the length of MCAO was increased, 
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eventually leading to vacuolation of myelin. Widespread oligodendrocyte cell 
death has been achieved within nine hours after a relatively short period of 
ischaemia of just 30 minutes (Mifsud et al., 2014). In most studies, samples of 
oligodendrocyte health are not obtained until many hours after the insult and 
establishment of reperfusion. This would suggest that the vulnerability seen is a 
result of secondary injury sustained during reperfusion of the tissue rather than 
the initial ischaemic insult. 
It is not known whether oligodendrocytes exhibit regional sensitivities to 
ischaemia. However, from the description of oligodendrocytes by Del Rio-
Hortega in 1921 we know that these cells are not homogeneous. He described 
interfascicular cells that are predominantly found in the WM and perineuronal 
cells that can be clearly seen in GM (Bunge, 1968). The perineuronal subtype of 
oligodendroglia are not explicitly connected to a myelin sheath (Ludwin, 1997). 
Ludwin (1997) proposed that these cells may assist with regulation of the 
neuronal microenvironment. The interfascicular oligodendrocytes are the cells 
which are closely associated with the myelin sheath. The appearance of these 
cells is that of a “string of pearls” and it is these cells which are responsible for 
the myelination of WM axons. Through the sequencing of RNA expression of 
ten brain regions, 13 different populations of oligodendrocytes have been 
described (Marques et al., 2016). The heterogeneity that has been found 
suggests that these subpopulations of oligodendrocytes may have different 
roles in the CNS depending upon their location. 
Petito et al. (1998) suggested oligodendrocytes may display regional 
susceptibility to ischaemic insult. They determined that GM oligodendrocytes 
were more sensitive to ischaemic injury than neurons. Although not as diverse 
as astrocytes, oligodendrocytes are a heterogeneous population that have 
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classically been divided into four subtypes (Butt et al., 1994). They have been 
grouped according to their branching pattern and the number of myelin sheaths 
that they support (Butt et al., 1994). This may have some bearing on their 
susceptibility to ischaemic insult. Those cells with more myelin sheaths have a 
greater amount of membrane to support. Thereby increasing the metabolic 
demands upon the cell and making then more susceptible to injury. 
It was decided to investigate oligodendrocytes in the same manner as 
astrocytes to see the effect that our OGD protocol would have on 
oligodendrocyte cell death and to determine whether there would be regional 
sensitivity to ischaemia or whether this is just a phenomenon observed in 
astrocytes. In addition, to explore whether it was acute ischaemic injury which 





3.2 RESULTS: PCR GENOTYPING 
To maintain the health of both transgenic mouse colonies (GFAP-GFP 
and PLP-GFP) mice were genotyped to determine new breeding pairs. The 
DNA used was extracted from ear notch samples, obtained exclusively for 
genotyping. Figure 3.1 shows the typical result obtained for genotyping, the 
bright bands show the presence of the GFP transgene in the sample (black 
arrows) and thus the expression of GFP in the cells of interest. For both lines 
wild-type mice were crossed with heterozygous mice, meaning only half of the 
offspring would have the transgene present. 
There are bands present in all lanes, however it was established that the 
brighter bands were indicative of animals which were positively expressing the 
GFP gene. 
 
Figure 3.1: Representative image of agarose gel. Black arrows show animals 




3.3 RESULTS: GREEN FLUORESCENT PROTEIN (GFP) EXPRESSION IN 
ASTROCYTES 
The transgenic mice used for the following work specifically express GFP 
in astrocytes, under the GFAP promoter. Astrocytes expressing GFP are visible 
during live imaging and in fixed tissue (figure 3.2). Astrocytes seen during live 
imaging are marked with white arrows in the confocal images (figures 3.1A and 
B). The images in the first column are from the corpus callosum (CC), whilst 
those in the second column are from the dentate gyrus (DG)  
First, it was determined whether the observed GFP was expressed in the 
correct cell type. Immunofluorescence staining was carried out on fixed frozen 
brain sections from adult mice (P30 and over) using an antibody against 
aldehyde dehydrogenase (ALDH1L1), which is an alternative marker for 
astrocytes. GFP (green) was observed in cells that morphologically had the 
appearance of astrocytes (figure 3.2C and D). ALDH1L1 (red) was detected in 
astrocyte cell bodies and processes (figure 3.2E and F). GFP expression in 
astrocytes was confirmed with the co-localisation of red and green signals, 
producing an orange colour (yellow arrows figure 3.2G-J). 
Not all of the GFP expressing astrocytes present are positive for 
ALDH1L1; this is as ALDH1L1 is not a universal astrocyte marker and is only 
present in a subset of the astrocyte population. The expressed GFP is present 
in cells which display astrocyte morphology and characteristics such as long 
branched processes. These images also show the difference in the number of 
astrocytes seen in these two regions (CC and DG). In WM there are many more 
astrocytes than in GM, showing the heterogeneous nature of astrocytes that 




Figure 3.2: GFP expression in astrocytes. A + B: GFP expressed under the 
GFAP promoter in astrocytes as seen during live imaging. White arrows show 
representative astrocytes. A, C, E, G + I: CC, B, D, F, H + J: DG. C – J: are 
confocal maximum projections of Z stacks of fixed tissue sections. C + D: GFP 
in green. E + F: ALDH1L1 in red. G + H: merged image, yellow arrows show co-
localisation of the green and red signals. I and J: show the area within boxes in 
images G and H respectively. Scale bars = 20µm.  
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3.4 RESULTS: GLIAL MORPHOLOGY 
Investigation of glial cell sensitivity to acute ischaemic insult and the 
mechanisms behind ischaemic sensitivity were carried out using two transgenic 
mouse lines. These allowed astrocyte and oligodendrocyte cells to be visualised 
through the expression of green fluorescent protein (GFP), which was under the 
control of cell-type specific promoters (see below). Astrocyte and 
oligodendrocyte morphology in white matter (corpus callosum, CC) and grey 
matter (dentate gyrus, DG) in these two transgenic lines can be clearly seen in 
confocal images (figure 3.3 and 3.4) There is a clear difference between the 
long branched processes of the astrocytes and the more organised directed 
processes of the oligodendrocytes. The cell somas of these glial cell types also 
display differences; the oligodendrocyte cell bodies have a more regular shape 
when compared to astrocyte cell bodies and exist closer together often in lines. 
From figure 3.3 and 3.4 it can be seen that there are differences between glial 
cell types located in different regions. For example, astrocytes in the CC are 
arranged differently to those in the DG. The DG cells are further apart and are 
not overlapping as much as those in the CC. A major difference between the 
regions is the cell density. It is apparent that there are many more 






Figure 3.3: Astrocyte and oligodendrocyte morphology. Images show 
differences in cellular morphology between astrocytes and oligodendrocytes. 
Upper panel corpus callosum, lower panel dentate gyrus. The images are Z 
projections of confocal images taken from fixed brain slices (100µm thick). 







Figure 3.4: Glial morphological differences: Zoomed in confocal images of fixed 
brain slices, both are cells in CC. The white arrows depict examples of 
processes. The astrocyte process are far reaching and branched. 
Oligodendrocyte processes are more organised, less branched and show the 
direction of axons. Yellow arrows show cell bodies and how they are differently 
arranged in WM. The astrocyte cell bodies have irregular placement, whilst 





3.5 RESULTS: ASTROCYTE SENSITIVITY TO ISCHAEMIA 
Next, it was determined which populations of astrocytes were most 
sensitive to OGD. Experiments lasted 100 minutes (figure 3.5A), the first 10 
minutes were under control conditions with oxygen and aCSF perfusion. This 
period was followed by 60 minutes of OGD aCSF perfusion with nitrogen and 
the final 30 minutes was reperfusion, where aCSF and oxygen were re-
introduced. The regions selected to be investigated were; corpus callosum 
(CC); optic nerve (ON); external capsule (EC); striatum (STR); hippocampal 
regions CA1 and dentate gyrus (DG); cortex, motor area (CTX (M)) and cortex, 
auditory/sensory (CTX (A/S)) (figure 3.5B). These regions were selected to give 
a variety of white and grey matter regions and to include those with known 
neuronal vulnerability. All regions showed no evidence of cell death under 





Figure 3.5: Experimental design and brain regions examined. A: Time points of 
live imaging protocol, 10 minutes of aCSF with oxygen, followed by 60 minutes 
of OGD with nitrogen and 30 minutes of reperfusion (aCSF with oxygen). 
Experiments lasted 100 minutes in total. B: Illustration of brain regions 
examined for astrocyte sensitivity to ischaemia (adapted from the Allen adult 




3.5.1 Astrocyte cell death in response to OGD 
Live confocal images of each region examined were obtained every 
minute in control and OGD conditions, shown at 0 minutes, 50 minutes and 100 
minutes (end of the reperfusion period, figures 3.6 to 3.15). For all images, the 
white arrows illustrate the cells, which survive throughout the experiment. The 
yellow arrows depict the cells which died during the experiment due to OGD and 
reperfusion of the tissue. 
3.5.1.1 White matter regional sensitivity 
The ON astrocyte population showed tolerance to OGD with 33.54 ± 
13.11% cell death by the end of the protocol (figure 3.6C). The majority of 
astrocytes that are present at the beginning of the experiment are therefore still 
present at 100 minutes (figure 3.6A). In these confocal images, the nerves are 
positioned across the field of view in both aCSF and OGD conditions.  
The corpus callosum (CC) astrocytes were also resistant to OGD with 
cell death only reaching 31.95 ± 9.33% by the end of the protocol (figure 3.7C). 
It was observed that many astrocytes survived OGD and the reperfusion period 
(figure 3.7A) and that most astrocytes in this region do not lose membrane 
integrity during OGD. The cell death observed in these white matter tracts 
suggests that WM fibrous astrocytes are tolerant of acute ischaemic insult. The 
cell death profiles of the ON and CC showed that the t for half maximal cell 
death were similar, 68.36 ± 6.82 mins and 62.00 ± 2.32 mins respectively which 
suggests that these astrocyte populations behave in a similar manner (figures 
3.6C and 3.7C).  
The final WM tract investigated was the external capsule (EC, figure 3.8). 
This region produced a high degree of cell death, 75.11 ± 3.36% (figure 3.5C), 
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which was significantly higher compared to the other two WM regions (p=0.031). 
It is known that this region is often affected during haemorrhagic stroke (Chung 
et al., 2000). This susceptibility may also predispose the region to be vulnerable 
to ischaemic stroke. The value for t for this region (figure 3.8C) was 57.83 ± 
3.61mins showing the EC behaved more similarly to hippocampal and striatal 





Figure 3.6: Astrocyte sensitivity to OGD in optic nerve (ON). A: Confocal images 
taken at 0, 50 and 100 minutes. Upper panel is control conditions with aCSF 
only, lower panel during experimental conditions with OGD. White arrows show 
cells present throughout experiments, yellow arrows show cells that died during 
OGD treatment. Scale bars = 20µM. B + C: Cell death over time with these 
treatments, B: aCSF n=35/2, C: OGD n=275/6 (n numbers = number of 





Figure 3.7: Astrocyte sensitivity to OGD in corpus callosum (CC). A: Confocal 
images taken at 0, 50 and 100 minutes. Upper panel is control conditions with 
aCSF only, lower panel during experimental conditions with OGD. White arrows 
show cells present throughout experiments, yellow arrows show cells that died 
during OGD treatment. Scale bars = 20µM. B + C: Cell death over time with 
these treatments, B: aCSF n=75/2, C: OGD n=193/6 (n numbers = number of 






Figure 3.8: Astrocyte sensitivity to OGD in external capsule (EC). A: Confocal 
images taken at 0, 50 and 100 minutes. Upper panel is control conditions with 
aCSF only, lower panel during experimental conditions with OGD. White arrows 
show cells present throughout experiments, yellow arrows show cells that died 
during OGD treatment. Scale bars = 20µM. B + C: Cell death over time with 
these treatments, B: aCSF n=26/2, C: OGD n=184/6 (n numbers = number of 





3.5.1.2 Grey matter regional sensitivity 
In the GM regions examined, it was generally observed that there were 
higher levels of astrocyte cell death. In the cortex (motor area) (CTX (M)), cell 
death reached 63.17 ± 6.59% (figure 3.9C). In the confocal images, the upper 
edge of the cortex is visible; this is the edge of the brain slice (figure 3.9A). On 
the pial surface are astrocytes, which are located on the edge of the cortex and 
project their processes down into the cortex.  
To see whether this amount of cell death was unique to this region of the 
cortex, another cortical region was also examined, the auditory/sensory area 
(CTX (A/S)) (figure 3.10). In both aCSF and OGD images, the edge of the slice 
can be seen (figure 3.10A). In the OGD images cell death was observed, the 
yellow arrows depict cells which have died. The cell pointed out by the arrow in 
the upper right corner shows this well. This region showed high cell death in 
response to OGD of 81.33 ± 13.36% (figure 3.10C), which illustrates that 
cortical astrocyte populations are sensitive to acute ischaemic insult. The t half 
maxima for CTX (M) was 70.25 ± 2.98 mins and CTX (A/S) was 66.58 ± 
3.77mins (figure 3.9C and 3.10C). These results suggest that astrocytes located 
in cortical regions have a comparable response to ischaemic insult. 
The pial astrocytes would appear to be a subtype, if not a separate 
population of astrocytes. Their morphology is quite different from other 
protoplasmic astrocytes; their processes are not highly branched and they 
project down into the cortex and across the pial surface (figures 3.9A and 
3.10A). Work carried out by the group has found that these pial astrocytes may 
be particularly vulnerable to ischaemia (unpublished). The relationship between 
cell distance from the cortex surface and time of cell death was therefore 
investigated (figure 3.11). A proportion of pial astrocytes died at 20 to 35 
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minutes ODG. There were pial astrocytes, which survived OGD and reperfusion 
(figures 3.9A and 3.10A). Most cortical astrocytes die towards the end of OGD 
and into the reperfusion period regardless of the distance from the surface 
(figure 3.11).  
The astrocytes in different cortical layers were examined more closely, to 
see if astrocytes from the same layers died at a similar time point (figure 3.12). 
The number of cells to die at each time point was plotted for whole cortex 
(pooled results of the two cortical regions examined, figure 3.12A). Here, it 
shows that initial cell death occurs early after a short period of OGD. However, 
most cell death occurs after 30 to 40 minutes of OGD.  
The cell death was examined for the individual cortical layers. The cell 
death of pial astrocytes on the surface almost depicts two populations (figure 
3.12B). Those that are vulnerable to OGD and those that die towards the end of 
OGD and during reperfusion. This population behaves like other cortical 
astrocytes and show some tolerance. Astrocytes in layer 1 were located 
between 0 and 100µm from the surface (figure 3.12C). This layer contains no 
neuronal cell bodies and OGD induced cell death of astrocytes in this layer 
occurred in the late OGD period and during reperfusion. The astrocytes in layer 
2, located over 100µm from the surface, responded to OGD in a similar manner 
as layer 1 (figure 3.12D). In these layers, most astrocyte death occurred after 30 
to 40 minutes of OGD. There were significant differences between the total 
amounts of cell death seen in each layer (figure 3.12E). The lowest cell death 
was seen in layer 1, 14.51 ± 3.57%, cell death of pial astrocytes was higher at 
18.56 ± 3.46% (not significant). The highest amount of cell death was in layer 2 
and over which achieved 37.74 ± 4.76 % cell death. This was significantly 
higher than pial astrocyte cell death (p=0.0047) and layer 1 cell death 
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(p=0.0006). Overall, these findings suggest that for cortical astrocytes the 
distance from the surface does not affect the time at which OGD induced cell 
death occurs and that the majority of cell death occurs further from the surface 





Figure 3.9: Astrocyte sensitivity to OGD in cortex, motor area (CTX (M). A: 
Confocal images taken at 0, 50 and 100 minutes. Upper panel is control 
conditions with aCSF only, lower panel during experimental conditions with 
OGD. In both panels the edge of the cortex can be seen. White arrows show 
cells present throughout experiments, yellow arrows show cells that died during 
OGD treatment. Scale bars = 20µM. B + C: Cell death over time with these 
treatments, B: aCSF n=23/2, C: OGD n=150/6 (n numbers = number of 






Figure 3.10: Astrocyte sensitivity to OGD in cortex, auditory/sensory area (CTX 
(A/S). A: Confocal images taken at 0, 50 and 100 minutes. Upper panel is 
control conditions with aCSF only, lower panel during experimental conditions 
with OGD. In both panels the edge of the cortex can be seen. White arrows 
show cells present throughout experiments, yellow arrows show cells that died 
during OGD treatment. Scale bars = 20µM. B + C: Cell death over time with 
these treatments, B: aCSF n=29/2, C: OGD n=195/6 (n numbers = number of 






Figure 3.11: Effect of distance from cortex surface on OGD induced astrocyte 
cell death. Astrocytes from both cortex regions examined, CTX (M) n = 150/6, 





Figure 3.12: OGD induced astrocyte cell death in different cortical layers. A: Cell 
death events in each 5 minute period throughout cortex (pooled data). B: cell 
death events for pial astrocytes on cortex surface. C: cell death events for layer 
1 astrocytes (within100µm from cortex surface). D: cell death events for layer 2 
astrocytes and those situated over 100µm from the cortex surface. E: total 




The hippocampal astrocytes in the CA1 region and the dentate gyrus 
(DG) behaved in a similar manner to those in the cortex in response to OGD. 
The cell death recorded in these regions was approximately 94.04 ± 1.81% 
(figure 3.13C) for CA1 and 97.30 ± 1.24% for DG (figure 3.14C). In the OGD 
images for both regions clouds of GFP can be seen, this occurs after the cellular 
contents is released when cells rupture due to a loss of membrane integrity 
(figures 3.13A and 3.14A). In the aCSF confocal images, the edge of the 
dentate gyrus is running across the lower right corner of the images (figure 
3.14A). The t half maxima achieved for these regions was 49.17 ± 4.99 mins for 
CA1 and 54.64 ± 3.3 mins for DG. These were the lowest values obtained for t 
which illustrates that cell death occurred rapidly in these regions. 
Cell death caused by OGD in the striatum (STR) was similar to other GM 
regions and reached around 97.37 ± 1.19% (figure 3.15C). The structure 
present in the OGD panel of the confocal images is a blood vessel (figure 
3.15A). The astrocytes that are wrapping the blood vessel are periventricular 
astrocytes. These periventricular astrocytes appear brighter than other astrocyte 
populations; it is unknown why this phenomenon occurs. The cell death rate in 
STR is similar to that for the hippocampal astrocytes (figure 3.15C). From these 
results, it would seem that striatal astrocytes have more in common with the 





Figure 3.13: Astrocyte sensitivity to OGD in CA1 region of hippocampus (CA1). 
A: Confocal images taken at 0, 50 and 100 minutes. Upper panel is control 
conditions with aCSF only, lower panel during experimental conditions with 
OGD. White arrows show cells present throughout experiments, yellow arrows 
show cells that died during OGD treatment. Scale bars = 20µM. B + C: Cell 
death over time with these treatments, B: aCSF n=25/2, C: OGD n=222/6 (n 





Figure 3.14: Astrocyte sensitivity to OGD in dentate gyrus of hippocampus 
(DG). A: Confocal images taken at 0, 50 and 100 minutes. Upper panel is 
control conditions with aCSF only, lower panel during experimental conditions 
with OGD. White arrows show cells present throughout experiments, yellow 
arrows show cells that died during OGD treatment. Scale bars = 20µM. B + C: 
Cell death over time with these treatments, B: aCSF n=85/2, C: OGD n=210/6 





Figure 3.15: Astrocyte sensitivity to OGD in striatum (STR). A: Confocal images 
taken at 0, 50 and 100 minutes. Upper panel is control conditions with aCSF 
only, lower panel during experimental conditions with OGD. White arrows show 
cells present throughout experiments, yellow arrows show cells that died during 
OGD treatment. Scale bars = 20µM. B + C: Cell death over time with these 
treatments, B: aCSF n=28/2, C: OGD n=189/6 (n numbers = number of 





3.5.1.3 Comparison of regional sensitivity 
To find which regions were most sensitive to OGD, the cell death for 
each region investigated was compared using one way ANOVA. First, OGD 
induced cell death for each region was compared to control conditions (aCSF 
only, figure 3.16A). This comparison confirmed that cell death was the result of 
OGD, as no cell death occurred during aCSF only conditions. Next, the amount 
of cell death was compared at the end of OGD to the end of reperfusion, for 
each region (figure 3.16B). It was seen that for most regions, the majority of cell 
death occurs during OGD and less occurs during reperfusion. The only 
exception is in the striatum where there was a significant increase in cell death 
from the end of OGD to the end of the reperfusion period (figure 3.16B, 
p=0.0141). This suggests that the high amount of astrocyte cell death in this 
region is due to reperfusion injury as well as the initial ischaemic insult. 
These findings show that there were differences in the amount of 
astrocyte cell death, depending upon astrocyte location. The OGD induced cell 
death was then compared between regions, after OGD (figure 3.16C) and after 
the reperfusion period (3.16D). The main differences in amounts of cell death 
were between WM and GM astrocytes. The greatest difference at the end of 
OGD was between ON and CA1, ON and DG (p=<0.0001). There were 
significant differences between CC and both the hippocampal regions (CA1 and 
DG, p=<0.0001).These significant differences in the regions remained after the 
reperfusion period. 
Differences in cell death were also observed between WM regions; 
significantly increased cell death is seen in EC when compared to ON and CC 
at the end of OGD (p=0.0310) and the end of reperfusion (p=0.0180). After OGD 
(figure 3.16C), significant differences in amounts of cell death were seen 
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between different GM regions, between the CTX (M) and the CA1 (p=0.0012) 
and the CTX (M) and DG (p=0.0047). Although these did not remain after the 
reperfusion period, the comparisons found that cell death in different GM 





Figure 3.16: Astrocyte sensitivity to OGD varies between regions. A: total 
astrocyte cell death for each region in control (aCSF only) and OGD conditions. 
OGD compared to aCSF for that region only. N numbers = number of 
cells/number of slices. B: astrocyte cell death for each region after 60 minutes 
OGD (black bars) and at the end of reperfusion (green bars). Comparison made 
between these two time points for each region only. C: shows cell death after 60 
minutes OGD. D: total astrocyte cell death after 60 minutes OGD and 30 
minutes reperfusion. C + D: Each region compared to every other region, 
comparisons without bars not significant. Error bars = SEM. For p values, 
*=<0.05, **=<0.01, ***=0,001 and ****=<0.0001. A, C + D Black bars are white 





The rate of cell death also shows some variance between WM and GM 
(figure 3.17). In all regions little cell death occurs before 30 minutes OGD, the 
highest observed was 23.01 ± 12.65% in CA1. The majority of astrocyte cell 
death occurred in the latter half of the OGD period, less cell death occurred 
during the reperfusion period (70-100 minutes). The WM regions exhibit similar 
rates of cell death, where t ranges from 62.00 ± 2.32 to 68.36 ± 6.82 mins, 
excluding the EC which had a slightly lower t of 57.50 ± 3.61 mins. The cortical 
regions had a steady progression of cell death throughout the experiment; this 
pattern was also observed in STR. Although, in this region the cell death was 
faster and greater. In CA1 and DG most cell death occurred after 30 minutes 
OGD, with less cell death occurring during the reperfusion period. The EC cell 
death profile was more similar to that of hippocampal astrocytes than the WM 
astrocytes, as mentioned previously. 
Taken together these findings strongly suggest that astrocyte sensitivity 
to ischaemic insult depends upon the physical location of astrocyte populations 
within the CNS. It was determined that the CC was the region where astrocytes 
were most resistant to OGD, whereas DG contained astrocytes, which were 
most sensitive to ischaemia. These regions were taken forward to investigate 
the mechanisms behind the differences discovered in regional astrocyte 




Figure 3.17: Astrocyte cell death region comparison. Graphs for each region 
showing the percentage of cell death after 30 minutes OGD, 60 minutes OGD 




3.5.2 Neonate astrocyte sensitivity to OGD 
After establishing the presence of astrocyte regional sensitivity to OGD in 
adult brain slices, astrocyte sensitivity in neonatal (P10) brain slices was 
investigated. This was to see if neonates exhibited the same pattern of astrocyte 
sensitivity to ischaemia as was seen in adults. Previously, it had been found that 
neonatal GM astrocytes were more resistant to OGD than neonatal WM 
astrocytes (Shannon, Salter & Fern, 2007). Earlier work by the group found the 
amount of astrocyte cell death in neonate ON was 59.5% ± 5.2% (Fern, 1998). 
There are a greater density of GFP expressing cells present in neonatal 
CC and DG than in the same regions in adults (figure 3.18A), only those 
showing clear astrocyte morphology were counted. The cell death profiles for 
each neonatal region (CC and DG) differ to those obtained for the same regions 
in adults (figures 3.18B and C). The t value for each region was higher than the 
same adult region. For CC t increased from 62.00 ± 2.32 for adult cells to 78.30 
± 5.33 mins in the neonate (p=0.0029) and for DG t was increased from 54.64 ± 
3.30 mins to 68.50 ± 3.13 mins for the neonate (p=0.0033). This suggests that 
neonatal astrocytes display resistance to insult. The total amount of cell death in 
neonatal regions was significantly lower than that observed in adult regions 
(p=0.0112 for CC and p=0.0088 for DG, figure 3.18D). The neonate CC 
astrocyte cell death was 10.86 ± 3.10% and neonate DG cell death was 67.38 ± 
12.21%. This suggests that neonatal astrocytes are much more resistant to 
ischaemic injury than adult astrocytes from the same region. The total cell death 
seen in neonate DG is significantly higher than that in the neonate CC 
(p=<0.0001, figure 3.18D), following the same pattern of sensitivity as the adult 




Figure 3.18: Neonatal astrocytes are more resistant to OGD than adult 
astrocytes: A: Confocal images of corpus callosum and dentate gyrus astrocytes 
taken at 0, 50 and 100 minutes. Scale bar = 20µm. B + C: neonate (green bars) 
and adult (black bars) astrocyte cell death over time in corpus callosum and 
dentate gyrus respectively. D: Comparison of total astrocyte cell death in 
neonate and adult brain regions after 60 minutes OGD and 30 minutes 
reperfusion. Error bars = SEM.  
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3.6 RESULTS: OLIGODENDROCYTE SENSITIVITY TO ISCHAEMIA 
Astrocytes are not the only type of glial cell to interact with neurons and 
have a role in neuronal support (as previously discussed). Oligodendrocytes are 
also important for the correct function of neurons. The process of myelination 
puts oligodendrocytes in close proximity to neurons, allowing them to receive 
and respond to neuronal signals and provide metabolic support.  
Due to the specific role that oligodendrocytes have, it was important to 
establish whether these cells were sensitive to acute ischaemic injury. Any 
injury to oligodendrocytes would be damaging to neurons and may impact 
neuronal survival during and after insult. 
3.6.1 Oligodendrocytes are tolerant of OGD 
To investigate oligodendrocyte sensitivity to ischaemia, oligodendrocytes 
in ON, CC and DG were observed. The same experimental protocol was 
followed as for investigation into astrocyte sensitivity. However, for 
oligodendrocyte experiments PLP-GFP transgenic mice were used. In these 
mice, oligodendrocytes express GFP under the promoter for proteolipid protein 
(Mallon et al., 2002), which is specific to oligodendrocytes. There are numerous 
oligodendrocytes found in ON, these are interfascicular oligodendrocytes. In the 
confocal images the nerve is running across the field of view (figure 3.19A). In 
aCSF conditions, there was no cell death (figure 3.19B). Interestingly there was 
no OGD induced oligodendrocyte cell death in this region (figure 3.19C).  
A similar pattern was seen in CC where it was found that there was very 
low OGD induced oligodendrocyte cell death (figure 3.20). The confocal images 
show the high density of oligodendrocytes in CC (figure 3.20A), due to white 
matter tracts containing myelinated axons. In the OGD 100 minutes image, it 
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appears as though there has been cell death. However, this is due to a change 
in the focal plane as the tissue preparation swells, distorting and moving the 
view of the cells. Only cells that were clearly visible throughout the experiment 
and not altered by the swelling of tissue were counted.  
In the DG there are fewer oligodendrocytes present than in the WM 
(figure 3.21A) these are perineuronal oligodendrocytes. Again, in the OGD 100 
minutes image it looks as though there has been death of oligodendrocytes, 
however this is due to the swelling of the surrounding tissue which alters the 
focus of the cells in view. In cases where cells could not be followed for the 
entirety of the experiment, they were disregarded and were not counted. The 
cell death profiles are given for control (aCSF, figure 3.21B) and OGD 
conditions (figure 3.21C). Even with OGD treatment GM oligodendrocytes still 
showed tolerance to insult as there was low cell death. All of the regions 
examined showed that oligodendrocytes are very tolerant to ischaemic insult. 
The low cell death achieved with ischaemic insult was not significantly different 
from control conditions (figure 3.22). When oligodendrocyte cell death was 
compared between regions, no significant differences were found. Taken 
together these findings suggest that oligodendrocytes in both GM and WM are 
very tolerant of acute ischaemic injury. This finding is in contrast with reports 
from the literature, where it is accepted that oligodendrocytes are extremely 





Figure 3.19: Oligodendrocyte sensitivity to OGD in optic nerve (ON). A: 
Confocal images of ON taken at time 0, 50 and 100 minutes. Scale bars = 20µm 






Figure 3.20: Oligodendrocyte sensitivity to OGD in corpus callosum (CC) A: 
Confocal images of CC taken at time 0, 50 and 100 minutes. Scale bars = 20µm 





Figure 3.21: Oligodendrocyte sensitivity to OGD in dentate gyrus (DG) A: 
Confocal images of DG taken at time 0, 50 and 100 minutes. Scale bars = 20µm 







Figure 3.20: Oligodendrocytes are resistant to OGD. Graph of total 
oligodendrocyte cell death at 100 minutes. N numbers = number of cells/number 





3.7 COMPARISON OF GLIAL SENSITIVITY TO OGD  
To see the differences in glial sensitivity to OGD the data from astrocytes 
and oligodendrocytes was compared for CC (figure 3.23 A and B), DG (figure 
3.23 C and D) and ON regions (figure 3.23 E and F). For all regions examined, 
the cell death over time was very different between the two cell types, with 
astrocyte death generally increasing over time, whereas oligodendrocyte death 
remained low (figures 3.23A, C and E). When oligodendrocyte cell death did 
occur, it happened later during the OGD period than astrocytes cell death. In CC 
the OGD induced cell death that did occur was during reperfusion. There was a 
vast difference in the total amounts of cell death observed in each region 
between the two cell types (figures 3.23B, D and F). In CC and DG (figure 3.23B 
and D), there was the most dramatic difference in OGD induced cell death, with 
greater astrocyte cell death in both regions (p=<0.0001). In ON (figure 3.23F), 
astrocyte cell death in OGD conditions was higher when compared to 
oligodendrocyte death, however the significance was lower (p=0.0231). These 
results show that astrocytes are more sensitive to ischaemic injury than 
oligodendrocytes, even though it is accepted that oligodendrocytes are the 





Figure 3.23: Astrocytes are more sensitive to OGD than oligodendrocytes. A, C 
+ E: Astrocyte (black bars) and oligodendrocyte (green bars) cell death over 
time. B, D + F: total cell death at time 100 minutes for CC (A+B), DG (C+D) and 




3.8 DISCUSSION: GLIAL SENSITIVITY TO OGD 
Astrocytes and oligodendrocytes are both essential for the correct working 
of the CNS. Astrocytes are support cells to neurons and are responsible for the 
homeostatic regulation of the ECS as well as many other roles. 
Oligodendrocytes enable fast conduction of action potentials through the 
myelination of axons and have been implicated in axonal metabolic support. 
Due to the important roles these cells have, if either are damaged then this will 
have a detrimental effect on neuronal and CNS function. During ischaemic 
insult, all cell types within the ischaemic core and surrounding penumbra are 
affected. However, it is unknown how much the anatomical location of glial cells 
may determine their sensitivity to ischaemic insult. This work has established 
that regional sensitivity of astrocytes to OGD exists and it has been discovered 
that oligodendrocytes are resistant to acute ischaemic insult in the mature brain.  
3.8.1 Astrocytes show regional sensitivity to OGD 
First, the expression of GFP in astrocytes under the GFAP promoter was 
successfully confirmed through co-localisation with the astrocyte marker 
ALDH1L1 (figure 3.2). Not all astrocytes that were expressing GFP were 
positive for ALDH1L1, as ALDH1L1 does not detect all astrocyte populations 
and only identifies a certain subpopulation. The confocal images illustrate that 
the cells expressing GFP have definite astrocyte morphology, which also 
confirms that GFP was expressed in the correct cell type (figure 3.2). 
This work has found that astrocyte sensitivity to OGD varies depending 
upon the physical location of the astrocyte population. Generally, astrocytes 
found in WM tracts were more resistant to ischaemic insult than cells found in 
GM matter regions (figure 3.16). The GM astrocyte populations were found to 
be very sensitive to OGD. The GM sensitivity to OGD found here is in 
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agreement with the literature where sensitive GM regions have been identified 
as cortex, hippocampus and striatum (Xu, Sapolsky & Giffard, 2001) Within GM 
regions, cell death began at slightly different time points and occurred at 
different rates (figure 3.16 and 3.17). However, when the total amount of OGD 
induced cell death was compared between GM regions, the variance was 
minimal. Investigation into cell death in different cortical layers found that there 
was not relationship between distance from the pial surface and time of 
astrocyte cell death event. However, it was noticed that layers that contained 
high neuronal density also showed astrocyte sensitivity to ischaemia. This 
suggests that astrocyte and neuronal survival are interlinked, which was 
previously posed by Zhao and Flavin (2000). 
In the WM of the CC and ON, astrocytes behaved in a very similar 
manner and both displayed tolerance to acute ischaemic insult. Pantoni et al. 
(1996) found that WM astrocytes are physically affected after just 30 minutes of 
OGD, however there has been little further investigation into WM astrocyte 
sensitivity. Unlike the GM regions, the WM astrocyte population did show 
variance in the amount of OGD induced cell death achieved at the end of the 
experimental protocol. The EC was much more sensitive to OGD than the other 
WM regions investigated (figures 3.8 and 3.16). During ischaemia, the EC 
behaved more like a GM region such as CA1 or DG. This may be due the 
physical location of the EC, which is a relatively thin WM tract surrounded by 
large GM areas. It is known that this area is particularly susceptible to 
spontaneous intracerebral haemorrhage (Chung et al., 2000), and so it may also 
be vulnerable to ischaemic stroke. 
We have found that there are also differences in the sensitivities of 
neonatal (P10) astrocytes; those in CC (WM) are more resistant to ischaemic 
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insult than those in DG (GM) (figure 3.18). This follows the same pattern as for 
the adult astrocytes, but is contrary to the findings of Shannon et al. (2007) who 
found WM astrocyte more sensitive than GM. This may be as different WM 
tracts were used, Shannon et al. (2007) studied ON astrocytes, whereas for the 
current work CC was used. It is possible that astrocytes in different WM tracts 
behave differently in neonates and so this requires further investigation. When 
the total OGD induced astrocyte cell death from neonates and adults was 
compared, it was found that the neonatal astrocytes were much more tolerant 
than adult cells to ischaemia. During birth and development, the young 
developing brain may undergo periods of ischaemia or suffer ischaemia like 
conditions. Therefore it is important that developing and immature astrocytes 
survive these stressful periods so as the cells can mature and take up their role 
in the CNS. When these periods of ischaemia are more severe and longer 
lasting, they often result in conditions such as cerebral palsy.  
3.8.2 Oligodendrocytes show resistance to OGD 
Unlike astrocytes, when oligodendrocytes were exposed to OGD it was 
found that they were very resistant to acute ischaemic insult. All regions showed 
less than 5% cell death (figure 3.22) which was significantly lower than the total 
astrocyte cell death seen in the same regions (figure 3.23). In the literature, the 
majority of studies demonstrate that oligodendrocytes are very sensitive to 
ischaemic insult. It has been found that neonatal oligodendrocyte cultures are 
particularly sensitive to OGD, with many cells dying after a short exposure. It 
was reported that the majority of immature oligodendrocytes died within 30 
minutes of OGD and after 60 minutes of OGD most of the cells present had died 
(Fern & Moller, 2000). This study also showed that mature cultured 
oligodendrocytes were very tolerant to OGD, 55 minutes of OGD resulted in 
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43.4 ± 5.3% cell death. The tolerance to insult has also been observed in whole 
mount ON preparations. P10 mouse ON oligodendrocytes were found to survive 
after 60 minutes of OGD, where only 30% cell death was seen at this time point 
(Salter & Fern, 2005). Oligodendrocyte resistance to OGD has been seen in CC 
slices where a minimum of one hour reperfusion was required for significant cell 
death to occur (Tekkok & Goldberg, 2001). 
The resistance of oligodendrocytes to ischaemia has been demonstrated 
here. The majority of investigations which showed oligodendrocyte sensitivity, 
relatively short periods of ischaemia (10-30 minutes) were combined with longer 
periods of reperfusion (minimum of one hour). For this work interest lies in the 
acute injury of ischaemia and the initial effects of the insult. This evidence 
suggests that mature oligodendrocyte somas show resistance to ischaemic 
insult but are more sensitive to reperfusion. McIver et al. (2010) found that 24 
hours after transient MCAO (60 minutes) there was not a significant loss of 
oligodendrocytes when compared to sham controls. Significant oligodendrocyte 
cell death was only observed 48 hours after insult (McIver et al., 2010). This 
evidence confirms that mature oligodendrocyte cells are extremely tolerant to 
acute ischaemic insult and are more resistant than astrocytes. However, 
oligodendrocyte cell death was measured in the same manner as astrocyte cell 
death and so may not be representative of any oligodendrocyte injury that has 
occurred as a result of acute ischaemia. The in situ studies that have reported 
oligodendrocyte cell death have done so after long periods of reperfusion and 
not at the time of acute injury. 
Oligodendrocyte cell somas express resistance to injury, however their 
processes and myelin are vulnerable to insult. Many studies have reported early 
defects and changes in oligodendrocyte processes after short periods of OGD, 
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such as Pantoni et al. 1996, who observed vacuolation and swollen processes 
after 30 minutes of MCAO. After six hours of MCAO, the myelin sheath had 
detached from the axolemma. Oligodendrocyte process loss has also been 
seen prior to cell soma loss (McIver et al., 2010), here disintegration of proximal 
and distal processes was determined after 24 hours of reperfusion after 60 
minutes ischaemia. The pathology observed in animal models has also been 
found in patients. In post-mortem samples, oligodendrocytes within the 
ischaemic infarct and in the penumbra displayed severe damage of distal 
processes and destruction of myelin (Aboul-Enein et al., 2003).  
The data in this chapter has demonstrated that astrocyte tolerance to 
modelled ischaemia varied significantly depending upon their physical location 
within the CNS. It has been determined that oligodendrocytes in brain slices and 
ON preparations are tolerant to acute ischaemic insult. Glial cells play such a 
pivotal role in the CNS that any damage or insult that occurs to them will not 
only be detrimental these cells but also to neurons and other cells in the CNS. 
By looking at how astrocytes and oligodendrocytes cope and respond to 
ischaemia will allow us to investigate the mechanisms of glial cell death. This 
will improve our understanding of the effect of ischaemic insults on the CNS and 
may provide possible therapeutic targets.  
The CC was the least sensitive region to OGD (31.95 ± 9.33% cell 
death), whilst the most sensitive was DG (97.30 ± 1.24% cell death), as such 
these two regions were used to investigate the mechanisms behind the 
observed difference. There are many possible reasons as to why different 
astrocyte populations have varying sensitivities to OGD. The general astrocyte 
population is known to be heterogeneous; therefore, the differences that 
specialise them to a particular location may also determine their sensitivity to 
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ischaemia. From the literature and the previous work carried out by the group, it 
became apparent that there were three main areas, which may affect sensitivity 
to OGD. These were the role of glycogen stores, the role of glutamate receptors 
and sodium mediated cell swelling. Each of these have been investigated and 











4 THE ROLE OF GLYCOGEN IN ISCHAEMIC INJURY OF 
GLIA 
4.1 INTRODUCTION 
Many processes carried out by astrocytes require energy, demand for 
which cannot always be satisfied by glucose from the circulation alone. The 
shortfall can be accounted for via the breakdown of astrocyte glycogen stores. 
Astrocytes are the major glycogen store in the brain and glycogenolysis can 
occur quickly to yield ATP during periods of high demand (Sickmann et al., 
2009), making it a useful energy reserve. A major product of glycogenolysis is 
lactate, which can be used by axons as an energy source, to survive and 
function during aglycaemia (Brown et al., 2005; Fern, 2015; Ransom & Fern, 
1997; Tekkok et al., 2005; Wender et al., 2000). Tekkok et al., (2005) found that 
lactate was transported via monocarboxylate transporters (MCTs) from 
astrocytes to axons in mouse optic nerve (ON). It has been shown in vitro that 
lactate from glia is metabolized by axons (Funfschilling et al., 2012), allowing 
axons to continue to function for a few minutes, when there is a lack of glucose.  
Early studies into glial supply of metabolites were carried out in the 
honeybee drone retina. This preparation contains only two cell populations, 
photoreceptors (neuronal cells) and outer pigment cells (glial cells) (Coles & 
Tsacopoulos, 1981), making it ideal for the investigation of metabolite supply. 
The drone retina is highly compartmentalised, with glycolysis occurring in the 
glial cells only, whilst photoreceptors are the major site of oxygen consumption 
(Tsacopoulos et al., 1988). The photoreceptors rely upon the glial cells, much 
like neurons rely upon astrocytes, for ionic homeostasis and buffering. In this 
model the glial cells are also responsible for metabolite supply to the 
photoreceptors and contain high levels of glycogen (Coles & Tsacopoulos, 
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1981). In these glial cells glucose and glycogen are converted into alanine 
which is released for use by the photoreceptors, where it is transaminated into 
pyruvate for use in the TCA cycle (Tsacopoulos et al., 1994). 
During ischaemia, it is thought that astrocytes in the penumbra may 
breakdown glycogen stores to produce lactate, which is released into the ECS 
for uptake by neurons. However, it is unknown if this energy store is used by 
astrocytes to maintain their own function during ischemia. A small glycogen 
store has been found in neurons, the cells examined were cultured from 
neocortex and hippocampus (Saez et al., 2014). The glycogen levels 
determined were very low, just a fraction of the amount that is found in 
astrocytes. Saez et al. (2014) suggested that this store could be used during 
ischaemic insults to fuel neurons. 
4.1.1 Astrocytes, glycogen and metabolism 
The role of astrocytic glycogen has been found to be essential to the 
CNS. The lactate generated from glycogen breakdown can be used as a 
metabolic substrate, but is also utilized as a signalling molecule (Lauritzen et al., 
2014). During aglycaemic conditions, astrocytic glycogen is required for the 
survival of neurons in culture (Swanson & Choi, 1993). Involvement of glycogen 
in higher brain functions has been discovered and extends to processes such as 
memory consolidation, learning and the sleep/wake cycle (Gibbs, Anderson & 
Hertz, 2006; Naylor et al., 2012; Suzuki et al., 2011).  
Initial work on lactate signalling was carried out in a neonatal chick 
learning model, where it was found that glycogenolysis was required for memory 
consolidation (Gibbs, Anderson & Hertz, 2006). The inhibition of glycogenolysis 
inhibited long term memory and was required for short term memory and recall 
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(Gibbs, Anderson & Hertz, 2006). The discovery of the expression of the lactate 
receptor GPR81 supported the role of lactate as a signalling molecule 
(Lauritzen et al., 2014). This G-protein coupled receptor has been found to be 
expressed in cortex and hippocampus, particularly on synaptic membranes 
(Lauritzen et al., 2014), which are regions of high neuronal activity. This 
receptor can exert an effect on numerous neurons by acting as a volume 
transmitter. Lactate signalling can respond to neuronal activity, via the inhibition 
of adenylyl cyclase (Lauritzen et al., 2014). Lactate signalling has been shown 
to alter cerebral blood flow (Gordon et al., 2008) and may be involved in other 
homeostatic processes such as osmoregulation, ventilation, glucose and 
sodium sensing (Magistretti & Allaman, 2018). Glycogen is utilized in the uptake 
and processing of glutamate (Sickmann et al., 2009), which is further discussed 
below. 
Glycogen is used for the active uptake of ions which is important for the 
maintenance of ionic gradients and for homeostasis. In particular, 
glycogenolysis is used to power the sodium/potassium ATPase (NKA) (Xu et al., 
2013). This transporter extrudes sodium whilst importing excess extracellular 
potassium, which can then be distributed throughout the astrocyte network to 
lower the extracellular concentration (Xu et al., 2013). The NKA is activated by 
increases in extracellular potassium concentration, even small increases will 
stimulate the transporter and glycogenolysis (Hof, Pascale & Magistretti, 1988). 
These extracellular increases were seen by Xu et al (2013), who found they 
were required for glycogenolysis to occur. The levels of potassium in the 
extracellular space increase with neuronal activity (Xu et al., 2013).  
The utilization of glycogen under normal physiological conditions is 
associated with an increase in extracellular potassium concentration which 
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causes an increase in free intracellular calcium (Sotelo-Hitschfeld et al., 2015). 
This triggers phosphorylase kinase, which phosphorylates and thereby activates 
the enzyme glycogen phosphorylase. Glycogen granules are broken down via 
glycogen phosphorylase and glycogen debranching enzyme, resulting in 
pyruvate which can be converted to lactate. Brain slice studies have found that 
depolarization and calcium influx can stimulate glycogen phosphorylase and 
trigger glycogenolysis (Ververken et al., 1982). During times of high energy 
demand glucose can be trafficked between astrocytes through gap junctions, 
which has been observed in hippocampal astrocytes (Rouach et al., 2008). 
These prior findings show that astrocytic glycogen is essential to the CNS and 
has a definite role during physiological conditions and times of low glucose. 
4.1.1.1 Lactate as a neuronal metabolic substrate 
It was discovered that astrocytes release lactate (Walz & Mukerji, 1988), 
however the reasons behind this release are unknown. It has been suggested 
that the lactate released is used as a metabolic substrate by neurons. This 
phenomenon has been summarised by the astrocyte-neuron lactate shuttle 
hypothesis (ANLS) as described by the Magistretti group (1994). There is 
evidence that neurons will use alternative metabolites in the absence of glucose 
and it has also been shown that neurons will use lactate to sustain excitability 
(Wyss et al., 2011). The lactate that supports neuronal function was found to be 
derived from glycogen (Brown et al., 2005). During aglycaemia, neuronal 
survival and function was enhanced by increasing astrocyte glycogen levels. 
The ANLS hypothesis proposes that when required, astrocytes break 
down glycogen and convert it to lactate which is then transported to neurons 
(Pellerin & Magistretti, 1994). This is likely to occur during times of increased 
neuronal activity when glucose demand is high or under conditions of reduced 
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glucose delivery. There is some controversy about the ANLS hypothesis, even 
though there is evidence in the literature to support the movement of lactate 
from astrocytes to neurons the theory has not been directly proven. Astrocytes 
express monocarboxylate transporters (MCTS), specifically MCT1 and 4 and 
neurons express MCT2 (Bergersen, Rafiki & Ottersen, 2002; Pierre et al., 
2000). The location and affinities of these MCTs supports the release of lactate 
from astrocytes and the uptake by neurons. MCT2 expression has also been 
found on axons (Funfschilling et al., 2012), as axons are covered in a myelin 
sheath then it would imply that metabolites may also be released by 
oligodendrocytes (Krasnow & Attwell, 2016). These metabolites are the result of 
oligodendrocyte glycolysis (Funfschilling et al., 2012; Lee et al., 2012b). It has 
been suggested that this occurs through a NMDA receptor dependent 
mechanism, which causes an increase in GLUT1 trafficking (Saab et al., 2016), 
thereby increasing glucose transport into oligodendrocytes. This process of 
metabolite movement through oligodendrocytes shares similarities with the 
ANLS hypothesis (Krasnow & Attwell, 2016). 
Mächler et al. (2015) have established the existence of a lactate gradient 
from astrocytes to neurons. This was determined through the investigation of 
MCT expression and the fact that neurons have lower levels of lactate but their 
MCTs have a higher affinity for the metabolite (Machler et al., 2016), an analysis 
that supports the ANLS hypothesis. Astrocyte derived lactate has been shown 
to fuel ON axons, there is evidence to suggest that hippocampal neurons can 
metabolize lactate (Matsui et al., 2017) and WM axons may also utilize this 
metabolite. Investigation into the role of lactate in mouse ON has also been 
carried out. Tekkok et al. (2005) first showed that during 60 minutes of 
aglycaemia lactate was utilized by ON and sustained compound action potential 
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(CAP) for 30 minutes. They found that CAP function was partially rescued by 
the administration of lactate. They also determined that lactate has a role in 
CAP function during physiological conditions, the absence of lactate increased 
the speed of nerve deterioration. This evidence suggests that exogenous lactate 
can support axonal function and is an additional energy substrate to glucose 
(Tekkok et al., 2005). 
Recently it was discovered that astrocytes contain a cytosolic lactate pool 
as well as glycogen stores (Sotelo-Hitschfeld et al., 2015). This lactate pool can 
be quickly released when required, allowing time for glycogenolysis to occur to 
produce more lactate. This reservoir can be released against the lactate 
gradient and once released can be used by other cells. An increase in the 
extracellular potassium concentration causes the release of the lactate pool 
(Sotelo-Hitschfeld et al., 2015). MCTs are not responsible for this lactate 
release, but it occurs through a novel and as yet unidentified anion channel 
which is permeable to lactate and chloride. The study also suggested that this 
astrocyte lactate pool may be utilized as a signalling molecule as well as a 
metabolite. The lactate receptor GPR81 is a G-protein coupled receptor which 
has been found to be expressed in synaptic regions, perivascular positions and 
on glia (Lauritzen et al., 2014), this is consistent with the use of lactate as a 
signalling molecule. Lactate as a signalling molecule has been shown to reduce 
spontaneous activity in cultured cortical neurons (Bozzo, Puyal & Chatton, 
2013), whilst in other regions it has caused neuronal excitement.  
4.1.2 Glycogen and glutamate  
Glycogen is frequently mobilised for the de novo synthesis of glutamine 
and is used throughout the glutamate-glutamine cycle. It has been shown that 
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glycogen is necessary for glutamatergic neurotransmission to occur (Sickmann 
et al., 2009).  
Glutamate cannot enter the brain from the circulation and so its formation 
has to occur in situ. Astrocytes are the only cells which are able to synthesize 
de novo glutamate. Pyruvate, resulting from glycogenolysis is a precursor for 
glutamate formation and is converted to α-ketoglutarate prior to glutamate and 
then glutamine (Gibbs et al., 2007; Hertz & Rothman, 2017). Glutamine is 
produced by astrocytes for export to neurons, where it is converted into 
glutamate four use in neurotransmission. During times of high neuronal activity 
such as learning, glutamate levels are increased due to stimulation of glutamine 
synthesis (Gibbs et al., 2007; Hertz et al., 2003). Glutamate released by 
synapses is taken up by astrocytes. A proportion of this glutamate is lost to 
oxidative degradation (McKenna, 2013) as glutamate is converted into the TCA 
cycle intermediate α-ketoglutarate. This loss occurs for approximately 20% of 
glutamate that enters astrocytes (Hertz et al., 2015). Glutamate is also recycled 
by astrocytes, the uptake of which requires glycogenolysis (Sickmann et al., 
2009). Once converted from glutamate to glutamine it is released from 
astrocytes for use by neurons.  
The GM contains regions of high neuronal activity, where glycogen turn-
over is high during neuronal stimulation (Dienel & Cruz, 2003; Swanson, 1992). 
Glycogen is the preferred substrate for the formation of glutamine (Gibbs et al., 
2007) and so within GM astrocytes there is a constant turnover as glycogen 
stores are used to fuel neurotransmission and are replenished. An essential role 
for glycogen has been discovered during learning and the breakdown of 
glycogen is responsible for the increase in glutamate seen during learning 
activities (Gibbs et al., 2007).  
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Many signalling molecules and neurotransmitters can stimulate 
glycogenolysis such as ATP, serotonin, noradrenaline, and adenosine (Hertz et 
al., 2015). These all act to increase the intracellular calcium concentration which 
can activate glycogen phosphorylase and thus trigger glycogenolysis.  
4.1.3 Oligodendrocytes and metabolism 
Recently, a new role for oligodendrocytes in axonal metabolic support 
has been found. Close proximity to axons puts oligodendrocytes in the ideal 
position to assist with axon fuelling. It may not be feasible that neuronal cell 
somas can energetically supply axons, due to the distance that axons extend 
from the somata. The nature of the myelin sheath means it acts as a physical 
barrier around the axon preventing the uptake of metabolites from the 
extracellular space. Thus, axons must obtain metabolites from alternative 
sources. This new role for oligodendrocytes has been discovered along with 
their expression of MCT1 (Rinholm et al., 2011) which can be used to export 
lactate from cells, corresponding with the neuronal expression of MCT2 for 
lactate import (Pierre et al., 2000). Oligodendrocytes have been found to supply 
lactate to neurons via glycolysis (Funfschilling et al., 2012). It has previously 
been mentioned that axons can be sustained by lactate when glucose is not 
available (Tekkok et al., 2005). WM has particularly high glycolytic activity 
(Morland et al., 2007), which will produce excess lactate in glial cells, which may 
be released for use by other cells.  
The expression of MCT1 has been found in oligodendrocytes, specifically 
on the myelin processes that wrap axons (Rinholm et al., 2011). MCT1 is 
essential for axon maintenance, knock out of the transporter causes axonal 
injury and neuronal loss (Lee et al., 2012b). Oligodendrocytes form coupled 
networks with astrocytes, providing another route through which metabolites 
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can be distributed ultimately for use by axons. These two types of glial cells are 
coupled through gap junctions created from connexins (Orthmann-Murphy et al., 
2007). Oligodendrocytes express the connexins Cx47 and Cx32 which couple 
with the astrocyte connexins Cx43 and Cx30. It is thought that metabolites can 
pass through these mixed glia networks as they can in the astrocyte syncytium. 
A recent study carried out on axonal metabolite preferences, found that 
CC axons preferentially use glucose delivered by oligodendrocytes (Meyer et 
al., 2018). However, during aglycaemia lactate was found to partially recover 
axon compound action potentials (CAP). Full CAP recovery was only achieved 
with glucose administration. Meyer et al (2018) also determined that the 
metabolites used by axons are transferred from oligodendrocytes to neurons. 
CAP rescue was only seen when metabolites were directly loaded into 
oligodendrocytes but not astrocytes. This evidence suggests that only ON axons 
may exclusively use lactate as an alternative fuel. For this functional rescue of 
CC axons to occur, both GLUT1 and MCTs were required (Meyer et al., 2018), 
which indicates that lactate has a role in axonal function but is not the sole 
substrate used in physiological conditions. Thus indicating that normally a 
mixture of glucose and lactate are used for ATP generation. However, when 
glucose is not available, lactate is able to partly sustain axon function for a short 
period of time. Many previous studies have found that in both WM and GM, 
lactate does have a role in supporting axonal function in the absence of glucose 
in the cortex, corpus callosum, optic nerve and hippocampus (Brown et al., 
2005; Lauritzen et al., 2014). 
Oligodendrocytes provide a link between glucose uptake, axonal activity 
and metabolic demand (Saab et al., 2016). Neuronal activity is detected through 
the expression of glutamate N-methyl-D-aspartate receptors (NMDARs) on 
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oligodendrocyte processes (Saab et al., 2016), facing the periaxonal space 
(Micu et al., 2016). Activation of NMDARs recruits GLUT1 (glucose transporter 
1) to the membrane to increase glucose transport into oligodendrocytes (Saab 
et al., 2016). This has been described as a “power switch” through which the 
flow of metabolic substrates to neurons via oligodendrocytes can be controlled 
(Krasnow & Attwell, 2016). 
4.1.4 Astrocyte metabolism during ischaemia 
The core of the lesion caused by ischaemia suffers complete loss of 
blood supply, in the penumbra the blood supply is only reduced. In this region 
there is a degree of astrocyte survival as glucose and oxygen delivery is 
decreased, cells resort to other ways to produce energy. Penumbral astrocytes 
may be served by collateral vessels which are not affected by the occlusion. 
Here astrocytes can continue to function to maintain the working of the CNS and 
limit the damage caused by insult. The higher the tolerance of astrocytes to 
ischemia the more viable astrocytes to assist with regaining metabolic 
equilibrium and to ensure neuron survival after insult (Goss et al., 1998; Li et al., 
2008).  
During ischaemic insult all ion and metabolite concentration gradients are 
disrupted which in turn affects normal cellular processes. The disruption of the 
lactate gradient (Machler et al., 2016) may contribute to neuronal cell death as 
neurons are unable to take up lactate, either due to injury or changes in the 
concentration gradients. The homeostatic disruption that occurs during 
ischaemia means that there is increased extracellular potassium, which causes 
release of lactate under physiological conditions (Sotelo-Hitschfeld et al., 2015). 
The lactate that is released may be taken up by neurons if possible or may 
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function as a signalling molecule which can feedback to astrocytes to release 
more lactate. 
It is possible that the lactate and glycogen produced by astrocytes may 
be used by astrocytes in the penumbra to increase their chances of survival 
during ischaemic insult. It has been found that during ischaemia astrocytic gap 
junctions are able to operate (Cotrina et al., 1998), thus allowing the transfer of 
metabolites throughout the astrocyte network (Rouach et al., 2008).  
The therapeutic potential of lactate has been investigated and has been 
found to attenuate neuronal death when administered post insult (Berthet et al., 
2009). In cultured cells, increasing astrocyte glycogen content provided 
protection from hypoxic cell death (Hossain, Roulston & Stapleton, 2014). This 
would suggest that, at least in low oxygen conditions, astrocytes are able to 
utilize glycogen to promote their own and neuronal survival. 
The evidence from the literature suggests that the location of neurons 
determines their metabolic preferences, which can be supplied by both 
astrocytes and oligodendrocytes (Meyer et al., 2018; Rouach et al., 2008) It is 
possible that the ANLS relates to the astrocyte support of neuronal cell bodies 
and to synapses whilst oligodendrocytes are responsible for the maintenance of 
axons. 
In this chapter the role of astrocytic glycogen during acute ischaemia was 
investigated. Previous work by the group has found that the presence of 
glycogen stores conferred ischaemic tolerance in pre-myelinated white matter 
(Fern, 2015). In the following work the role of glycogen in preventing ischaemic 
astrocyte cell death was investigated in adult brain slices, to see if the findings 
would correspond with those for neonatal animals. By preventing the use of 
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astrocyte glycogen stores during OGD it can be determined whether the 
presence of these stores enables astrocytes to survive for longer during an 
ischaemic insult. Our hypothesis was that the presence of glycogen is required 
for astrocyte survival during ischaemic conditions. Glycogenolysis was 
prevented in two ways, firstly with the addition of sodium iodoacetate and 




4.2 RESULTS: SODIUM IODOACETATE INHIBITION OF GLYCOGEN STORES 
During times of high energy demand astrocytes utilize their glycogen 
stores to ensure a supply of metabolic substrate (Sickmann et al., 2009). 
Astrocytes can be prevented from utilizing their glycogen stores through 
treatment with sodium iodoacetate (IA) (figure 4.1). IA blocks the active site of 
glyceraldehyde-3-phosphate dehydrogenase, by binding to cysteine residues 
and stopping the function of the enzyme. Ultimately this prevents the production 
of pyruvate from glycogen sources and so the store cannot be used to fuel the 
cell. Under physiological conditions, IA would interrupt the utilization of glucose 
supplied to the cell. However, in the absence of external glucose, IA will 
selectively prevent access to the glycogen store. 
 
Figure 4.1: Action of sodium iodoacetate (IA). Sodium iodoacetate prevents the 
production of pyruvate in the TCA cycle by blocking the enzyme glyceraldehyde-
3-phosphate dehydrogenase. Under OGD this prevents the utilisation of the 
glycogen store. 
 
4.2.1 IA affected OGD induced astrocyte cell death in CC and DG 
The addition of IA had an effect on OGD induced astrocyte cell death in 
CC (figure 4.1). In the OGD with IA images the majority of astrocytes have died 
and at 100 minutes no cell bodies can be seen in the images (figure 4.2A), 
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which contrasts to OGD only conditions, where the majority of cells survive. In 
the OGD images a GFP “cloud” is often apparent after cells have lysed, this is a 
result of GFP release from astrocytes when the cells die. Treatment with IA had 
a highly significant effect in CC, where the t  value  was significantly decreased 
from 62.00 ± 2.32 to 42.25 ± 3.17 mins with IA, (p=0.0007, figure 4.2B). This 
suggests that cell death occurs more quickly as the time to reach half of the 
maximal cell death is reduced. The addition of IA caused cell death to increase 
from 40.17 ± 6.45% in OGD only conditions to 98.61 ± 1.39% (p=0.001,figure 
4.2C).  
IA treatment also increased the rate of OGD induced astrocyte cell death 
in DG (figure 4.3), the confocal images illustrate similar amounts of cell death in 
both conditions (figure 4.3A).  The rate of cell death in DG was significantly 
decreased by the addition of IA. The t for DG was 54.64 ± 3.30 mins, this was 
reduced to 38.13 ± 4.89 mins with IA (p=0.018, figure 4.3B). The total amount of 
cell death in DG was only slightly increased from 97.61 ± 1.01% to 100 ± 0% 
(not significant), with the addition of IA (figure 4.3C). Comparison of the DG cell 
death profile with that for CC, found that IA treatment made both regions behave 
in the same manner as there was a similar increase in the rate of cell death. 
These findings suggest that glycogen has an important role to play in ischaemic 
insult tolerance in astrocytes. 
Astrocyte cell death at different time points throughout the experiment 
were compared for each region (figure 4.4). From this it can be seen that for CC 
astrocytes the amount of cell death is consistently higher at each time point with 
IA treatment (figure 4.4A). After 30 minutes, OGD induced cell death was 
increased from 0 ± 0% to 38.21 ± 11.51% (p=0.0025). At the end of OGD, 
astrocyte death with IA treatment was increased from 23.11 ± 7.12% to 
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98.61±1.39% (p=<0.0001). This significant increase was present at the end of 
the reperfusion period (p=<0.0001). For DG astrocytes cell death with IA 
treatment was only significantly higher after 30 minutes OGD, where astrocyte 
death was increased from 14.04 ± 7.77% to 55.85 ± 16.09% (p=0.0009). Taken 
together the findings show an increase in the rate of cell death in both fibrous 





Figure 4.2: Sodium Iodoacetate (IA) treatment (2mM) increased OGD induced 
astrocyte cell death in corpus callosum (CC). A: Confocal images during OGD 
(upper panel) and OGD with IA treatment (lower panel). Images taken at 0 and 
100 minutes. Scale bar =20 µm. B: Astrocyte cell death over time. C: total cell 
death at time 100 minutes, OGD only (black bar) and OGD with IA (green bar). 
Error bars = SEM. N numbers = number of cells/number of slices. IA added 





Figure 4.3: Sodium Iodoacetate (IA) treatment (2mM) affected the rate of OGD 
induced astrocyte cell death in dentate gyrus (DG). A: Confocal images during 
OGD (upper panel) and OGD with IA treatment (lower panel. Images taken at 0 
and 100 minutes. Scale bar =20 µm. B: Astrocyte cell death over time. C: total 
cell death at time 100 minutes, OGD only (black bar) and OGD with IA (green 
bar). Error bars = SEM. N numbers = numbers of cells/number of slices. IA 





Figure 4.4: Effect of IA on OGD induced cell death at defined time points in CC 
and DG. Astrocyte cell death after 30 and 60 minutes OGD and at the end of 
reperfusion with OGD only (black bars) and OGD with IA treatment (green bars). 




4.3 RESULTS: 2-DEOXY-GLUCOSE TREATMENT OF ASTROCYTES AND 
OLIGODENDROCYTES 
2-deoxy-glucose (2DOG) is a glucose analogue and once inside the cell is 
phosphorylated by glucose hexokinase which normally phosphorylates glucose. 
This yields 2-deoxy-glucose-6-phosphate, the phosphorylation prevents the 
molecule from leaving the cell (SOLS & CRANE, 1954). The presence of 
phosphorylated 2DOG is mistaken by cells for a supply of glucose and so the 
glycogen stores are preserved and not used (figure 4.5). 
  
Figure 4.5: Action of 2-deoxy-glucose (2DOG). 2-deoxy-glucose is a glucose 
mimic and is phosphorylated by the same hexokinase that phosphorylates 
glucose, preserving glycogen stores.  
 
4.3.1 2DOG affects OGD induced astrocyte cell death in CC and DG 
but not in the ON 
The presence of 2DOG increased astrocyte death in CC (figure 4.6). 
Fewer astrocytes were visible at the end of the reperfusion period in the 
presence of 2DOG than in OGD alone (figure 4.6A). Treatment with 2DOG also 
altered the cell death profile (figure 4.6B). The t value was reduced from 62.00 ± 
2.32 mins to 47.33 ± 5.74 mins (p=0.029), showing the addition of 2DOG 
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increased the rate of cell death. Total astrocyte cell death in CC was 
significantly higher at the end of the perfusion period with 2DOG treatment, 
77.71 ± 8 .73%, than OGD alone, 40.17 ± 6.45% (p=0.0035, figure 4.6C). 
In DG, the images obtained with 2DOG treatment (figure 4.7A lower 
panel) are similar to those for OGD (figure 4.7A upper panel). The addition of 
2DOG did not significantly alter the t value, which for DG was 54.64 ± 3.30 mins 
and with 2DOG was 45.42 ± 3.92 mins (figure 4.7B). The presence of 2DOG 
increased total cell death from 97.61 ± 1.01% to 99.12 ± 0.88% (not significant, 
figure 4.7C). 
ON OGD induced astrocyte cell death was examined in the presence of 
2DOG, as another WM tract, to compare to the results obtained for CC (figure 
4.8). ON astrocytes remain tolerant of the ischaemic insult with 2DOG treatment 
(figure 4.8A). The rate of cell death was similar for both conditions, the t values 
obtained were similar under both conditions (figure 4.8B). The t for ON was 
68.36 ± 6.82 mins and with 2DOG was 63.42 ± 6.03 mins (not significant). The 
total amount of astrocyte cell death was increased with 2DOG treatment, from 
39.42 ± 11.03% to 56.67 ± 9.49% (not significant, figure 4.8C). These findings 
indicate that astrocyte glycogen stores may have a different role in the ON than 
in other regions.  
By comparing the cell death at different time points, it can be seen at 
which phase astrocyte cell death is most affected. 2DOG treatment significantly 
increased OGD induced cell death at each time point in CC (figure 4.9A). After 
30 minutes OGD, 2DOG treatment increased cell death from 0% to 32.38 ± 
15.35% (p=0.019). At the end of OGD, cell death was significantly increased 
from 23.11 ± 7.12% to 64.38 ± 10.38% with 2DOG treatment (p=0.0091). This 
accounts for the majority of cell death in this region in the presence of 2DOG. 
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For DG the 2DOG treatment caused significantly increased cell death during 
early OGD (figure 4.9B). After 30 minutes OGD, 2DOG increased cell death 
from 11.01 ± 4.03% to 32.67 ± 11.40% (p=0.396). In ON, OGD induced 
astrocyte cell death was not significantly altered by 2DOG treatment (figure 
4.9C). These results suggest that the presence of 2DOG increases astrocyte 





Figure 4.6: 2-deoxy-glucose (2DOG) treatment (10µM) increased astrocyte cell 
death in corpus callosum (CC). A: Confocal images of during OGD (upper 
panel) and OGD with 2DOG treatment (lower panel). Images taken at 0 and 100 
minutes. Scale bar =20 µm. B: astrocyte cell death over time. C: total cell death 
at time 100 minutes, OGD only (black bar) and OGD with 2DOG (green bar). 
Error bars = SEM. N numbers = number of cells/number of slices. 2DOG added 





Figure 4.7: 2-deoxy-glucose (2DOG) treatment (10µM) had no effect on 
astrocyte cell death in dentate gyrus (DG). A: Confocal images of during OGD 
(upper panel) and OGD with 2DOG treatment (lower panel). Images taken at 0 
and 100 minutes. Scale bar =20 µm. B: astrocyte cell death over time. C: total 
cell death at time 100 minutes, OGD only (black bar) and OGD with 2DOG 
(green bar). Error bars = SEM. N numbers = number of cells/number of slices. 





Figure 4.8: 2-deoxy-glucose (2DOG) treatment (10µM) had little effect on OGD 
induced astrocyte cell death in optic nerve (ON). A: Confocal images of during 
OGD (upper panel) and OGD with 2DOG treatment (lower panel). Images taken 
at 0 and 100 minutes. Scale bar =20 µm. B: astrocyte cell death over time. C: 
total cell death at time 100 minutes, OGD only (black bar) and OGD with 2DOG 
(green bar). Error bars = SEM. N numbers = number of cells/number of slices. 





Figure 4.9: Effect of 2DOG on OGD induced astrocyte cell death at defined time 
points in CC, DG and ON. Astrocyte cell death after 30 and 60 minutes OGD 
and at the end of reperfusion, with OGD only (black bars) and OGD with 2DOG 
(green bars) treatment. A: corpus callosum. B: dentate gyrus. C: optic nerve. 




4.3.2 2DOG treatment had no effect on OGD induced 
oligodendrocyte cell death 
Astrocytes are not the only glial cells which are affected by ischaemic 
insult; oligodendrocytes are also susceptible to injury. It was investigated 
whether preventing the breakdown of astrocyte glycogen stores impacted 
oligodendrocyte cell death during OGD.  
The presence of 2DOG did not alter oligodendrocyte cell death in CC 
(figure 4.10). Oligodendrocytes survived the length of the experiment under both 
conditions, OGD and OGD with 2DOG (figure 4.10A). The cell death profile with 
2DOG treatment is very similar to that for OGD only conditions (figure 4.10B). 
The addition of 2DOG did not increase OGD induced oligodendrocyte cell death 
(figure 4.10C). Total cell death with was decreased from 1.31 ± 0.71% to 0% 
with 2DOG treatment (not significant). 
In DG, the resilience of oligodendrocytes to acute ischaemia remained 
even with 2DOG treatment (figure 4.11). Most oligodendrocytes survive OGD 
and OGD with the addition of 2DOG (figure 4.11A). Again, in these images (as 
previously mentioned) some cells in the OGD panel appear that they have died, 
however they have gone out of the focal plane due to the swelling of the tissue. 
The addition of 2DOG has only slightly altered the cell death profile in this 
region (figure 4.11B). Total oligodendrocyte cell death was increased from 1.83 
± 1.83% to 3.70 ± 3.70% (not significant, figure 4.11C).  
2DOG treatment during OGD had no effect on OGD induced 
oligodendrocyte cell death in ON (figure 4.12). All oligodendrocytes monitored 
survived for the duration of the experiment, with the focal plane altering slightly 
(figure 4.12A). The cell death profile is unchanged with the administration of 
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2DOG (figure 4.12B). The presence of 2DOG did not cause significant 
oligodendrocyte cell death to occur (figure 4.12C). The total cell death achieved 
was 1.06 ± 0.67% in OGD conditions and 0% with 2DOG treatment. Taking 
these findings into consideration it can be seen that 2DOG treatment, 
preventing the utilization of glycogen stores, has no effect on OGD induced 





Figure 4.10: 2-deoxy-glucose (2DOG) treatment (10µM) had no effect on OGD 
induced oligodendrocyte cell death in corpus callosum (CC). A: Confocal 
images during OGD (upper panel) and OGD with 2DOG treatment (lower 
panel). Images taken at 0 and 100 minutes. Scale bar =20 µm. B: 
oligodendrocyte cell death over time. C: total cell death at time 100 minutes, 
OGD only (black bar) and OGD with 2DOG. Error bars = SEM. N numbers = 




Figure 4.11: 2-deoxy-glucose (2DOG) treatment (10µM) had no effect on OGD 
induced oligodendrocyte cell death in dentate gyrus (DG). A: Confocal images 
during OGD (upper panel) and OGD with 2DOG treatment (lower panel). 
Images taken at 0 and 100 minutes. Scale bar =20 µm. B: oligodendrocyte cell 
death over time. C: total cell death at time 100 minutes, OGD only (black bar) 
and OGD with 2DOG (green bar). Error bars = SEM. N numbers = number of 





Figure 4.12: 2-deoxy-glucose (2DOG) treatment (10µM) had no effect on OGD 
induced oligodendrocyte cell death optic nerve (ON). A: Confocal images during 
OGD (upper panel) and OGD with 2DOG treatment (lower panel). Images taken 
at 0 and 100 minutes. Scale bar =20 µm. B: oligodendrocyte cell death over 
time. C: total cell death at time 100 minutes, OGD only (black bar) and OGD 
with 2DOG. Error bars = SEM. N numbers = number of cells/number of slices. 





Figure 4.13: 2DOG treatment had no effect on OGD induced oligodendrocyte 
cell death at defined time points in CC, DG and ON. Oligodendrocyte cell death 
after 30 and 60 minutes OGD and at the end of reperfusion with OGD only 
(black) and OGD with 2DOG treatment (green). A: corpus callosum. B: dentate 
gyrus. C: optic nerve Error bars = SEM.  
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4.3.3 Results: Comparison of 2DOG treatment on glial cells 
Oligodendrocyte cell death at defined time points was compared to see 
the effects of 2DOG treatment (figure 4.13). Comparisons were carried out for 
each region and found that the presence of 2DOG during OGD did not 
significantly alter oligodendrocyte cell death, in any region (CC figure 4.13A, DG 
figure 4.13B and ON figure 4.13C). 
When comparing the effects of 2DOG treatment on each glial cell type, it 
was found that 2DOG had a greater effect on astrocyte cell death (figure 4.14). 
For each region the total astrocyte cell death was significantly higher than the 
total oligodendrocyte cell death. In CC, the difference in total cell death was 
from 77.71 ± 8.73% in astrocytes to 0% in oligodendrocytes, (p=<0.0001, figure 
4.14A and B). In DG, astrocyte cell death was 99.12 ± 0.88%, whilst 
oligodendrocyte cell death was only 3.70 ± 3.70%, (p=<0.0001, figure 4.14C 
and D). In ON, the astrocyte cell death with 2DOG treatment was 56.67 ± 
9.49%, whereas oligodendrocyte death was 0%, (p=0.0001, figure 4.14E and 
F). These findings show that blocking glycogenolysis had a much greater effect 





Figure 4.14: 2-deoxy-glucose (2DOG) treatment (10µM) increased OGD 
induced astrocyte cell death only. A: corpus callosum, OGD induced cell death 
over time. B: corpus callosum, total OGD induced cell death. C: dentate gyrus, 
OGD induced cell death over time. D: dentate gyrus, total OGD induced cell 
death. E: optic nerve, OGD induced cell death over time. F: optic nerve, total 
OGD induced cell death. Error bars = SEM. Astrocytes (black), 





4.4 RESULTS: GLYCOGEN STAINING – PERIODIC ACID SCHIFF STAIN 
At first this method of staining seemed quite promising, however it soon 
became apparent that the white matter was heavily stained, whereas the grey 
matter was not stained to the same extent. The pink staining was also found to 
be widespread throughout the region (WM) and did not appear to be restricted 
to astrocytes (figure 4.15). It would have been expected that the staining would 
be confined to astrocytes as they are the major glycogen store of the brain. 
From this and reports in the literature it was clear that this is not a reliable 
method to visualise glycogen stores in astrocytes. Recently is has been 
proposed that the PAS stain may in fact stain for glycoproteins as well as 
cellular glycogen, therefore resulting in widespread staining. 
Due to the limitations that were discovered using this stain an alternative 
method needed to be found. There are no commercially available glycogen 
antibodies. However, we were able to obtain an aliquot of an anti-glycogen IgM 
courtesy of Professor Hitoshi Ashida’s group in Japan. This antibody has been 







Figure 4.15: Example of PAS stain and co-staining with GFAP. Upper panel 
images taken with x20 objective. Lower panel taken using x40 objective. Both 
panels show images of the corpus callosum. Pink colouration is the product of 
the PAS stain, green is GFAP, merge shows overlay of the two images. Grey 




4.5 RESULTS: GLYCOGEN STAINING – ANTI-GLYCOGEN ANTIBODY 
After observing the effects of IA and 2DOG on astrocyte cell death during 
OGD, astrocyte glycogen levels were examined in each region (CC and DG) 
during OGD, OGD with glycogenolysis block and aCSF only conditions. This 
was achieved using fixed brain slices which were incubated with an anti-
glycogen IgM antibody. The slices were fixed after undergoing OGD, OGD with 
2DOG or aCSF only.  
The confocal images of CC stained for glycogen are Z projections of fixed 
sections (figure 4.16A). The upper panel shows control slices (aCSF), the 
central panel shows OGD slices and the lower panel shows OGD slices treated 
with 2DOG. In the first column GFP expressed by astrocytes is green, glycogen 
granules are shown in red in the second column and the third column is the 
merged image (GFP and glycogen). In the final column images have undergone 
“RG2B co-localization” in which co-localised red and green pixels are displayed 
as blue. Quantification of co-localised pixels was carried out by measuring the 
intensity of co-localised pixels, given in arbitrary units (AU) (figure 4.16B).  
In CC, after OGD the amount of astrocytic glycogen is significantly 
reduced in surviving cells from 7.08 ± 0.25 AU in control (aCSF) to 5.49 ± 0.28 
AU after OGD, (p=0.0014, figure 4.16B). The presence of 2DOG preserves the 
astrocyte glycogen stores, which is visible in those cells which have survived 
OGD. 2DOG treatment maintained glycogen levels which were 7.06 ± 0.47 AU 
after OGD. This was significantly higher than levels seen after OGD (p=0.0139) 
and was not significantly different from control levels. These findings show the 
presence of viable astrocytes after OGD and suggests that in CC, 2DOG is 




Confocal images of DG astrocyte glycogen levels were obtained as for CC 
astrocytes (figure 4.17A arranged as for figure 4.17A). Quantification of 
astrocyte glycogen was carried out and was as co-localised pixel intensity 
(figure 4.17B). After OGD, astrocyte glycogen levels in DG astrocytes were 
reduced from 10.32 ± 0.39 AU in control (aCSF) to 9.34 ± 0.73 AU (not 
significant) in surviving cells. The addition of 2DOG caused DG astrocyte 
glycogen levels to be significantly reduced when compared to control 
(p=0.0077). Here, astrocyte glycogen dropped to 7.83 ± 0.85 AU. This region 
had fewer viable astrocytes after OGD and after OGD with 2DOG treatment and 
so measurements were limited to the surviving cells. 
The amount of astrocyte glycogen co-localisation was compared for the 
two regions (figure 4.18). It was found that the DG contained significantly more 
astrocyte located glycogen than the CC (p=<0.0001). The levels seen in CC 
were 7.08 ± 0.25 AU, whereas in DG levels were higher at 10.32 ± 0.39 AU. 
These findings suggest that DG astrocytes naturally have larger glycogen stores 
than CC astrocytes. The evidence shows that for both regions glycogen stores 
are depleted after one hour of OGD in surviving astrocytes. However, it would 





Figure 4.16: Changes in astrocyte glycogen levels in different conditions in 
corpus callosum (CC). A: confocal images of Z projections from fixed frozen 
sections showing glycogen staining. Green is GFP, red is glycogen, “RG2B co-
localization” shows co-localised pixels in blue. Scale bars = 20µm. B: 
quantification of glycogen staining in whole cells. Error bars = SEM. N numbers 
= number of cells/number of regions of interest.  
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Figure 4.17: Changes in astrocyte glycogen levels in different conditions in 
dentate gyrus (DG). A: confocal images of Z projections showing glycogen 
staining. Green is GFP, red is glycogen, “RG2B co-localization” shows co-
localised pixels in blue. Scale bars = 20µm. B: quantification of glycogen 
staining in whole cells. Error bars = SEM. N numbers = number of cells/number 





Figure 4.18: Higher levels of glycogen are found in DG. Comparison of glycogen 
co-localisation in CC (black bar) and DG (green bar) found significantly more 





4.6 DISCUSSION: ROLE OF ASTROCYTIC GLYCOGEN IN ISCHAEMIA 
In this chapter the role of astrocytic glycogen stores during acute 
ischaemic insult was examined. I also investigated whether these stores 
affected glial survival during and after injury. The presence of astrocytic 
glycogen is known to promote neuronal survival (Swanson & Choi, 1993), 
however the role that glycogen may play in glial response to insult has not been 
widely investigated in adult models. Fern (2015) found in neonatal WM that the 
presence of glycogen increased tolerance to ischaemic injury. It is possible that 
astrocytes use glycogen to extend their own survival for a limited time, during 
ischaemia. 
4.6.1 Glycogen stores contribute to astrocyte survival. 
The inhibition of glycogenolysis with IA or 2DOG significantly increased 
OGD induced astrocyte cell death (p=0.0001) in CC (figures 4.2 and 4.6). 
Blocking access to glycogen stores caused astrocytes in this WM region to 
behave like GM astrocytes and experience extensive cell death. The use of IA 
achieved a more dramatic effect in CC than in DG (figure 4.2B and C), while 
2DOG had no significant effect upon DG astrocyte death (figure 4.7C). This may 
be due to fact that the maximum amount of cell death in DG is already achieved 
with OGD, thus limiting any effect of the metabolic block upon cell death. In 
support of this interpretation, block of glycogen utilization in the DG resulted in 
cell death beginning significantly earlier time point (figure 4.3 and 4.7) in the 
presence of IA or 2DOG. In ON, the addition of 2DOG treatment increased OGD 
induced cell death, although this was not significant and was not to the same 
extent in the CC. This suggests a lesser role for glycogen in ON and that the 
tolerance of these cells to ischaemia may be due to other mechanisms. The lack 
of astrocyte cell death in the presence of 2DOG illustrates the heterogeneous 
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nature of the astrocyte population. The ON was examined as previous work had 
been carried out on pre-myelinated ON (P0-P2), which found that glycogen was 
necessary for axonal function during ischaemic conditions (Fern, 2015).  
The evidence here shows that the glycogenolysis and the utilization of 
the resulting metabolites is required for CC astrocyte survival during acute 
ischaemic insult. In DG, the presence of glycogen stores delays OGD induced 
cell death, however even with functioning glycogenolysis these cells remain 
very sensitive to ischaemic injury. In the adult ON, glycogen does not appear to 
be significant for astrocyte survival in ischemic conditions. 
4.6.2 Glycogen levels vary between regions and conditions  
Immunofluorescence staining of brain sections allowed the levels of 
astrocyte glycogen in CC and DG to be visualised and quantified. The effect of 
OGD and OGD with 2DOG on astrocyte glycogen levels in these regions was 
investigated in the surviving cells. 
When the co-localised glycogen levels were compared in CC and DG, it 
was found that DG contained significantly more (p=<0.0001) astrocytic glycogen 
than CC (figure 4.18). This finding corresponds with the literature, where it has 
been found that the highest amounts of glycogen are in the hippocampus (Oe et 
al., 2016). The DG is a region of high energy demand which will need to utilize 
these larger glycogen stores for synthesis of glutamine, during which pyruvate 
derived from glycogen is preferred (Gibbs et al., 2007). Glycogenolysis is also 
utilized for glutamate uptake through the fuelling of the NKA (Xu et al., 2013) for 
sodium extrusion which is the driving force for glutamate uptake. The discovery 
that glycogen is involved in memory and learning (Gibbs, Anderson & Hertz, 
2006) also explains the high levels that are seen in the hippocampus. However, 
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it is interesting that higher levels of glycogen seen here in the DG does not 
correspond to ischaemic protection, even though preventing access to glycogen 
stores increased cell death in CC. This suggests the presence of glycogen does 
not equate to cell survival during ischaemia.  
In CC there was significant decrease (p=0.0014) in astrocyte glycogen 
levels after one hour OGD (figure 4.16). Glycogen was present in viable 
astrocytes at the end of OGD, these cells had retained their morphology and 
had not lost their cytoplasmic GFP despite the ischaemic insult. This would 
suggest that not only are CC astrocytes tolerant to insult but that there is a role 
for glycogen during ischaemic insult. When 2DOG was administered in CC, the 
glycogen stores were effectively protected in surviving astrocytes, showing that 
glycogenolysis was successfully inhibited during OGD (figure 4.16B). It is 
possible that surviving astrocytes are able to utilize stores before cell death due 
to the resilience of cells and glycolytic nature of astrocytes (Supplie et al., 2017).  
The changes in DG astrocyte glycogen levels after OGD and OGD with 
2DOG differed to those seen in CC. In DG, astrocyte glycogen levels were 
reduced in surviving astrocytes after OGD, however this was not significant 
when compared to control conditions (figure 4.17B). This suggests that DG 
astrocyte glycogen stores are not accessed to the same extent as CC astrocyte 
glycogen stores, which may be due to the sensitivity of DG astrocytes to 
ischaemia. The significant reduction in the surviving astrocyte glycogen levels 
seen in the presence of 2DOG may be due to the catastrophic cell death that 
occurs under these conditions. The lack of viable cells after injury results in a 
loss of astrocyte glycogen in the region, even if glycogenolysis was successfully 
inhibited. The addition of 2DOG seemed to stress DG astrocytes and greatly 
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increased the sensitivity of these cells to ischaemia. This caused widespread 
cell death, which resulted in few surviving cells.  
The evidence obtained suggests that glycogen is used  to aid astrocyte 
survival during and after ischaemic insult in the CC.. The finding of higher 
glycogen levels in the DG is consistent with the high metabolic demand that 
exists in this region as glycogen is required for glutamatergic transmission 
(Sickmann et al., 2009). The higher levels of glycogen in DG astrocytes did not 
prevent ischaemic induced cell death. This would suggest that there are 
differences in cell death mechanisms between regions. Also the glycogen in this 
region must have a specific role, such as neurotransmitter synthesis. 
4.6.3 Glycogen stores are not utilized by oligodendrocytes 
The discovery that oligodendrocytes   show tolerance to acute ischaemic 
insult has raised questions as to how they are able to survive acute ischaemic 
injury. Thus, the role of glycogen in oligodendrocyte survival was investigated. 
When astrocytic glycogen stores were inhibited, the lack of access to lactate 
had no effect on oligodendrocyte ischaemic cell death (figures 4.10-4.13). This 
suggests that metabolic products from glycogenolysis are not used by 
oligodendrocytes during ischaemic insults and their tolerance to ischaemic 
injury is due to a different mechanism. When investigating the role of glycogen 
store inhibition on oligodendrocytes only 2DOG was used as this fully prevented 
the breakdown of glycogen stores. Whilst IA prevents the utilization of the stores 
after their breakdown, via the inhibition of the enzyme responsible for the sixth 










5 GLIA AND GLUTAMATE RECEPTORS 
5.1 INTRODUCTION 
It has been shown that astrocytes and oligodendrocytes can express both 
NMDA and AMPA/kainate ionotropic glutamate receptors (GluRs) (Burnashev, 
1996; Conti et al., 1996). Binding of glutamate to the GluRs produces opening of 
the receptor pore, allowing the influx of cations and triggering intracellular 
increases in ion concentrations and depolarization. The influx of ions through 
NMDA GluRs may be prevented through endogenous magnesium block, which 
occludes the pore opening, this block is voltage dependent (Mayer, Westbrook 
& Guthrie, 1984; Nowak et al., 1984). Regional variability in astrocyte GluR 
expression levels has been suggested (Dzamba et al., 2015), which would 
result in location dependent amounts of GluR mediated ion influx. 
The subunit arrangement of GluRs affects the permeability of receptor 
pore to various ions (Dzamba, Honsa & Anderova, 2013). Investigation of these 
subunits determined that the GluRs expressed by glial cells are more 
permeable to calcium ions that other GluRs (Burnashev, 1996), and those 
expressed by astrocytes have low calcium permeability (Kirischuk, Parpura & 
Verkhratsky, 2012; Palygin et al., 2010). GluRs are also permeable to cations 
such as sodium and potassium (Dzamba, Honsa & Anderova, 2013). Sodium 
influx into astrocytes is involved in physiological and cytotoxic cell swelling 
which precedes ischaemic cell death and will be further discussed in the next 
chapter. 
5.1.1 Astrocytes and glutamate receptors 
Astrocytes express both NMDA and AMPA/kainate receptors 
(Burnashev, 1996; Conti et al., 1996). This has triggered further investigation 
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into the role of glial GluRs. The known involvement of GluRs in ischaemia 
induced neuronal cell death via excitotoxicity (Coyle et al., 1981; Lucas & 
Newhouse, 1957; Pulsinelli, Sarokin & Buchan, 1993), identified GluRs as a 
suitable target to examine for a role ischaemic astrocyte cell death. 
Both NMDA and AMPA/kainate receptors are permeable to calcium and 
other ions. Under physiological conditions this contributes to the astrocyte 
homeostatic maintenance of the extracellular space (ECS). For AMPA/kainate 
receptors, the amount of GluR2 subunits incorporation into the receptor 
determines the receptor permeability to calcium, a lower level of expression 
results in increased permeability (Hollmann, Hartley & Heinemann, 1991; Jonas 
& Burnashev, 1995). The AMPA/kainate receptor channels are also permeable 
to sodium and potassium ions allowing more of these ions to pass through when 
the receptor is activated (Citri & Malenka, 2008). 
The presence of GluRs on astrocytes suggests they have a physiological 
role to play. The important role that has been discovered for GluRs is 
involvement in neuron to glia signalling. There are two possible routes that two-
way communication can occur, through the ectopic release of neurotransmitters 
(Araque, Carmignoto & Haydon, 2001) or via gap junction connections (Alvarez-
Maubecin et al., 2000). 
The activation of AMPA/kainate and NMDA receptors triggers an 
increase astrocyte intracellular calcium concentration (Kim, Rioult & Cornell-
Bell, 1994; Müller et al., 1993). In astrocytes this calcium increase can be 
transmitted to other astrocytes via gap junctions, producing calcium waves 
across the astrocyte syncytium (Charles et al., 1991; Cornell-Bell et al., 1990; 
Dani, Chernjavsky & Smith, 1992). This will then inform and direct astrocyte 
responses to neuronal communication. Cortical NMDA receptors have been 
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found to be more sensitive to glutamate than AMPA receptors (Lalo et al., 
2006). Lalo et al. (2006) determined the glutamate EC50 for each receptor in 
cortical astrocytes, for NMDA receptors the EC50 was 1.9 ± 0.5µM and for 
AMPA receptors the EC50 was 52.1 ± 14.06µM. This suggests that astrocytes 
can detect different concentrations of extracellular glutamate, also that different 
concentrations of glutamate may elicit diverse responses from astrocytes. 
Glutamate can be utilized as a metabolite, when converted into α-ketoglutarate 
which can then enter the TCA cycle to generate ATP (McKenna, 2007). 
Approximately 20% of glutamate taken up by astrocytes is converted and lost to 
the TCA cycle (Hertz et al., 2015; McKenna, 2013). 
It is widely accepted that astrocytes are resistant to excitotoxicity. 
However, it has been found that over activation of AMPA receptors can be 
severely damaging to neocortical astrocytes (David et al., 1996), showing that 
immature astrocytes have an increased sensitivity to higher glutamate levels 
than mature cells, which are resistant to excitotoxicity. It has been reported that 
a transient increase in glutamate concentration can cause astrocyte cell 
swelling and longer exposures caused oxidative stress in cells, which goes on to 
trigger cell death (Chen, Liao & Kuo, 2000). 
5.1.2 Oligodendrocytes and glutamate receptors 
Oligodendrocytes were initially thought to only express AMPA/kainate 
receptors (Gallo et al., 1994; Patneau et al., 1994). These receptors are 
involved in CNS development and in pathological oligodendrocyte damage. It 
has now been shown that NMDA receptor expression is normal for WM 
oligodendrocytes (Karadottir et al., 2005). The receptors found on 
oligodendrocytes have a specific subunit composition, containing mainly NR1, 
NR2C and NR3 subunits (Karadottir et al., 2005). The binding of glutamate to 
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oligodendrocyte located GluRs causes intracellular increase of calcium, either 
by influx of calcium across the cell membrane (Willard & Koochekpour, 2013) or 
release from internal calcium stores (Micu et al., 2016). Further investigation 
found that NMDA receptors are predominantly localised to oligodendrocyte 
processes and are involved in ischaemic injury via calcium influx and 
accumulation, triggered by excitotoxicity (Micu et al., 2006; Salter & Fern, 2005). 
Recently, the group has established that axonal vesicular glutamate release is 
the source of glutamate responsible for excitotoxic myelin damage (Doyle et al., 
2018). It was also determined that injury was mediated by NMDA receptors 
containing GluN2C/D subunits. 
In oligodendrocytes, GluRs are used for neuron to glia signalling and 
myelin located receptors are in a perfect position to respond to axonal glutamate 
release. During development axons use glutamate to signal to oligodendrocyte 
precursor cells via AMPA/kainate receptors (Kukley, Capetillo-Zarate & Dietrich, 
2007), which may allow the identification of axons. Glutamate activation of 
NMDA receptors on precursor cells initiates their differentiation into myelinating 
oligodendrocytes via the (Lundgaard et al., 2013). Recently it has been 
discovered that signalling occurs between neuronal axons and the covering 
myelin sheath (Micu et al., 2016). This kind of axonal signalling has been 
implicated in communicating axonal metabolic demand to glial cells 
(Funfschilling et al., 2012).  
5.1.3 Glutamate receptors involvement in ischaemic glial injury 
The main mechanism of acute ischaemic neuronal cell death is 
excitotoxicity, whereby increased concentrations of glutamate over-activate 
GluRs causing a cytotoxic influx of calcium (Coyle et al., 1981; Lucas & 
Newhouse, 1957; Pulsinelli, Sarokin & Buchan, 1993). The increase in 
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intracellular calcium also causes accumulation of calcium within mitochondria. 
This increase depolarizes the mitochondrial membrane triggering the release of 
apoptotic factors (Matute, 2006). This cell death mechanism is also responsible 
for oligodendrocyte cell death after ischaemic insult. Initially, oligodendrocyte 
excitotoxicity was thought to be caused by AMPA/kainate receptors (Matute et 
al., 2002). However, with the discovery of oligodendrocyte NMDA receptor 
expression, it has now been suggested that the different kinds of receptors may 
be responsible for different kinds of injury. 
Salter and Fern (2005) found that over-activation of NMDA receptors 
caused process loss in P10 ON oligodendrocytes and suggested that there may 
be differential expression of GluRs (Salter & Fern, 2005). They also suggested 
that NMDA receptors are responsible for injury to processes after insult, whilst 
AMPA/kainate receptors may be responsible for cytotoxicity (Salter & Fern, 
2005). Excitoxicity is not only responsible for process loss and cell death but 
also causes damage and vacuolation to myelin (Pantoni, Garcia & Gutierrez, 
1996). The excessive activation of particularly AMPA/kainate receptors was 
found to cause widespread death of cultured cortical astrocytes (David et al., 
1996). Increased levels of glutamate can cause astrocyte cell swelling and 
prolonged exposure caused cell death, most likely via oxidative stress (Chen, 
Liao & Kuo, 2000).  
Previous work has found that in P2 mice, astrocyte cell death was due to 
cytotoxic influx of calcium (Fern, 1998). However, the mechanism of ischaemic 
astrocyte cell death changes with age of the animal and the point of 
development. In P10 mice it was found that cell death was the result of sodium 
influx, which was suggested to occur via the sodium-potassium-chloride co-
transporter 1 (NKCC1) (Salter & Fern, 2008; Thomas et al., 2004). In this 
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chapter the involvement of calcium and GluRs were investigated to see their 
effect on glial cell death and to determine whether the mechanism for adult 
ischaemic cell death is different to that for P10 animals. Here the hypothesis 






5.2 RESULTS: ZERO CALCIUM CONDITIONS INCREASED OGD INDUCED 
ASTROCYTE CELL DEATH 
Studies investigating ischaemia induced neuronal death have established 
that it is a calcium dependent process. First, it was examined whether calcium 
was required for OGD induced astrocyte cell death. Slices that underwent OGD 
did so with either normal calcium or calcium-free OGD aCSF. Calcium-free 
OGD aCSF contained a calcium chelator (EGTA 0.05mM), thereby lowering 
extracellular calcium during the OGD period and reduces calcium influx into 
cells. 
Contrary to the effect seen on neuronal cell death previously reported, 
zero calcium conditions increased OGD induced astrocyte cell death in CC 
(figure 5.1). Few astrocytes survive in the confocal images of OGD with zero 
calcium (figure 5.1A). The use of calcium-free aCSF caused a significant 
reduction in the t value from 62.00 ± 2.32 mins to 48.58 ± 2.81 mins (p=0.0034, 
figure 5.1B). This suggests a lack of external calcium increased the rate of OGD 
induced cell death. The total amount of cell death was significantly higher with 
OGD and zero calcium conditions, cell death was increased to 97.17 ± 1.91% 
from 40.17 ± 6.45 (p=<0.0001, figure 5.1C).  
In DG cell death was already high at 97.61 ± 1.01%, with zero calcium this 
was increased to 99.28 ± 0.73% (not significant, figure 5.2C). The removal of 
calcium from the aCSF caused a decrease in t value from 54.64 ± 3.30 mins to 
40.83 ± 3.12 mins (p=0.012, figure 5.2B). The DG confocal images show little 
difference between astrocytes that underwent OGD only and those that 
experienced OGD without calcium, widespread cell death is seen under both 
conditions (figure 5.2A). 
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The OGD induced astrocyte cell death was compared between the two 
conditions for each region at defined time points throughout the experiment 
(figure 5.3). For CC the removal of calcium from the aCSF caused OGD induced 
cell death to be significantly increased at each time point (figure 5.3A). After 30 
minutes OGD cell death was increased from 0 ± 0% to 22.54 ± 8.74% without 
calcium (p=0.0476). The significance of increased cell death was greater as the 
experiment progressed. At 60 minutes OGD cell death increased from 22.11 ± 
7.12% to 93.06 ± 4.10%, (p=<0.0001) whereas at the end of reperfusion cell 
death had increase from 40.17 ± 6.45% to 97.17 ± 1.91% (p=<0.0001). This 
suggests that a lack of calcium increased CC astrocyte sensitivity to OGD.  
For DG, only one time point was significantly increased, this was after 30 
minutes OGD (figure 5.3B). Here, cell death was increased from 14.04 ± 4.77% 
to 49.59 ± 10.89% (p=0.0006). Zero calcium conditions caused DG astrocytes 
to become very sensitive to the initial ischaemic insult. Taken together these 
results suggest that ischaemia induced CC and DG astrocyte cell death occurs 
in an external calcium independent manner. The removal of calcium did not 





Figure 5.1: Zero Calcium conditions increased OGD induced astrocyte cell 
death in corpus callosum (CC). A: Confocal images of during OGD (upper 
panel) and OGD with 0 Ca (lower panel). Images taken at 0 and 100 minutes. 
Scale bar = 20 µm. B: Astrocyte cell death over time. C: Total cell death at time 
100 minutes, OGD only (black bar) and OGD with 0Ca2+ (green bar). Error bars 





Figure 5.2: Zero Calcium conditions increased the rate of OGD induced 
astrocyte cell death in dentate gyrus (DG). A: Confocal images of during OGD 
(upper panel) and OGD with 0 Ca (lower panel). Images taken at 0 and 100 
minutes. Scale bar = 20 µm. B: Astrocyte cell death over time. C: Total cell 
death at time 100 minutes, OGD only (black bar) and OGD with 0Ca2+ (green 





Figure 5.3: Zero calcium conditions altered cell death at defined time points. A: 
corpus callosum, B: dentate gyrus. Cell death at 30 and 60 minutes OGD the 
end of reperfusion, with (black bars) and without calcium (green bars). Error 




5.3 RESULTS: EFFECT OF GLUTAMATE RECEPTOR INHIBITORS ON GLIAL 
CELL DEATH 
Glutamate receptor antagonists have been found to increase neuronal 
survival during ischaemic insults (Pulsinelli, Sarokin & Buchan, 1993). 
Astrocytes and oligodendrocytes also express GluRs and so it was investigated 
whether inhibiting these receptors would have an effect on OGD induced glial 
cell death. The inhibitors used were NBQX (2,3-dioxo-6-nitro-1,2,3.4-
tetrahydrobenzo[ƒ]quinoxaline-7-sulfonamide) which blocks AMPA receptors 
and MK801 ((5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-
5,10-imine maleate) which blocks NMDA receptors. Brain slices were incubated 
with these inhibitors for 20 minutes prior to OGD exposure, to allow the 
inhibitors to penetrate the slices.  
5.3.1 Results: Glutamate receptor inhibitors NBQX and MK801 
increased OGD induced astrocyte cell death in CC 
Inhibiting AMPA and NMDA GluRs increased OGD induced astrocyte cell 
death in CC (figure 5.4). In the confocal images, the effect of the addition of 
NBQX and MK801 shows there are fewer surviving astrocytes (figure 5.4A). The 
presence of the antagonists had no effect on the rate of cell death, as the t 
values for both conditions were similar (figure 5.4B). For CC the t value was 
62.00 ± 2.32 mins, whilst with antagonists the value was 55.42 ± 2.63 mins (not 
significant) The total amount of cell death was significantly increased from 40.17 
± 6.45% to 67.93 ± 4.86% with the addition of antagonists, p=0.0093 (figure 
5.4C).  
In DG treatment with GluR inhibitors caused no significant change in 
OGD induced astrocyte cell death (figure 5.5). The addition of NBQX and 
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MK801 increased the resistance of some astrocytes to OGD, illustrated by the 
confocal images (figure 5.5A). The t value with the addition of inhibitors was 
found to be similar to that for OGD only, 55.38 ± 6.60 mins and 54.64 ± 3.30 
mins respectively (figure 5.5B). The total cell death achieved with the use of 
GluRIs was lower than that for OGD alone, 92.49 ± 3.44% and 97.61 ± 0.01% 
respectively (not  significant, figure 5.5C). The addition of NBQX and MK801 
caused a rise in OGD induced cell death to occur in CC, whereas in DG, OGD 





Figure 5.4: Glutamate receptor inhibitors NBQX (20µM) and MK801 (10µM) 
increased OGD induced astrocyte cell death in corpus callosum (CC). A: 
Confocal images during OGD (upper panel) and OGD with NBQX and MK801 
(lower panel). Images taken at 0 and 100 minutes. Scale bar = 20 µm. B: 
Astrocyte cell death over time. C: Total cell death at time 100 minutes, OGD 
only (black bar) and OGD with NBQX and MK801 (green bar). Error bars = 





Figure 5.5: Glutamate receptor inhibitors NBQX (20µM) and MK801 (10µM) had 
no effect on OGD induced astrocyte cell death in dentate gyrus (DG). A: 
Confocal images during OGD (upper panel) and OGD with NBQX and MK801 
(lower panel). Images taken at 0 and 100 minutes. Scale bar = 20 µm. B: 
Astrocyte cell death over time. C: Total cell death at time 100 minutes, OGD 
only (black bar) and OGD with NBQX and MK801 (green bar). Error bars = 




5.3.2 Results: MK801 alone increased OGD induced astrocyte cell 
death in CC 
To determine whether the cause of this increase cell death during OGD 
in the CC was due to NMDA or AMPA receptors, slices were treated with 
MK801 alone. MK801 selectively inhibits NMDA receptors, leaving AMPA GluR 
free to be activated. Previous work investigating oligodendrocytes has 
determined that AMPA receptors may be responsible for cytotoxic injury (Matute 
et al., 1997; Micu et al., 2006; Salter & Fern, 2005). The addition of MK801 
increased OGD induced astrocyte loss in CC, which can be seen in the confocal 
images (figure 5.6A). NMDA GluR inhibition caused a significant reduction in t 
value from 62.00 ± 2.32 mins to 50.67 ± 2.02 mins (p=0.004, figure 5.6B). The 
total amount of cell death obtained by using MK801 was significantly increased 
from 40.17 ± 6.45% to 94.49 ± 2.61% (p=<0.0001, figure 5.6C).  
In the DG, the presence of MK801 during OGD resulted in widespread 
astrocyte death as seen in the confocal images (figure 5.7A). By inhibiting 
NMDA GluRs the cell death profile was shifted and there was a significant 
reduction in t value. For DG, this was 54.64 ± 3.30 mins and with MK801 this 
was decreased to 39.75 ± 3.53 mins (p=0.0105, figure 5.7B). The total amount 
of cell death achieved with MK801 was increased from 97.61 ± 1.01% with OGD 
and 100 ± 0% with MK801 (not significant, figure 5.7C).Taken together these 
findings suggest that NMDA GluRs may have a protective role in cytotoxic 
astrocyte cell death, as increased cell death was observed when NMDA 





Figure 5.6: MK801 treatment increased OGD induced astrocyte cell death in 
corpus callosum (CC). A: Confocal images during OGD (upper panel) and with 
MK801 (lower panel) Images taken at 0 and 100 minutes. Scale bars = 20µm. B: 
Astrocyte cell death over time. C: Total cell death at 100 minutes, OGD only 
(black bar) and OGD with MK801 (green bar). Error bars = SEM. N numbers = 





Figure 5.7: MK801 treatment had no effect on OGD induced astrocyte cell death 
in dentate gyrus (DG). A: Confocal images during OGD (upper panel) and with 
MK801 (lower panel) Images taken at 0 and 100 minutes. Scale bars = 20µm. B: 
Astrocyte cell death over time. C: total cell death at 100 minutes, OGD only 
(black bar) and OGD with MK801 (green bar). Error bars = SEM. N numbers = 




5.3.3 Results: Comparison of glutamate receptor inhibitor 
combinations 
The effect of the combinations of GluR antagonists used was compared 
to determine the potential role of AMPA receptors in astrocyte cell death (figure 
5.8). In CC, inhibiting NMDA receptors caused cell death to occur at a similar 
rate to the inhibition of both receptors, the t values been 55.42 ± 2.63 mins and 
50.67 ± 2.02 mins (not significant, figure 5.8A). The use of MK801 alone 
resulted in significantly increased cell death in CC of 94.49 ± 2.61%, when 
compared with that achieved with both inhibitors 67.93 ± 4.86% (p=0.0007, 
figure 5.8C). The comparison of different time points found that in CC, there 
were no significant differences in cell death after 30 minutes OGD (figure 5.8E). 
However, after 60 minutes OGD the use of both inhibitors significantly increased 
astrocyte death when compared to OGD from 23.11 ± 7.12% to 51.21 ± 6.46% 
(p=0.0092, figure 5.8E) and using MK801 further increased this to 88.72 ± 
2.35%.(p=<0.0001, figure 5.8E). At the end of reperfusion (100 minutes) the use 
of inhibitors caused significantly higher cell death when compared to OGD 
alone, p=0.0075 with NBQX and MK801 and p=<0.0001 with MK801 only (figure 
5.8E).  
In DG the cell death profiles were found to be similar (figure 5.8B), 
although MK801 treatment caused cell death to begin earlier at 20 minutes 
rather than 35 minutes with NBQX and MK801. The t value obtained from 
MK801 only treatment was significantly lower than that for both inhibitors, 39.75 
± 3.53 mins and 55.38 ± 6.60 mins respectively (p=0.021). The total cell death 
achieved using MK801 was significantly higher than when both inhibitors were 
used (p=0.0246, figure 5.8D). The comparison of cell death at defined time 
points revealed that at 30 minutes, OGD with MK801 resulted in significantly 
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higher cell death when compared to values for OGD only, 52.46 ± 11.43% with 
MK801 and 14.64 ± 4.77% with OGD, (p=0.0334, figure 5.8F). The only other 
significant difference seen was at the end of reperfusion where MK801 
treatment resulted in greater cell death than the presence of both inhibitors, 100 
± 0% and 92.49 ± 3.44% respectively, (p=0.0156, figure 5.8F). These findings 
would suggest that there is a role for AMPA receptors in OGD induced astrocyte 
cell death, as the inhibition of NMDA receptors caused increased cell death in 





Figure 5.8: Blocking only NMDA receptors increased OGD induced astrocyte 
cell death. A + B: Astrocyte cell death over time with glutamate receptor 
inhibitors, NBQX and MK801 (black) and MK801 only (green), C + D: astrocyte 
cell death at time 100 minutes, OGD with NBQX and MK801 (black bar) OGD 
with MK801 only (green) and E + F: astrocyte cell death at defined time points, 
OGD only black bars, OGD with NBQX and MK801 (green bars) and OGD with 
MK801 only (blue bars). A, C + E: corpus callosum, B, D + F: dentate gyrus. 
Error bars = SEM  
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5.3.4 Results: Glutamate receptor inhibitors did not affect OGD 
induced oligodendrocyte cell death. 
Astrocytes are not the only glial cells to express GluRs, they are also 
found on oligodendrocytes. GluRs are involved in ischaemic cell death via 
excitotoxicity, which oligodendrocytes are sensitive to (Karadottir et al., 2005; 
Matute et al., 2002; Matute, Domercq & Sánchez-Gómez, 2006). Here it was 
investigated whether using GluR inhibitors would confer the same effect on 
oligodendrocyte cell death as for astrocytes, or whether the inhibitors would 
prevent cell death. It was found that the presence of NBQX and MK801 did not 
affect OGD induced oligodendrocyte cell death in CC (figure 5.9). The confocal 
images illustrate that after OGD and OGD in the presence of the antagonists 
there was very little change and few cells were lost (figure 5.9A). The cell death 
profiles for both conditions are very similar and were unaffected by the presence 
of GluRIs (figure 5.9B). The total OGD induced oligodendrocyte cell death 
achieved with GluRIs was reduced from 1.31 ± 0.71% with OGD alone to 0.89 ± 
0.89% (not significant, figure 5.9C).  
The presence of NBQX and MK801 had no significant effect on DG 
oligodendrocytes (figure 5.10A). The treatment with GluRIs had little effect on 
the cell death profile (figure 5.10B). The addition of GluRIs did reduce OGD 
induced DG oligodendrocyte cell death. Total cell death with OGD only 
conditions was 1.85 ± 1.85%, the addition of NBQX and MK801 cell death was 0 
± 0% (figure 5.10C). These findings suggest that GluRIs may prevent OGD 
induced oligodendrocyte cell death. However, oligodendrocyte cell death was 
very low after 60 minutes OGD and 30 minutes reperfusion and so any 





Figure 5.9: Glutamate receptor inhibitors NBQX (20µM) and MK801 (10µM) had 
no effect on OGD induced oligodendrocyte cell death in corpus callosum (CC). 
A: Confocal images during OGD (upper panel) and glutamate receptor inhibitors 
(lower panel). Images taken at 0 and 100 minutes. Scale bars = 20µM. B: 
Oligodendrocyte cell death over time. C: total cell death at 100 minutes, OGD 
only (black bar) and OGD with NBQX and MK801 (green bar). Error bars = 





Figure 5.10: Glutamate receptor inhibitors NBQX (20µM) and MK801 (10µM) 
had no effect on OGD induced oligodendrocyte cell death in dentate gyrus 
(DG). A: Confocal images during OGD (upper panel) and glutamate receptor 
inhibitors (lower panel). Images taken at 0 and 100 minutes. Scale bars = 20µM. 
B: Oligodendrocyte cell death over time. C: total cell death at 100 minutes, OGD 
only (black bar) and OGD with NBQX and MK801. Error bars = SEM. N 




5.4 RESULTS: COBALT STAIN VISUALISATION OF DIVALENT CATION ENTRY 
INTO CELLS 
During ischaemia ionic gradients are disrupted and cytotoxic influx of ions 
can occur. One route for ions to enter cells is through activated GluRs, which 
are permeable to divalent cations such as calcium. Calcium is required for 
neuronal and oligodendrocyte ischaemic cell death, however we have found 
that removal of extracellular calcium increases OGD induced astrocyte cell 
death (figures 5.1 and 5.2), indicating that calcium may also be beneficial to cell 
viability. 
Cobalt is a divalent cation which is able to enter neural cells through 
activated GluR pores (Albuquerque et al., 2001; Aurousseau, Osswald & Bowie, 
2012; Pruss et al., 1991). Cobalt staining thus allows the visualisation of cation 
entry into all cells in live tissue preparations and reveals the presence of 
activated GluRs. Cobalt staining of live tissue was carried out for three regions 
(ON, CC and DG) under different conditions which were, aCSF with agonist 
(first panel), aCSF with GluR inhibitor and agonist (central panel) and OGD 
(final panel, figure 5.11A). The GluR agonist used throughout the cobalt staining 
was L-glutamate to ensure activation of GluRs. However, the agonist was not 
added during OGD since I am looking at receptor gating by ischaemic glutamate 
release. Also glutamate can be converted into the TCA cycle intermediate α-
ketoglutarate which may act as an energy source (McKenna, 2007). The 
evidence of cobalt entry is shown through the presence of a black precipitate in 
cells and can be seen in neurons, astrocytes and oligodendrocytes. The 
treatment of tissue preparations with GluRIs prevented the entry of cobalt into 
cells, illustrating that cobalt entered cells via activated GluRs. Under OGD 
conditions, cobalt staining will be limited to those cells which survived OGD. The 
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cells which experienced cobalt entry under OGD show that this is due to 
activated GluRs on OGD tolerant cells. Quantification of the cobalt positive cells 
in the tissue regions of interest was carried out (figure 5.11B). Under 
physiological conditions the most cobalt positive cells were seen in DG, in this 
brain region there are a high number of neuronal cell bodies which account for 
this. Fewer positive cells were seen in the WM tracts, as these contain only 
axons, oligodendrocytes and astrocytes. The use of GluRIs significantly 
reduced the cobalt entry into cells in all regions (p=<0.0001), thus also reducing 
the cation entry into cells. The number of cobalt positive cells in all regions was 
significantly reduced under OGD conditions (p=<0.0001). Under these 
conditions some cells do survive and can be seen (figure 5.11A final panel, ON 
and CC). It is likely that the cells that do survive are glial cells as they display 
tolerance to ischaemic insult. These findings show that cation entry occurs 





Figure 5.11: Cobalt staining of divalent cation entry into cells in different 
conditions. A: Representative images of cobalt positive cells in optic nerve (ON), 
corpus callosum (CC) and dentate gyrus (DG). In physiological conditions 
(aCSF), use of glutamate receptor inhibitors (GluRI) and oxygen glucose 
deprivation (OGD). Scale bars = 50µm. B: Quantification of number of cobalt 
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positive cells in each region (ON black, CC green and DG blue) and condition. 
Error bars = SEM.   
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5.5 DISCUSSION: ROLE OF CALCIUM AND GLUTAMATE RECEPTORS IN GLIAL 
ISCHAEMIC INJURY 
The over-activation of GluRs in response to an ischaemic challenge is, 
termed excitotoxicity and results in cytotoxic calcium influx in neurons, 
oligodendrocytes and immature astrocytes (Coyle et al., 1981; David et al., 
1996; Lucas & Newhouse, 1957; Pantoni, Garcia & Gutierrez, 1996; Salter & 
Fern, 2005). This has a detrimental effect on cells and leads to the triggering of 
cell death mechanisms (Matute, 2006). This chapter aimed to investigate 
whether calcium influx and GluRs have a role to play in ischaemic cell death of 
adult mature glia in situ. 
5.5.1 OGD induced astrocyte cell death is not mediated by calcium 
influx 
Cytotoxic calcium influx and excitotoxicity have a role to play in neuronal 
ischaemic cell death (Coyle et al., 1981; Lucas & Newhouse, 1957; Pulsinelli, 
Sarokin & Buchan, 1993). Previous work has found that in P0-P2 mice, calcium 
influx is responsible for astrocyte cell death (Fern, 1998), however this was not 
so for P10 mice (Salter & Fern, 2008; Thomas et al., 2004). This work has found 
that in adult mice, ischaemic astrocyte cell death occurs independently of 
external calcium influx. Interestingly, removing calcium caused earlier and 
significantly increased cell death in CC (p=<0.0001) and earlier, more rapid cell 
death in DG (figures 5.1 and 5.2). In DG, cell death was increased but not 
significantly, due to the high levels of cell death that exist in this region during 
OGD. The effect observed under calcium free conditions would suggest that 
calcium may have a role in protecting astrocytes during OGD and that cytotoxic 




The ion concentrations surrounding astrocytes can affect cell survival 
(Bondarenko & Chesler, 2001). The phenomenon of zero calcium conditions 
increasing cell death was previously observed by Thomas et al (2004) and 
Salter and Fern (2008). There is evidence that zero calcium conditions are also 
detrimental to neurons (Goldberg & Choi, 1993). Calcium is required by 
astrocytes for volume regulation (O'Connor & Kimelberg, 1993).The absence of 
calcium may cause cell death as astrocytes are not able to combat the effect of 
ischaemia induced swelling. Calcium is used by astrocytes for glial 
communication via waves which transmit across astrocytes and the syncytium 
(Cornell-Bell et al., 1990). A reduction in the calcium may result in the disruption 
of glial signalling and astrocyte communication with neurons, thus disrupting 
any potential survival signal. There is evidence to suggest that calcium is 
involved in cell survival as this ion is required for the regulation of several 
cellular processes (Chiesa et al., 1998). A lack of calcium can cause changes in 
astrocyte function, a reduction in calcium can itself act as an apoptotic signal 
(Chiesa et al., 1998). In a model of traumatic brain injury, zero extracellular 
calcium also caused increased astrocyte cell death (Rzigalinski et al., 1997), 
suggesting the reduction of calcium can trigger apoptosis. The increase in cell 
death shows how the mechanism of astrocyte cell death changes as the cells 
mature and corresponds with the findings of Thomas et al (2004).  
5.5.2 Glial glutamate receptor inhibition and OGD induced cell death 
Inhibition of GluRs has been found to provide to protection to neurons 
that experience ischaemic insult (Pulsinelli, Sarokin & Buchan, 1993), thus the 
effect of the inhibitors, NBQX and MK801, on astrocyte cell death was 
investigated. The only significant change in OGD induced astrocyte cell death 
produced by GluR block was seen in CC (p=0.0093), where cell death was 
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increased (figure 5.4). Whilst a decrease in DG astrocyte cell death was seen, it 
was not significant (figure 5.5). The results show that simultaneous block of both 
NMDA and AMPA GluRs tends to potentiate injury in adult WM astrocytes and 
would indicate that astrocytes in different regions may have different 
mechanisms of cell death in response to ischaemic injury.  
The selective NMDA receptor blocker MK801 caused a significant 
increase in CC astrocyte death during OGD (p=<0.0001, figure 5.6) when 
applied alone. In DG, MK801 treatment caused ischaemic cell death to occur 
earlier and increased the amount of cell death, although not significantly (figure 
5.7). These findings suggest that ionotropic GluR generally and NMDA 
receptors specifically are protective against ischaemic cell death in mature 
astrocytes. The inhibition of NMDA receptors may affect astrocytes by 
preventing NMDA receptor initiated cell survival signals. There is evidence in 
the literature which suggests that NMDA receptors trigger the activation of 
transcription factors and anti-apoptotic factors which encourage cell survival and 
neuroprotection (Papadia et al., 2005; Soriano & Hardingham, 2007). This pro-
survival signalling can cause post-translational modification of proteins and 
initiate gene expression (Papadia et al., 2005; Soriano & Hardingham, 2007). A 
study carried out in neurons has found that NMDA receptor inhibition results in 
increased cell death during injury, due to the prevention of survival signals 
(Ikonomidou, Stefovska & Turski, 2000; Tashiro et al., 2006). The process of 
pre-conditioning cells to develop resistance to ischaemic insult is thought to 
occur via NMDA receptor signalling (Mabuchi et al., 2001). The exact role for 
astrocyte NMDA receptors is unknown and so it is possible that their presence 
on astrocytes is for pro-survival signalling. If astrocyte NMDA receptors have a 
role in cell survival, then the inhibition with MK801 will lead to an increased 
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amount of cell death due to the lack of survival signals. The inhibition of 
neuronal NMDA receptors may also prevent the communication of cell survival 
signals from neurons to astrocytes. 
There are previous studies which have reported that over activation of 
glutamate receptors can damage astrocytes (Matute et al., 2002). It is known 
that AMPA receptors are more permeable to sodium ions (Citri & Malenka, 
2008), which have been found to contribute to ischaemic cell death in P10 mice 
(Thomas et al., 2004). The over excitation of AMPA receptors may cause influx 
of sodium ions and result in sodium dependent cell death. The role of sodium is 
further discussed and investigated in the next chapter. It would appear that 
there is a role for GluRs in astrocyte ischaemic cell death, via influx of other ions 
apart from calcium and further investigation is required.  
Inhibition of GluRs had no effect on OGD induced oligodendrocyte cell 
death (figures 5.9 and 5.10). In OGD conditions, oligodendrocyte cell death was 
already very low and so any protective effect may not be detectable. 
Excitotoxicity is thought to be a major mechanism of ischaemic oligodendrocyte 
cell death (Leuchtmann et al., 2003), thus it would be expected that inhibition of 
GluRs would prevent cell death. It is possible that the use of GluRIs does 
protect oligodendrocytes, however it has been found that cell death is not seen 
until at least one hour after insult (Pantoni, Garcia & Gutierrez, 1996) and 
widespread oligodendrocyte cell death has been documented nine hours after 
insult (Tekkok & Goldberg, 2001). Also the observable effect of GluR inhibition 
may be limited due to the low amount of OGD induced oligodendrocyte cell 
death that occurs. This work is concerned with the acute ischaemic injury and 
so pathological oligodendrocyte cell death has not yet occurred. 
197 
 
5.5.3 Cobalt staining of cation entry 
Activated GluRs are permeable to divalent and monovalent cations such 
as calcium, sodium and potassium. Cobalt is a divalent cation, which is able to 
enter cells via GluR channels. The cobalt staining method used here has shown 
that cobalt permeable GluRs are present in ON, CC and DG (figure 5.11). When 
tissue preparations were treated with GluRIs, cobalt was prevented from 
entering which confirmed that NMDA and AMPA GluRs are the major route of 
calcium entry in the presence of the agonist (L-glutamate). Under OGD 
conditions cobalt was able to enter some cells but not to the same extent as 
under normoxic conditions in the presence of the agonist. The cells that did 
show staining after OGD had survived the insult and displayed glial morphology. 
The data confirm that the influx of calcium during OGD, together with the 
findings from the calcium removal experiments highlights the differing protection 
that this event confers. The calcium influx via GluR under ischaemic conditions 
in astrocytes is therefore a form of glutamate excito-protection, contrasting to 
the well-established excitotoxicity found in neurons and oligodendrocytes. 
This chapter has shown that external calcium influx is not responsible for 
OGD induced astrocyte cell death in either CC or DG, however cell death could 
result from calcium release from internal stores and further work is required to 
establish whether this source of calcium is a possible ischaemia induced cell 
death mechanism. This supports previous findings that showed sodium influx 
and not calcium was responsible for astrocyte cell death in P10 mice (Thomas 
et al., 2004). AMPA receptors may be responsible for astrocyte cell death as 
inhibition of NMDA receptors caused widespread astrocyte death, possibly due 
to sodium influx which causes cytotoxic cell swelling. The role of sodium in 













6 ROLE OF SODIUM AND ASTROCYTE SWELLING 
6.1 INTRODUCTION 
Sodium has an important role in the CNS, where it is utilized for several 
processes, including signalling and the maintenance of ionic gradients. 
Transmembrane sodium movement generally obeys the established ionic 
concentration gradient and occurs through a variety of transporters and ion 
channels, which include sodium–hydrogen exchanger (NHE), sodium-calcium 
exchanger (NCX), sodium-bicarbonate co-transporter (NBC) and voltage-
insensitive sodium channels (Nx). Astrocytes express voltage gated sodium 
channels (Verkhratsky & Steinhäuser, 2000), although expression levels are 
generally lower than in neurons or some populations of oligodendroglia 
(Káradóttir et al., 2008). The expression of these channels by astrocytes in vivo  
is still being discussed (Rose & Verkhratsky, 2016), however it has been shown 
in spinal cord that in the event of sodium channel blockade they can serve as 
pathway for sodium entry (Rose, Ransom & Waxman, 1997). Sodium can also 
enter astrocytes through receptor pores such as ionotropic glutamate receptors 
(iGluRs), which are permeable to ions when activated. iGluR ion permeability is 
determined by their subunit expression (discussed in the previous chapter). 
Another route for sodium entry is via cation chloride co-transporters (CCC), 
which includes the sodium-potassium-chloride co-transporter 1 (NKCC1). This 
transporter has been implicated in astrocytic cell swelling. A major route for 
sodium extrusion occurs via the action of the sodium/potassium ATPase. During 
times of CNS injury or insult ionic gradients are disrupted and homeostatic 
maintenance breaks down, altering cell function and leading to changes in cell 
volume that can be fatal to the cell. 
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6.1.1 Sodium homeostasis 
Under normal physiological conditions, astrocytes regulate the ECS 
sodium concentration and contribute to the maintenance of the large inwardly 
directed sodium gradient. The energy contained within this sodium gradient is 
harnessed to transport other ions and molecules across the cell membrane, via 
expression of several sodium-dependent transporters. There is also a natural 
flow of sodium into cells, as some channels such as neurotransmitter receptor 
pores generate sodium currents (Lalo et al., 2011). These pores are permeable 
to cations and so sodium is the major cation which enters cells (Kirischuk, 
Parpura & Verkhratsky, 2012; Lalo et al., 2011). 
High extracellular sodium concentration or increases in sodium 
concentration, will trigger sodium uptake by astrocytes. This increases astrocyte 
intracellular sodium levels which can dissipate throughout the astrocyte 
syncytium via gap junctions, which lowers the intracellular sodium concentration 
(Rose & Ransom, 1997; Rouach et al., 2008). It has been determined that the 
conduction of gap junctions is not uniform and alterations to conductance 
change how sodium is distributed throughout the syncytium (Rouach et al., 
2008). The homeostatic control of sodium is not an independent process and is 
tightly linked to potassium homeostasis and pH regulation.  
6.1.2 Sodium transporters 
A variety of channels and transporters are involved in sodium influx and 
efflux (figure 6.1). Below are brief descriptions of the roles of the main sodium 
transporters expressed in astrocytes with particular interest shown for CCCs, of 
these the NKCC1 and KCC (potassium-chloride co-transporter) were 
specifically examined. Most of these channels are driven by the inward sodium 
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gradient that is generated between the extracellular space and the intracellular 
space, which involves the sodium/potassium pump. 
Figure 6.1: Key sodium transporters expressed by astrocytes. Sodium 
transporters and the direction of movement. NCX – sodium/calcium exchanger, 
KCC – potassium-chloride co-transporter, Nx – sodium channel, NBC – sodium-
bicarbonate co-transporter, Na/K ATPase – sodium/potassium ATPase, NHE – 
sodium/hydrogen exchanger. NKCC1 – sodium-potassium-chloride co-
transporter. 
There is a concentration of sodium transporters and iGluRs on astrocyte 
perisynaptic processes (Kirischuk, Parpura & Verkhratsky, 2012). The 
interaction of these processes with synapses allows astrocytes to respond to 
neuronal activity. The transporters in this location include NCX and glutamate 
transporters (Minelli et al., 2007). The NCX can function in both forward and 
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reverse modes, the working direction of the exchanger is determined by both 
the intracellular and extracellular sodium and calcium concentrations, as well as 
the membrane potential (Kirischuk, Parpura & Verkhratsky, 2012). The NCX 
reversal potential is close to the membrane resting potential (Kirischuk, 
Kettenmann & Verkhratsky, 1997) and so changes in the membrane potential 
will alter the direction of the exchanger. Therefore the NCX fluctuates between 
forward and reverse directions as activity levels change (Rojas, Ramos & 
Dipolo, 2004).  
Under physiological conditions, the sodium/potassium ATPase (NKA) 
extrudes sodium from cells in exchange for potassium and is the main exporter 
of sodium and a major energy consumer (Erecińska & Silver, 1994). The NKA 
accounts for approximately 50% of cellular ATP hydrolysis (Astrup, Sørensen & 
Sørensen, 1981) and the high energy usage links the process of homeostasis to 
cellular metabolism (Silver & Erecińska, 1997). Any loss of function of this 
transporter can cause neurological disorder symptoms, such as aspects of 
parkinsonism and Alzheimer’s disease (Moseley et al., 2007). The NKA is 
sensitive to changes in both sodium and potassium concentration (Walz & 
Hertz, 1982), and even small rises in extracellular potassium concentration 
trigger activation of the transporter (Dinuzzo et al., 2012). The presence of NKA 
on perisynaptic processes associates it with synaptic activity and it has been 
established that glutamate uptake and accompanying sodium influx triggers 
NKA activity (Pellerin & Magistretti, 1997). Co-assembly of aquaporin 4 (AQP4) 
and NKA has been found on astrocyte process endfeet, implicating NKA activity 
with water movement (Illarionova et al., 2010). 
Astrocyte Nx channels are sensitive to extracellular increases in sodium 
concentration, but are insensitive to changes in voltage (Noda & Hiyama, 2005). 
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Activation of Nx causes intracellular increase in sodium, which activates NKA to 
extrude the accumulated sodium. The Nx mediated stimulation of NKA causes 
glycolysis and subsequent lactate release, linking extracellular sodium 
increases with metabolite export (Rose & Verkhratsky, 2016). 
The sodium-potassium-chloride co-transporter 1 (NKCC1) is widely 
expressed in astrocytes and has been confirmed in cortex, corpus callosum, 
hippocampus, cerebellum and optic nerve (MacVicar et al., 2002; Yan, 
Dempsey & Sun, 2001a). During physiological conditions this transporter directs 
the movement of sodium, potassium and chloride ions into the cell, by utilizing 
the inwardly directed sodium gradient (Jayakumar & Norenberg, 2010). NKCC1 
can be activated by an increase in the extracellular potassium concentration (Su 
et al., 2002). The movement of chloride ions into astrocytes by NKCC1 can lead 
to the intracellular accumulation of chloride, triggering the influx of water which 
causes an increase in cell volume and swelling (Su et al., 2002). Normal 
increases in cell volume can be corrected via regulated volume decrease. The 
genetic ablation of NKCC1 reduced cell swelling, which indicates a role for 
NKCC1 in volume regulation (Su et al., 2002). NKCC1 may also contribute to 
pathology and has been implicated in cytotoxic cell swelling (Chen & Sun, 2005; 
Jayakumar & Norenberg, 2010).  
The regulation of pH is partly achieved with the activation of the sodium-
bicarbonate co-transporter (NBC) which is sensitive to increases in the 
extracellular potassium concentration, arising from neuronal activity (Rose & 
Verkhratsky, 2016). NBC activation can stimulate the glycolysis regulatory 
enzyme phosphofructokinase, which triggers glycolysis (Ruminot et al., 2011) 
and links neuronal activity to astrocyte metabolism. Sodium-hydrogen 
exchangers (NHE) work in conjunction with NBCs to achieve pH regulation, 
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through sodium export and proton import. This transporter is also important for 
sodium extrusion. The absence of NHE increased astrocyte tolerance to OGD 
(Kintner et al., 2004), suggesting a role in ischaemic injury. 
The uptake of neurotransmitters and precursors utilizes the sodium 
gradient. Therefore glutamate or γ-aminobutyric acid (GABA) movement by 
excitatory amino acid transporters 1 and 2 (EAAT1 and 2), is accompanied by 
sodium ions (Schousboe, 2003). This results in transient increases in 
intracellular sodium concentration mainly within astrocyte processes, however 
more general cell wide increases can occur (Chatton, Marquet & Magistretti, 
2000). 
6.1.3 Role of astrocytic sodium in the CNS 
Sodium transporter, receptors and channels have been found to be 
concentrated on astrocyte perisynaptic processes (Kirischuk, Parpura & 
Verkhratsky, 2012). These processes are in a unique location to interact with 
synapses. From this position astrocytes can detect the size and duration of 
neuronal activity and respond accordingly. Fluctuations in sodium levels allow 
astrocytes to regulate many physiological processes and link sodium 
concentration with homeostasis and metabolism. The resting concentration of 
astrocyte intracellular sodium concentration is approximately 15mM (Rose & 
Verkhratsky, 2016) which is in part maintained through passive sodium entry 
into cells, during resting conditions (Rose & Ransom, 1996). 
Calcium is the predominant astrocyte signalling molecule, however it has 
been found that astrocytes are also sensitive to changes in sodium 
concentrations and produce sodium fluctuations (Verkhratsky et al., 2013). 
Astrocyte calcium responses induced by synaptic activity are short acting, 
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whereas astrocyte sodium transients are more prolonged and can outlast 
synaptic transmission (Kirischuk, Kettenmann & Verkhratsky, 2007; Verkhratsky 
et al., 2013). This indicates that astrocytes have the capability to produce 
different responses to neuronal stimuli through the use of different signalling 
molecules. Astrocyte sodium signals are proportional to synaptic activation and 
can differ in both time course and amplitude (Rose & Verkhratsky, 2016). The 
sodium transients generated in perisynaptic processes can spread throughout 
the astrocyte and trigger propagating waves that spread throughout the 
astrocyte network (Bernardinelli, Magistretti & Chatton, 2004). The sodium 
waves transmit across the astrocyte syncytia in a similar manner to calcium 
waves, predominantly through hemi-channels that form gap junctions with 
neighbouring cells (Langer et al., 2012).  
Sodium signalling can trigger a variety of homeostatic responses based 
upon the levels of neuronal activity (Kirischuk, Parpura & Verkhratsky, 2012). 
Sodium signals can function independently, direct calcium signals or work in 
conjunction with calcium signals. For example, increases in sodium 
concentration can cause rapid transient calcium increases within astrocyte 
microdomains (Kirischuk, Parpura & Verkhratsky, 2012), which occur due to the 
reversal of the NCX. There are many signalling functions of sodium, which 
require further investigation. 
The neurotransmitter shuttles for glutamine/glutamate and 
glutamate/GABA are modulated by sodium, via direct regulation of glutamine 
synthetase (Benjamin, 1987). Sodium increases can dictate the speed and 
direction of GABA and calcium transport (Kirischuk, Parpura & Verkhratsky, 
2012) which occurs via sodium dependent GABA transporters (GATs). GABA 
release can be triggered by changes in intracellular sodium concentration 
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(Kirmse & Kirischuk, 2006), which also regulate glutamate uptake (Chatton, 
Marquet & Magistretti, 2000). 
The homeostatic regulation of potassium is a complex process involving 
sodium, in which many systems and transporters cooperate. Sodium increases 
trigger activation of the NKA and NKCC1, both of which allow entry of potassium 
into the astrocytes thereby lowering the extracellular concentration (Kirischuk, 
Parpura & Verkhratsky, 2012). Inwardly rectifying potassium channels, which 
are involved in lowering the extracellular potassium concentration, can be 
inhibited by increases in intracellular sodium concentration (Rose & 
Verkhratsky, 2016), thereby disrupting potassium homeostasis. The sodium 
concentration is used to modulate transporters involved in intra and extracellular 
pH homeostasis (Deitmer & Rose, 2010). The main transporters involved to 
achieve this are the NHE and NBC, thus regulating the movement of protons, 
hydroxide and bicarbonate ions to maintain the pH. The transmembrane sodium 
gradient is also utilized for the scavenging of reactive oxygen species (ROS) by 
ascorbic acid (Rose & Verkhratsky, 2016). 
Sodium has an impact on metabolic regulation, activation of the NKA can 
stimulate glycolysis which produces lactate, possibly for the ANLS hypothesis 
(Pellerin & Magistretti, 1994). Intracellular sodium increases stimulate glucose 
uptake in astrocyte process endfeet (Voutsinos-Porche et al., 2003), which 
partly provides substrate for the increase in glycolysis. Mitochondria can also 
respond to sodium signals through increases in intra-mitochondrial sodium 
concentration (Bernardinelli, Azarias & Chatton, 2006). This regulates astrocyte 
mitochondrial metabolism and can result in further lactate production by 
stimulating glycolysis (Azarias et al., 2011). 
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Cell swelling occurs in response to extracellular increases in sodium and 
potassium concentration and is thought to be predominantly mediated by 
several transporters including NKCC1, NBC and KCC (Florence, Baillie & 
Mulligan, 2012; Payne et al., 2003). The KCC is part of the same solute carrier 
family as NKCC1 (Mercado, Mount & Gamba, 2004) and is able to function bi-
directionally (Dunham & Ellory, 1981). The sodium dependent transmembrane 
movement of ions generates an osmotic gradient, which triggers the movement 
of water (Brookes, 2005) into astrocytes via aquaporin channels, (Brookes, 
2005; Nielsen et al., 1997; Payne et al., 2003), water efflux can also occur 
through these pores. Under physiological conditions, increases in cell volume 
are corrected via active volume regulation. The KCC can be stimulated to 
reduce cell volume (Brookes, 2005) through the export of potassium and 
chloride ions. Astrocyte cell volume is also regulated by the NHE which works 
alongside anion exchangers to maintain the correct volume of the cell (Brookes, 
2005).  
In some cell populations sodium can act as a regulator of protein activity 
by physically binding to the protein channel. Some of the channels that have 
been found to be regulated in this manner are NMDA receptors (Yu & Salter, 
1998), voltage gated calcium channels, G-protein gated potassium channels 
(Blumenstein et al., 2004) and sodium dependent potassium channels 
(Bhattacharjee & Kaczmarek, 2005).  
6.1.4 Sodium influx, transporters and ischaemia 
The maintenance of ionic gradients and ion homeostasis is an energy 
intensive process. During ischaemia, the reduced energy and oxygen supply 
disrupts ionic gradients causing cellular dysfunction. A major mechanism of 
ischaemia induced astrocyte cell death is via cytotoxic cell swelling. Astrocytes 
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are susceptible to cell swelling due to their role in glutamate uptake and 
potassium clearance, both of which utilize the sodium gradient (Boscia et al., 
2016). The disruption of ions during ischaemia and over-activation of 
transporters and receptors allows the influx of sodium, potassium and chloride 
into astrocytes. Movement of water into cells follows this influx due to osmotic 
overload, this increases cell volume and results in astrocyte swelling (Su et al., 
2002; Su, Kintner & Sun, 2002). Cell swelling can occur to such an extent that it 
becomes cytotoxic, cell membranes lose integrity and burst (Gurer et al., 2009). 
Under physiological conditions any swelling can be corrected via regulated 
volume decrease. This process requires energy and cannot occur during 
ischaemia as ATP is unavailable and so astrocytes succumb to injury. 
Previous work by the group has established that in P10 ON, ischaemic 
injury is sodium dependent (Thomas et al., 2004). This study suggested that 
ischaemic injury was mediated by NKCC1. Further evidence from the literature 
suggests that NKCC1 has a role in ischaemic injury, due to its role in ion 
movement. Pharmacological inhibition of NKCC1 has been found to protect 
neurons from ischaemic injury (Yan, Dempsey & Sun, 2001b), possibly by 
preventing the swelling induced release of glutamate and reducing 
excitotoxicity, the main mechanism of ischaemic neuronal death. The inhibition 
of NKCC1 has also been found to reduce oedema and the size of ischaemic 
infarct (O'Donnell et al., 2004; Yan, Dempsey & Sun, 2001b).  
Ischaemia causes an increase in extracellular potassium, which can 
stimulate NKCC1 activity and induce astrocyte swelling, increasing cell size by 
approximately 20% (Su et al., 2002; Su, Kintner & Sun, 2002). This swelling was 
prevented through the inhibition of NKCC1 or the absence of chloride or sodium 
(Su, Kintner & Sun, 2002). Su et al (2002) determined that astrocyte NKCC1 
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remains active during cell swelling, implying that during ischaemia the 
transporter may remain open, thereby exacerbating injury. It has been 
suggested that there may be a feed forward effect, whereby NKCC1 is further 
stimulated by cell swelling (Mongin et al., 1994). During ischaemia volume 
regulation mechanisms are inhibited, which is detrimental to the cell (Mongin & 
Kimelberg, 2005). 
Reperfusion after ischaemic insult has been found to reactivate NKCC1 
which may be responsible for a proportion of reperfusion injury (Kintner et al., 
2007; Kintner et al., 2004; Lenart et al., 2004). The reintroduction of blood flow 
can also activate the NHE, causing sodium entry (Kintner et al., 2004). It has 
been found that NKCC1 can also be activated via phosphorylation of the 
transporter (Flemmer et al., 2002; Lenart et al., 2004). Once stimulated NKCC1 
has the ability to activate the reverse mode of NCX, due to the increase in 
intracellular sodium. In this chapter the role of sodium and CCCs in astrocyte 
ischaemic injury has been investigated. In order to study the potential 
involvement of these transporters inhibitors were used to block the transporter 
of interest. Here bumetanide was used to specifically inhibit NKCC1, DIOA was 
used to selectively inhibit KCC and furosemide was used as a non-specific CCC 
inhibitor (figure 6.2). In this chapter we investigated the hypothesis that cytotoxic 




Figure 6.2: Action of CCC inhibitors. Furosemide inhibits all CCCs, Bumetanide 




6.2 RESULTS: SODIUM DEPENDENT ASTROCYTE CELL DEATH IN DENTATE 
GYRUS. 
Sodium influx has been implicated in ischaemic astrocyte swelling and 
death in P10 rat optic nerve (Thomas et al., 2004). To investigate the role of 
sodium in ischaemic injury, sodium was removed from the aCSF during OGD 
and was replaced with NMDG chloride (128mM). This was to determine whether 
ischaemic injury of adult astrocytes was sodium dependent in the CC and the 
DG.  
In CC, the confocal images show that many astrocytes survive the period 
of OGD in both the presence and absence of sodium (figure 6.3A). The lack of 
sodium caused a significant increase in t value from 62.00 ± 2.32 mins to 71.25 
± 3.52 mins (p=0.0455, figure 6.1B), which suggests a slower rate of cell death. 
When sodium was removed from the aCSF, the total cell death was decreased 
from 40.17 ± 6.45% to 31.79 ± 8.41% (not significant, figure 6.3C).  
In DG, the removal of sodium had a profound effect upon OGD induced 
cell death (figure 6.4). The confocal images show that in the absence of sodium, 
GM astrocytes can survive the ischaemic insult and reperfusion (figure 6.4A, 
lower panel). The t values were not significantly different between the two 
conditions, for DG this was 54.64 ± 3.30 mins and without sodium was 64.92 ± 
3.48 mins (figure 6.4B). By removing sodium GM astrocytes behaved in a 
similar manner to those in WM. The overall cell death achieved without sodium 
was decreased from 97.61 ± 1.01% to 37.70 ± 9.80% (p=<0.0001, figure 6.4C). 
These results suggest that sodium influx during OGD accounts for the higher 




Figure 6.3: Zero Sodium conditions had no effect on OGD induced astrocyte cell 
death in corpus callosum (CC). A: Confocal images during OGD (upper panel) 
and OGD with 0 Na (lower panel). Images taken at 0 and 100 minutes. Scale 
bar = 20 µm. B: Astrocyte cell death over time. C: total cell death at time 100 
minutes, OGD only (black bar) and OGD with 0Na+ (green bar). Error bars = 






Figure 6.4: Zero Sodium conditions decreased OGD induced astrocyte cell 
death in dentate gyrus (DG). A: Confocal images during OGD (upper panel) and 
OGD with 0 Na (lower panel). Images taken at 0 and 100 minutes. Scale bar = 
20 µm. B: Astrocyte cell death over time. C: total cell death at time 100 minutes, 
OGD only (black bar) and OGD with 0Na+ (green bar). Error bars = SEM. N 




6.3 RESULTS: ROLE OF NKCC1 IN ISCHAEMIC ASTROCYTE CELL DEATH 
The NKCC1 is known to play a role in astrocyte cell swelling (Su, Kintner & 
Sun, 2002), which contributes to OGD induced cell death. The involvement of 
this transporter in ischaemic astrocyte cell death was examined by inhibiting the 
NKCC1 with bumetanide. Bumetanide is a well-known and widely used distal 
loop diuretic and is a specific inhibitor of the NKCC1 at the concentration used 
(50µM). 
6.3.1 Results: Effect of NKCC1 inhibition on OGD induced astrocyte 
death in adult slices 
The inhibition of NKCC1 increased OGD induced astrocyte cell death in 
CC (figure 6.3). The confocal images illustrate the difference in cell death 
between OGD only and OGD in the presence of bumetanide (figure 6.5A). The 
addition of bumetanide did not cause a significant change in t value, which was 
62.00 ± 2.32 mins for CC and 58.92 ± 2.39 mins for CC with NKCC1 inhibition 
(figure 6.5B). The total amount of cell death achieved with OGD and 
bumetanide was significantly higher than that seen in OGD only conditions 
(figure 6.5C). The inhibition of NKCC1 caused cell death to increase from 40.17 
± 6.45% to 92.65 ± 2.64 % (p=<0.0001), which is similar to the amount of OGD 
induced cell death seen in GM astrocytes. 
In DG, the presence of bumetanide did not affect OGD induced astrocyte 
cell death (figure 6.6). Exposure to OGD either in the presence or absence of 
the drug caused the majority of astrocyte to die as seen in the confocal images 
(figure 6.6A). The t value was not significantly altered by the addition of 
bumetanide, the t for DG was 54.64 ± 3.30 mins and with inhibitor was 52.58 ± 
2.63 mins, suggesting that the presence of bumetanide had very little effect 
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(figure 6.6B). The inhibition of NKCC1 did not alter the total amount of OGD 
induced astrocyte death, 97.61 ± 1.01% with OGD and 97.69 ± 1.73% with 
OGD and bumetanide (not significant, figure 6.6C). Taken together these results 
suggest that NKCC1 has different roles in CC and DG during ischaemic insult. 
The inhibition of the transporter had a greater effect in CC showing that there is 





Figure 6.5: NKCC1 inhibitor bumetanide (50µM) increased OGD induced 
astrocyte cell death in corpus callosum (CC). A: Confocal images during OGD 
(upper panel) and OGD with bumetanide treatment (lower panel). Images taken 
at 0 and 100 minutes. Scale bar = 20 µm. B: Astrocyte cell death over time. C: 
total cell death at time 100 minutes, OGD only (black bar) and OGD with 
bumetanide (green bar). Error bars = SEM. N numbers = number of 





Figure 6.6: NKCC1 inhibitor bumetanide (50µM) has no effect on OGD induced 
astrocyte cell death in dentate gyrus (DG). A: Confocal images during OGD 
(upper panel) and OGD with bumetanide treatment (lower panel). Images taken 
at 0 and 100 minutes. Scale bar = 20 µm. B: Astrocyte cell death over time. C: 
total cell death at time 100 minutes OGD only (black bar) and OGD with 
bumetanide (green bar). Error bars = SEM. N numbers = number of 





6.3.2 Results: NKCC1 inhibition and the effect on OGD induced cell 
death in neonatal astrocytes 
It was previously established that mechanisms of ischaemic astrocyte 
death change with age, from a calcium dependent mechanism in P2 ON to 
sodium dependent in P10 ON (Fern, 1998; Thomas et al., 2004). The previous 
section investigated NKCC1 inhibition in adult brain slices. Here the effect of 
bumetanide on neonatal astrocytes (P10) was examined to see if there were 
any differences in the mechanism of cell death at this age. In CC, the presence 
of bumetanide significantly increased astrocyte cell death from 10.86 ± 3.10% to 
38.69 ± 4.80%, p=0.0007 (figure 6.7C). The confocal images illustrate the 
increased astrocyte sensitivity to OGD that occurs with the addition of 
bumetanide (figure 6.7A). However, inhibition of NKCC1 did not cause a 
significant change in t value, which for neonate CC was 78.30 ± 5.33 mins and 
75.75 ± 5.13 mins with bumetanide (figure 6.5B).  
The neonatal DG astrocytes behaved differently to neonatal CC 
astrocytes. Inhibiting NKCC1 in DG significantly reduced astrocyte cell death 
from 67.38 ± 12.79% to 34.09 ± 4.36%, (p=0.0335, figure 6.8 C). The confocal 
images depict the tolerance of DG astrocytes in the presence of bumetanide 
compared with OGD only, where cell breakdown and death can be seen (figure 
6.8A). NKCC1 inhibition did not cause a significant change in t value, for 
neonate DG this was 68.50 ± 3.13 mins and with bumetanide was 73.42 ± 1.91 
mins (figure 6.8B). The addition of bumetanide had differing effects in each 
region investigated, suggesting that the mechanism of ischaemic cell death 
depends upon the region in which astrocytes are located. The results for the 
neonatal CC astrocytes were similar to those for the adult CC astrocytes, where 
NKCC1 inhibition increased sensitivity to OGD. However, for neonate DG 
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Figure 6.7: Bumetanide treatment (50µM) increased OGD induced astrocyte cell 
death in neonatal corpus callosum (CC). A: Confocal images taken during OGD 
(upper panel) and during OGD with bumetanide treatment (lower panel). Images 
taken at 0 and 100 minutes. Scale bars = 20µM. B: Astrocyte cell death over 
time. C: cell death at time 100 minutes, OGD only (black bar) and OGD with 






Figure 6.8: Bumetanide treatment (50µM) decreased OGD induced astrocyte 
cell death in neonatal dentate gyrus (DG). A: Confocal images taken during 
OGD (upper panel) and during OGD with bumetanide treatment (lower panel). 
Images taken at 0 and 100 minutes. Scale bars = 20µM. B: Astrocyte cell death 
over time. C: cell death at time 100 minutes, OGD only (black bar) and OGD 
with bumetanide (green bar). Error bar = SEM. N numbers = number of 





6.4 RESULTS: ROLE OF KCC IN ISCHAEMIC ASTROCYTE CELL DEATH 
The NKCC is not the only CCC expressed by astrocytes, the KCC was 
selected for investigation due to its transportation of chloride ions and 
involvement in astrocyte cell swelling (Ringel & Plesnila, 2008). Ringel and 
Plesnila (2008) found that the inhibition of KCC increased cell volume, 
suggesting dysfunction of this transporter may contribute to ischaemic astrocyte 
death. The KCC was selectively inhibited by the addition of 50µM DIOA (2-[[(2S-
2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-3H-inden-5-yl]oxy]acetic acid).  
In CC, the selective KCC inhibitor caused a significant increase in 
astrocyte OGD induced cell death from 40.17 ± 6.45% to 61.93 ± 4.87% 
(p=0.0332, figure 6.9C). The confocal images illustrate the loss of astrocytes 
due to OGD in the presence of DIOA (figure 6.9A). KCC inhibition caused a 
change in the rate of cell death as the t values were significantly different. The 
CC t value was 62.00 ± 2.32 mins and with the addition of DIOA was 48.08 ± 
2.19 mins (p=0.0012, figure 6.9B). 
The presence of DIOA decreased OGD induced astrocyte death in DG 
from 97.61 ± 1.01% to 88.19 ± 10.25% (not significant, figure 6.10C). The total 
cell death for slices treated with DIOA had more variability and so the reduction 
in cell death was not significant. The confocal images depict extensive cell 
death in both conditions (6.10A). The inhibition of KCC caused little change to 
the cell death profile and the t values were not significantly different, for DG this 
was 54.64 ± 3.30 mins and with DIOA was 49.08 ± 2.58 mins (figure 6.10B). 
The inhibition of the KCC neither protected nor caused widespread cell death, 
which would suggest that this transporter has a less prominent role in OGD 





Figure 6.9: DIOA treatment (50µM) increased OGD induced astrocyte cell death 
in corpus callosum (CC). A: Confocal images during OGD (upper panel) and 
OGD with DIOA treatment (lower panel). Images taken at 0 and 100 minutes. 
Scale bar =20 µm. B: Astrocyte cell death over time. C: total cell death at time 
100 minutes, OGD only (black bar) and OGD with DIOA (green bar). Error bars 





Figure 6.10: DIOA treatment (50µM) had no effect on OGD induced astrocyte 
cell death in dentate gyrus (DG). A: Confocal images during OGD (upper panel) 
and OGD with DIOA treatment (lower panel). Images taken at 0 and 100 
minutes. Scale bar =20 µm. B: Astrocyte cell death over time. C: total cell death 
at time 100 minutes, OGD only (black bar) and OGD with DIOA (green bar). 




6.5 RESULTS: BROAD-SPECTRUM INHIBITION OF CCCS REDUCED GM 
ASTROCYTE CELL DEATH 
The selective inhibition of NKCC1 and KCC had varying impacts on OGD 
induced astrocyte cell death in WM and GM. To investigate the role of all CCCs 
slices were then treated with furosemide, another widely used distal loop 
diuretic which at 5mM concentration will non-selectively inhibit the majority of 
CCCs.  
In CC, the addition of furosemide did not affect OGD induced astrocyte cell 
death when compared to OGD only conditions (figure 6.11). The confocal 
images illustrate that CC astrocytes were tolerant to OGD under both conditions 
(figure 6.11A). The inhibition of CCCs with furosemide slowed the rate of cell 
death and resulted in an increase in t value, however this was not significant 
(figure 6.11B). The t values for CC with and without furosemide were 70.25 ± 
5.60 mins and 62.00 ± 2.32 mins respectively. The presence of furosemide did 
not affect the total amount of OGD induced cell death (figure 6.11C). The 
astrocyte death in the presence of furosemide was 39.07 ± 6.78% and was 
40.17 ± 6.45% with OGD only (not significant). 
In DG, the presence of furosemide slightly increased astrocyte tolerance to 
ischaemia (figure 6.12). The confocal images show that inhibition of CCCs 
provided protection and resulted in astrocytes that survive OGD (figure 6.12A). 
Furosemide did not alter the rate of cell death as shown by the t value, which 
was 54.64 ± 3.30 mins for DG only and 62.00 ± 2.04 mins with inhibitor (figure 
6.12B). Inhibition of CCCs caused cell death to significantly decrease from 
97.61 ± 1.01% to 89.89 ± 2.75% (p=0.0073, figure 6.12C). The addition of 
furosemide had a greater effect on GM astrocytes, suggesting that CCCs have 




Figure 6.11: Furosemide treatment (5mM) had no effect on OGD induced 
astrocyte cell death in corpus callosum (CC). A: Confocal images taken during 
OGD (upper panel) and OGD with furosemide treatment (lower panel). Images 
taken at 0 and 100 minutes. Scale bar =20 µm. B: CC astrocyte cell death over 
time. C: total cell death at time 100 minutes, OGD only (black bar) and OGD 
with furosemide (green bar). Error bars = SEM. N numbers = number of 






Figure 6.12: Furosemide treatment (5mM) decreased OGD induced astrocyte 
cell death in dentate gyrus (DG). A: Confocal images taken during OGD (upper 
panel) and OGD with furosemide treatment (lower panel). Images taken at 0 
and 100 minutes. Scale bar =20 µm. B: CC astrocyte cell death over time. C: 
total cell death at time 100 minutes, OGD only (black bar) and OGD with 
furosemide (green bar). Error bars = SEM. N numbers = number of cells/number 
of slices.  
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6.6 RESULTS: COMPARISON OF CCC INHIBITORS 
To determine the effect of inhibiting CCCs on OGD induced astrocyte cell 
death, the regions were compared for each condition, (CC figures 6.13A, C, E 
and G, DG figures 6.13B, D, F and H) over time (figures 6.11A and B) and at 
selected time points (figures 6.13C-H). In CC, the results demonstrate that 
inhibition of NKCC1 with bumetanide had the greatest effect on OGD induced 
astrocyte cell death (figure 6.13A). The presence of bumetanide significantly 
increased CC cell death after 60 minutes OGD from 23.11 ± 7.12% to 73.35 ± 
5.60% (p=<0.0001, figure 6.13 E). Throughout the reperfusion period cell death 
was increased, this increase remained at the end of the experiment (figure 
6.13G). The addition of DIOA, to inhibit KCC, increased OGD induced cell death 
but to a lesser extent than in the presence of bumetanide. After 30 minutes of 
OGD, astrocyte death was increased from 0% to 10.91 ± 2.16% (p=<0.0001) 
and after 60 minutes OGD, DIOA increased cell death from 23.11 ± 7.12% to 
55.08 ± 4.67%, (p=0.0044, figures 6.13C and E). These results suggest that the 
inhibition of KCC increased sensitivity to ischaemic insult in CC astrocytes. The 
other inhibitors used did not significantly affect OGD induced astrocyte cell 
death. The data indicate that NKCC1 acts as an important protector of 
astrocytes in adult WM, which largely accounts for the ischaemia tolerance of 
these cells. 
The inhibition of NKCC1 did not affect OGD induced cell death in DG, 
where astrocytes behaved in a similar manner to those under OGD only 
conditions (figure 6.13B). In this region the most significant decrease in OGD 
induced cell death was seen in sodium free conditions, this reduced DG 
astrocyte sensitivity to OGD. After 60 minutes of insult, cell death dropped from 
81.61 ± 7.66% to 19.02 ± 4.17% with the absence of sodium (p=<0.0001, figure 
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6.13F). The reduction in cell death was maintained throughout the reperfusion 
period (p=<0.0001, figure 6.13H). The only other inhibitor which delayed cell 
death was furosemide (figure 6.13B). The CCC inhibitor did reduce cell death at 
each time point, however, this was not significant (figure 6.13D, F and H). The 
DG is very sensitive to OGD and widespread cell death is seen in this region, 
which limits the detection of increased sensitivity to OGD induced injury. The 
absence of any significant effect of drugs upon the rate of astrocyte cell death 
during OGD argue against a role for any of the CCC in the reduction of injury in 
this cell population. 
Sodium free conditions applied during OGD had a highly protective effect 
on DG astrocytes suggesting ischaemic cell death in GM is sodium dependent, 
whereas in CC sodium removal had little effect. The findings highlight the 






Figure 6.13: Comparison of sodium transporter inhibition. A + B: Cell death over 
time with OGD only and for each inhibitor. C + D: Astrocyte cell death after 30 
minutes OGD for each inhibitor. E + F: Astrocyte cell death after 60 minutes 
OGD for each inhibitor, G + H: Total astrocyte cell death after reperfusion 
period. A, C, E + G: CC, B, D, F + H: DG. Error bars = SEM. Comparison via 
ANOVA, inhibitors compared to OGD.  
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6.7 DISCUSSION: SODIUM AND CCCS IN OGD INDUCED ASTROCYTE CELL 
DEATH 
Previously, it was established that ischaemic insult causes cytotoxic cell 
swelling and astrocyte death, which is thought to be mediated by CCCs such as 
NKCC1, and that ischaemic injury is sodium dependent (Thomas et al., 2004). 
My data shows that this picture is too simplistic and that cellular mechanism of 
acute ischaemic injury differ significantly between astrocyte populations. During 
ischaemia, intracellular accumulation of sodium ions is accompanied by chloride 
and potassium ion influx, triggering water uptake and increase in cell volume 
(Su et al., 2002; Su, Kintner & Sun, 2002). Under normal, physiological 
conditions this would be rectified via ion redistribution or regulated volume 
decrease. Ischaemia induced cell swelling cannot be corrected due to reduced 
energy availability and the disruption of ion gradients, thus active volume 
regulation is not an option. The increased astrocyte volume strains the cell 
membrane, leading to the eventual loss of membrane integrity and cell rupture 
(Gurer et al., 2009). My data shows that acute injury is not prevented by 
removing extracellular calcium indicating that this is not a form of the calcium-
mediated injury that underlies neuron and oligodendrocyte cell death. Prior work 
has shown that zero-calcium conditions can exacerbate cytotoxic cell swelling in 
astrocytes (Thomas et al., 2004), which is consistent with my findings.  
6.7.1 DG OGD induced astrocyte cell death is sodium dependent 
The data in this chapter show that in the DG, OGD induced astrocyte cell 
death is sodium dependent, confirming the findings of Thomas et al. (2004) in 
the neonatal optic nerve. In the DG, the replacement of sodium was highly 
protective and the resulting OGD tolerance of cells was similar to that of WM 
astrocytes (figure 6.4). Astrocyte cell death in DG was reduced with the non-
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specific inhibition of CCCs with furosemide (figure 6.12) but the selective 
inhibition of NKCC1 and KCC did not affect DG astrocyte cell death. The data 
suggest that cytotoxic sodium influx during OGD occurs via a different route. It is 
possible that an alternative pathway for sodium influx is via activated glutamate 
receptors, which are known to be permeable to a variety of ions including 
sodium (Dzamba, Honsa & Anderova, 2013; Lalo et al., 2011).  
The hippocampus is a region of high neuronal activity and so the majority 
of hippocampal astrocytes will have processes that interact with synapses. 
These perisynaptic processes are rich in ionotropic glutamate receptors, CCCs 
and other sodium transporters. The presence of a variety of different channels 
on astrocyte perisynaptic processes provides sodium with many routes of entry, 
all of which may contribute to ischaemic cell death. The data suggest a 
furosemide sensitive but bumetanide and DIOA insensitive transporter, such as 
an anion exchanger may be important for DG astrocyte injury. This would 
indicate that the sodium and furosemide sensitive injury occur via parallel 
pathways. 
6.7.2 NKCC1 and KCC are required for CC astrocyte survival 
In CC, ischaemia induced cell death was not prevented by the absence 
of sodium, indicating a fundamentally different mode of injury to that in DG cells. 
The selective and general inhibition of CCCs gave differing results for each 
region investigated. Indicating that the roles of particular transporters depend 
upon the location of astrocytes and the levels of expression. This work has 
determined that in CC, NKCC1 and KCC are important for protecting astrocytes 
from ischaemic injury. The inhibition of these transporters caused significantly 
higher cell death in WM (figures 6.5 and 6.9). This finding is contrary to previous 
work where bumetanide provided protection to neonatal (P10) optic nerve 
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astrocytes during OGD (Salter & Fern, 2008; Thomas et al., 2004). This 
suggests that in the adult brain there may be different cell death mechanisms 
that are both region and development specific. The inhibition of KCC with DIOA 
increased CC astrocyte cell death but not to the extent seen with bumetanide 
treatment. It has been found that the inhibition of KCC increased cell swelling 
under physiological conditions (Ringel & Plesnila, 2008).  
The ischaemia induced sodium influx does not affect CC astrocytes to 
the same extent as DG astrocytes, showing regional differences in the cell 
death mechanism. The transporter inhibition did not prevent or reduce OGD 
induced astrocyte death in CC, whereas DG astrocyte death was reduced with 
the removal of sodium and in the presence of furosemide. The tolerance to 
OGD seen in CC astrocytes may result from the partial extrusion of any sodium 
influx. Alternatively, the OGD induced cell death that is observed may arise from 
the influx of another ion such as potassium. Potassium is also dysregulated 
during ischaemia and has been found to trigger cell swelling (Su, Kintner & Sun, 
2002). 
6.7.3 Sodium, CCCs and OGD induced astrocyte cell death 
The ischaemia induced sodium influx has been found to be detrimental to 
DG astrocytes but not CC astrocytes. Suggesting that different mechanisms of 
cell death exist for different astrocyte populations. The role of sodium 
transporters such as CCCs has also been found to differ depending upon 
region. The specific inhibition of CCCs was harmful to CC astrocytes, whereas 
CCC inhibition in DG astrocytes was protective. This conflicting effect 
demonstrates the difference in cell death mechanisms between regions and 
suggests that cytotoxic sodium influx is a significant cell death mechanism in 
GM. Here the levels of cell death have been manipulated to behave like those in 
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alternative locations (WM), through the removal of sodium and CCC inhibition. 
The difference seen in the involvement of CCCs may be due to differing 
expression levels of these transporters between regions. There is widespread 
expression of KCCs and NKCC1. Generally, the astrocyte expression of NKCC1 
peaks at approximately P21 and the level is constant throughout adulthood, this 
is so for regions including cortex, corpus callosum and hippocampus (Yan, 
Dempsey & Sun, 2001a). However, the authors suggested that there may be 
lower expression levels in the hippocampus compared to other regions. There is 
evidence to indicate that during ischaemia CCCs remain active and there is an 
increased expression of NKCC1 (Yan, Dempsey & Sun, 2001b). Therefore in 
cells with a higher tolerance to ischaemia the transporters will function to regain 
ionic balance and so the inhibition of the transporters will result in detrimental 
injury to cells.   
The use of sodium free aCSF does not only prevent the action of CCCs 
but inhibits other sodium transporters such as NHE, NCX and NKA. These 
transporters have also been implicated in ischaemic injury. In NHE null mice, 
astrocytes showed increased tolerance to ischaemic injury (Kintner et al., 2004). 
The inhibition of NCX reverse activity was found to attenuate ischaemic 
astrocyte injury (Matsuda et al., 2001). Even though there is astrocyte 
expression of NKA, during ischaemia it is unable to function (Pimentel et al., 
2013). The NHE and NCX are involved in the dysregulation of ion homeostasis 
during ischaemic insult (Boscia et al., 2016). It is possible that one of these 
transporters has a greater effect on astrocyte cell death, however further 
investigation into this is required. Alternatively, cytotoxic influx may occur 
through different, as yet unknown channels and may occur through the entry of 
a different ion entirely. Sodium is not the only ion which has been implicated in 
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cell swelling. Increases in extracellular potassium have been found to trigger 
cell swelling, most likely via NKCC1 but also other transporters (Su et al., 2002; 
Su, Kintner & Sun, 2002). 
Overall this chapter has determined that in DG, astrocyte ischaemic cell 
death is caused by cytotoxic influx of sodium. Whereas in CC, CCCs appear to 
have a beneficial role during ischaemia and cell death is not the result of 
cytotoxic sodium influx but by another mechanism. Further investigation is 
















Ischaemic stroke is a leading cause of death and disability worldwide 
(WHO, 2014). There has been little change in therapeutic strategy since the 
development of tissue plasminogen activator (tPA) and other thrombolytic 
treatments (Christophe et al., 2017; National Institute of Neurological & Stroke 
rt, 1995). The nature of ischaemic injury means that prophylactic treatments 
would be difficult to administer and so the emphasis is on enabling fast recovery 
and the repair of damaged tissue.  
For many years ischaemia research has focussed on the effect that the 
injury has on neurons, even though all CNS cell types are affected by ischaemic 
insult. Recently, the effect of ischaemia on glial cells has been investigated, this 
has been triggered by the discovery of the important role that glial cells have in 
the CNS. Oligodendrocytes are required to myelinate neuronal axons, allowing 
fast signal conduction to occur, and to metabolically support axons (Morrison, 
Lee & Rothstein, 2013; Saab, Tzvetanova & Nave, 2013). Astrocytes have a 
large and varied role within the CNS, providing support both directly and 
indirectly to neurons. One major function of astrocytes is the homeostatic 
maintenance of the ECS and ionic gradients (Bushong et al., 2002; Deitmer & 
Rose, 1996; Rothstein et al., 1996; Yao et al., 2008), both of which are severely 
disrupted during ischaemic insult. 
This thesis aimed to determine whether astrocyte tolerance to acute 
ischaemia varied between astrocyte populations located in different regions in 
the mature CNS. Once the existence of regional astrocyte sensitivity to OGD 
was established, the mechanism behind the differences in tolerance was 
investigated. The mechanisms examined were based upon previous work by the 
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group and included the role of glycogen, the involvement of GluRs and sodium 
influx, the results of which are discussed below. 
Regional sensitivity to ischaemic injury has been previously established in 
neuronal populations (Pulsinelli, Brierley & Plum, 1982). This shows the 
existence of CNS regional differences to injury and so would suggest that 
astrocyte populations may also display regional differences to injury. This thesis 
has shown that astrocyte populations also have different sensitivities to 
ischaemia depending on their physical location (figure 3.16). It was determined 
that WM astrocytes were generally more tolerant to OGD than GM astrocytes, 
which confirms and agrees with findings in the literature (Lukaszevicz et al., 
2002; Xu, Sapolsky & Giffard, 2001). Variation in sensitivity to ischaemia was 
observed between WM astrocyte populations. The DG was found to contain the 
most sensitive astrocytes whereas the most tolerant were in the CC (figures 
3.16 and 3.17). Investigation into the sensitivity of neonatal (P10) astrocytes 
found that they expressed a similar pattern of tolerance to the adult cells. This 
indicates that neonatal astrocytes also show regional sensitivity to OGD and this 
phenomenon is not restricted to adult cells. 
Previous studies have found that immature oligodendroglia are very 
sensitive to ischaemic injury (Salter & Fern, 2005; Salter & Fern, 2008). 
However, in this work it has been determined that mature oligodendrocytes cell 
bodies in the adult CNS are very tolerant to acute ischaemic injury (figure 3.22), 
which is contrary to the view taken in the literature. Studies that have reported 
oligodendrocyte sensitivity examine cell death after OGD and long periods of 
reperfusion. Cell death occurs after the re-introduction of physiological 
conditions, widespread oligodendrocyte cell death has been reported nine hours 
after ischaemic insult (Mifsud et al., 2014). The evidence in the literature 
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suggests that the majority of ischaemic oligodendrocyte cell death may be due 
to sensitivity to reperfusion injury and the production of ROS and subsequent 
oxidative stress (Juurlink & Sweeney, 1997). These findings also illustrate that 
astrocytes are much more sensitive to insult than oligodendrocytes (figure 3.23). 
During this work the criteria used to determine oligodendrocyte cell death was 
the same as for astrocytes. Using this method cell death was not seen, however 
this did not account for any damage that may have occurred to oligodendrocyte 
processes. The effect of ischaemia and other diseases on oligodendrocyte 
processes and myelin is currently being investigated by the group and others 
such as the Stys group. 
The mechanisms behind the observed regional differences in astrocyte 
sensitivity to ischaemia were then investigated, beginning with the role of 
glycogen. Astrocytes contain the major glycogen stores in the brain and these 
stores can be utilized during times of decreased energy supply or high neuronal 
activity. Glycogen has been found to be involved in many processes including 
memory consolidation (Gibbs, Anderson & Hertz, 2006). The breakdown of 
glycogen results in the production of lactate which may be exported as a 
possible metabolite source for neurons (Pellerin et al., 1998). Previous work has 
found that intact glycogen stores conferred tolerance to astrocytes during 
ischaemic insult in neonatal (P0-2) optic nerves (Fern, 2015), suggesting that 
these stores may have a prominent role in protecting astrocytes during insult. 
This work has confirmed that the presence of large molecule glycogen 
stores provides astrocyte resistance to OGD (chapter 4). The inhibition of 
glycogen stores increased astrocyte cell death in CC. The lack of access to 
glycogen stores caused CC astrocytes to become more sensitive to ischaemic 
injury as cell death was increased during the OGD period. This suggests that 
244 
 
during ischaemia CC astrocytes are able to metabolise glycogen for a limited 
time before the cells are affected by OGD. 
Investigation into glycogen content found that DG astrocytes contained 
higher levels of glycogen than CC astrocytes (figure 4.18).This finding agrees 
with the literature, where higher levels of glycogen in the DG have been found 
by Oe et al (2016) and suggests that glycogen stores are important and 
necessary to this region. Although the DG contained higher levels of glycogen 
this did not confer resistance or protection from ischaemic injury. This may be 
due to an inability to utilize the glycogen stores before cell death occurs as 
astrocytes in this regions are very sensitive to insult. The hippocampus is a 
region of high neuronal activity that requires vast amounts of energy, a 
proportion of this demand is met by the utilization of glycogen stores. It has also 
been discovered that there are times when glycogen is the preferred substrate, 
such as the synthesis of glutamate precursors (Gibbs et al., 2007).  
The inhibition of glycogen stores had no effect on oligodendrocyte cell 
death, which suggests that astrocyte glycogen does not have a role in 
oligodendrocyte tolerance to ischaemia. The death of astrocytes does not 
appear to affect oligodendrocytes, showing that astrocyte sensitivity to 
ischaemia does not affect oligodendrocytes. This also indicates that there are 
different mechanisms of cell death for astrocytes and oligodendrocytes. 
Next the role of glutamate receptors as a potential mechanism of astrocyte 
cell death was investigated. Glutamate and glutamate receptors (GluRs) are 
responsible for ischaemia induced neuronal cell death via the process of 
excitotoxicity (Coyle et al., 1981; Lucas & Newhouse, 1957; Pulsinelli, Sarokin & 
Buchan, 1993). It is widely accepted that astrocytes are resistant to 
excitotoxicity and so ischaemic astrocyte cell death must be caused via a 
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separate mechanism. However, oligodendrocytes are susceptible to 
excitotoxicity, which triggers cytotoxic calcium influx. It has been determined 
that different glutamate receptors may mediate injury for processes and cell 
soma (Salter & Fern, 2005). NMDA receptors were found to contribute to 
oligodendrocyte process damage, whereas AMPA receptors were found to be 
expressed on cell somas and have been implicated in cell body injury (Salter & 
Fern, 2005). This work partly informed the investigation into the role of 
glutamate receptors in OGD induced astrocyte cell death. 
Here it has been established that ischaemia induced cell death in adult 
astrocytes occurs in a calcium independent manner. When external calcium 
was removed, the amount OGD induced cell death was increased in CC and the 
rate of cell death was increased in both regions (figures 5.1 and 5.2). Thus, 
suggesting that calcium influx, as a result of excitotoxicity, does not cause 
ischaemic astrocyte cell death. Although we have shown that external calcium is 
not required for OGD induced astrocyte death, it cannot be dismissed that 
calcium release from internal stores may have a role in ischaemic astrocyte 
death. The increase in astrocyte death caused by calcium removal may also 
have been due to the fact that reduced calcium conditions are detrimental to 
cells. This has been previously reported by Thomas et al (2004) and Salter and 
Fern (2008). 
Investigation into the role of GluRs revealed that inhibition of NMDA 
receptors caused increased cell death, suggesting a role for activated AMPA 
receptors in astrocyte cell death (figure 5.8).It has been suggested that NMDA 
receptors are involved in cell survival signalling (Ikonomidou, Stefovska & 
Turski, 2000; Papadia et al., 2005; Soriano & Hardingham, 2007; Tashiro et al., 
2006) and so inhibition of these receptors may prevent these signals, thereby 
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increasing astrocyte death. The inhibition of GluRs in conjunction with cobalt 
staining illustrated that cations are able to enter cells via activated GluRs and 
that this provides a route for cytotoxic ion influx (figure 5.11). Ischaemia induced 
cell death may occur via cytotoxic influx of ions, just not by the influx of external 
calcium. GluR pores are permeable to different ions and those expressed by 
glia have been found to have low permeability to calcium and have been found 
to be permeable to other ions such as sodium (Palygin et al., 2010). 
The final mechanism of ischaemia induced astrocyte cell death to be 
investigated was the role of sodium. Under physiological conditions increases in 
intracellular sodium cause astrocyte swelling. These normal increases in cell 
volume can be corrected via regulated volume decrease (Brookes, 2005). 
During ischaemia, cytotoxic cell swelling is a prominent event, leading to 
extensive astrocyte cell death. Previous work had suggested that during 
ischaemia, astrocyte injury was mediated by sodium influx in P10 ON (Thomas 
et al., 2004). Here we have shown that sodium free conditions were protective 
for DG astrocytes but were not beneficial for the CC population (figures 6.3 and 
6.4). These results indicate that for GM astrocyte sodium mediated cell death is 
an important mechanism. 
Investigation into the role of the CCCs, specifically NKCC1 and KCC found 
that the roles for these transporters varied between the CC and DG. Individually, 
it would appear that these transporters have a somewhat protective role for CC 
astrocytes, as their inhibition increased cell death. However, this finding is 
contrary to what has previously been shown, although in other work the focus 
was reducing the size of infarct and not cell death such as Su et al (2002a). 
Thomas et al (2004) did investigate astrocyte death, however this was only in 
neonatal optic nerve. The only protective effect on DG astrocytes was seen 
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when all CCCs were inhibited, which decreased cell death (figure 6.13). These 
results suggest that whilst there is a role for CCCs in DG astrocyte cell death, 
that NKCC1 and KCC may not be the only transporters involved. Their inhibition 
did not prevent cell death to the same extent as sodium free conditions, 
indicating that other sodium channels and transporters could contribute to 
sodium influx. The difference seen between the regions may be due to variation 
in expression levels across regions. Yan et al (2001 a and b) suggested there is 
lower NKCC1 expression in the hippocampus. Cytotoxic sodium influx may also 
occur via over-activated GluRs which show permeability to a variety of ions. 
Injury in the CC may be due to increases in a different ion such as 
potassium or that other transporters are involved in cytotoxic ion influx such as 
NHE and NCX both of which can also function in a reverse mode. It is possible 
that ischaemia induced astrocyte cell death occurs as the result of a different 
mechanism such as acidification. Astrocyte acidosis is thought to arise from 
accumulation of lactate production from the anaerobic glycolysis of glycogen 
(Verkhratsky & Parpura, 2015). 
7.1 FINAL CONCLUSIONS 
Overall this work has shown that different mature astrocyte populations 
display different sensitivities to ischaemic insult depending on their physical 
location. It was determined that GM astrocytes are more sensitive to injury than 
WM astrocytes. Significant variation was also observed within the WM astrocyte 
populations. The evidence gathered regarding astrocyte sensitivity to ischaemia 
agrees with what has been shown in the literature. Here it has also been 
established that mature oligodendrocytes are tolerant to acute ischaemic insult, 
although their processes may show more sensitivity to injury. Ischaemic infarcts 
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involve all cell types and often affect multiple regions and so by understanding 
how these cells react to injury may allow the development of new therapeutic 
strategies. 
Investigation into three possible cell death mechanisms has found 
significant differences between regions. The presence of glycogen had a 
greater protective effect in CC astrocytes compared to DG cells. In both regions 
OGD induced astrocyte cell death occurs independently of calcium. Astrocytes 
in both regions displayed sensitivity to cytotoxic ion influx via AMPA receptors. 
Astrocyte cell death in the DG is mediated by sodium influx, however it is 
unknown through which transporters sodium influx occurs. Although it has been 
confirmed that cation entry can occur through activated glutamate receptors. 
Sodium does not mediate ischaemic astrocyte death in CC and cell death in this 
region may be the result of cytotoxic influx of a different ion, however CCCs 
were found to have a beneficial role during ischaemia.  
The investigation into the role of glycogen stores has found that glycogen 
has an important role in the protection of CC astrocytes from ischaemic insult, 
however the increased levels of glycogen seen in DG did not confer protection 
to DG astrocytes. The regional variations in glycogen levels seen here agree 
with findings from Oe et al (2016). It is possible that CC astrocytes are able to 
metabolise glycogen for a limited time before the consequences of OGD fully 
take effect. The potential use of glycogen by astrocytes during insult requires 
further investigation to understand how glycogen attenuates injury and 
ultimately protects cells. 
Currently the field is analysing transcriptomes and proteomes to determine 
differences in expression between physiological and ischaemic states. Changes 
in protein expression may provide clues for the mechanism of cell death or 
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highlight targets for developing treatments against ischaemic cell death. A 
recent study by Rakers et al (2019) has found an increase in STAT3 during 
ischaemia, which is involved in triggering apoptosis. The absence of STAT3 
caused a reduction in stroke volume and prevented apoptosis (Rakers et al., 
2019). This study is also part of the work being carried out into the prevention of 
astrocyte programmed cell death, with a focus on death signalling pathways 
during ischaemia. Other pathways that are being investigated are the NF-κB 
signalling pathway (Zhang et al., 2018), p38-MAPK signalling (Zhang et al., 
2019) and phospholipase C pathway (Roque, Mendes-Oliveira & Baltazar, 
2019), by preventing these pathways cell death was reduced  The inhibition of 
AQP4 and connexin hemi-channels has been shown to attenuate cell death 
(Zheng et al., 2019) and protect against reperfusion injury (Chen et al., 2018), 
the research focus being ion and water movement. Similar to the work in this 
thesis on CCCs, recently a role for transient receptor potential (TRP) channels 
in stroke has emerged. These channels are non-specific cation channels which 
have permeability to calcium and sodium (Gees, Colsoul & Nilius, 2010). TRP 
channels have been found to be involved in apoptosis (Chen et al., 2017) and 
can determine the size of ischaemic infarct (Miyanohara et al., 2015). 
This work has indicated that CC astrocytes benefit from having access to 
glycogen stores, functioning NMDA receptors and CCCs. These conditions 
enable CC astrocytes to show tolerance to ischaemia. Whereas, DG astrocytes 
show tolerance to insult in the absence of sodium and access to large glycogen 
stores did not enable cells to survive ischaemia. Investigation into the role of 
glutamate receptors in astrocyte injury has found that ischaemia induced 
astrocyte death may be in part mediated by AMPA receptors, providing insight 
into ischaemic cell death. This mechanism of cell death may be similar to the 
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oligodendrocyte soma injury mechanism suggested by Salter and Fern (2005). 
These findings contribute to our knowledge of potential necrotic astrocyte death 
mechanisms induced by ischaemia. The discovery of how ischaemic cell death 
occurs may help to develop treatments which can then prevent cell death, which 
is also being investigated via cell death signalling pathways. 
7.2 FUTURE WORK 
In regards to the work into astrocyte sensitivity it would be interesting to 
expand this into other adult brain regions and build a map of astrocyte sensitivity 
to acute ischaemic insult. Further investigation into neonate regional astrocyte 
sensitivity would reveal whether the pattern of sensitivity is the same as for the 
adult astrocytes. Differences in sensitivity may show the presence of alternative 
cell death mechanisms and age-related changes to astrocytes. To ensure 
astrocyte cell death is occurring immunofluorescence staining for the presence 
of cell death factors such as caspases could also be carried out.  
To confirm findings of adult astrocyte sensitivity, the experiment could be 
transferred to an in vivo model. The use of a focal model of ischaemia would 
also allow investigation into the effect of ischaemia on penumbral astrocytes. 
This could be used to observe any potential regional differences between this 
population of astrocytes. The effect of astrocyte cell death on neuronal function 
and survival  
The role of glycogen during acute ischaemia could also be expanded by 
investigating more regions. It would also be interesting to establish whether 
glycogen store block effects neonatal astrocytes to the same extent as in adult 
astrocytes. During this work IA (sodium iodoacetate) was only used to prevent 
access to glycogen stores in astrocytes, it would be useful to repeat this but see 
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if there is an effect on oligodendrocytes. The ability to access glycogen stores 
effects astrocyte survival, it would be useful to determine whether these stores 
also have an effect on neuronal survival. 
Further work is required to fully establish the role of cytotoxic ion influx in 
acute ischaemic injury. This could be achieved by developing a co-staining 
method to determine the role and location of AMPA receptors. The potential role 
of other sodium transporters needs to be determined such as NHE and NBC; as 
well as the possible role of other ions in cytotoxic influx such as potassium. 
Recently TRP channels have been implicated in ischaemia and have been 
found to be expressed by glial cells. Using our model of ischaemia it would be 
interesting to inhibit these channels and observe the effect on ischaemic 
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